Pamidronic acid
     RDKit          3D

 13 12  0  0  1  0  0  0  0  0999 V2000
    0.3155    1.6963   -0.1168 P   0  0  0  0  0  5  0  0  0  0  0  0
    0.9649   -1.4698   -0.2386 P   0  0  1  0  0  5  0  0  0  0  0  0
    0.6826    0.0622    1.8028 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9111    1.9173    0.0252 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1114    1.5590   -1.7135 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5002   -0.9612   -0.0306 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5305    2.7412    0.5479 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6494   -1.5201   -1.7161 O   0  0  0  0  0  1  0  0  0  0  0  0
    0.7216   -2.6566    0.6669 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6903   -0.6459   -0.0552 N   0  0  0  0  0  4  0  0  0  0  0  0
    0.0655   -0.0029    0.5073 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.4210   -0.3027    0.7842 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2804   -0.4167   -0.4637 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1  5  1  0
  1  7  2  0
  1 11  1  0
  2  6  1  6
  2  8  1  0
  2  9  2  0
  2 11  1  0
 11  3  1  1
 10 13  1  0
 11 12  1  0
 12 13  1  0
M  CHG  2   8  -1  10   1
M  END
>  <InChIKey>  (1) 
WRUUGTRCQOWXEG-UHFFFAOYSA-N

>  <PubChem_CID>  (1) 
44400012

>  <BOM_1A2>  (1) 


>  <BOM_2A6>  (1) 


>  <BOM_2B6>  (1) 


>  <BOM_2C8>  (1) 


>  <BOM_2C9>  (1) 


>  <BOM_2C19>  (1) 


>  <BOM_2D6>  (1) 


>  <BOM_2E1>  (1) 


>  <BOM_3A4>  (1) 


>  <References>  (1) 
FDA Approved Drug Products: Aredia Pamidronate Intravenous Injection

>  <FLAG_COMMENTS>  (1) 
Pamidronate is not metabolized in vivo.

>  <ID>  (1) 
Pamidronic acid

>  <Comment>  (1) 


>  <smile>  (1) 
[NH3+]CC[C@](O)(P(=O)(O)O)[P@@](=O)([O-])O

$$$$
Aminophenazone
     RDKit          3D

 17 18  0  0  1  0  0  0  0  0999 V2000
    0.6350   -2.0085    0.3333 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3248    1.4319    0.0412 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2845    0.1800    0.2138 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1629   -0.7792   -0.1850 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6810    1.2032   -0.1795 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0050   -0.0945   -0.0789 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7173   -0.7962    0.2137 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6773   -0.0370    0.0657 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6223    2.3307   -0.4419 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1217    2.5440    0.8744 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3022   -0.5171    0.6985 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2786   -1.9848   -1.0101 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2551   -1.2306    0.5097 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4840    0.9409   -0.5247 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6259   -1.4443    0.3645 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8548    0.7271   -0.6698 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4257   -0.4655   -0.2251 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  2  0
  2  3  1  0
  2  5  1  0
  2 10  1  0
  3  7  1  0
  3  8  1  0
  4  6  1  0
  4 11  1  0
  4 12  1  0
  5  6  2  0
  5  9  1  0
  6  7  1  0
  8 13  2  0
  8 14  1  0
 13 15  1  0
 14 16  2  0
 15 17  2  0
 16 17  1  0
M  END
>  <InChIKey>  (2) 
RMMXTBMQSGEXHJ-UHFFFAOYSA-N

>  <PubChem_CID>  (2) 
6009

>  <BOM_1A2>  (2) 
<12,4;Dealkylation;R1><12,H;Dealkylation;R1>/<11,4;Dealkylation;R1><11,H;Dealkylation;R1>
<10,2;Dealkylation;R2><10,H;Dealkylation;R2>

>  <BOM_2A6>  (2) 


>  <BOM_2B6>  (2) 


>  <BOM_2C8>  (2) 
<12,4;Dealkylation;R1><12,H;Dealkylation;R1>/<11,4;Dealkylation;R1><11,H;Dealkylation;R1>
<10,2;Dealkylation;R2><10,H;Dealkylation;R2>

>  <BOM_2C9>  (2) 
<12,4;Dealkylation;R1><12,H;Dealkylation;R1>/<11,4;Dealkylation;R1><11,H;Dealkylation;R1>

>  <BOM_2C19>  (2) 
<12,4;Dealkylation;R1><12,H;Dealkylation;R1>/<11,4;Dealkylation;R1><11,H;Dealkylation;R1>
<10,2;Dealkylation;R2><10,H;Dealkylation;R2>

>  <BOM_2D6>  (2) 
<12,4;Dealkylation;R1><12,H;Dealkylation;R1>/<11,4;Dealkylation;R1><11,H;Dealkylation;R1>
<10,2;Dealkylation;R2><10,H;Dealkylation;R2>

>  <BOM_2E1>  (2) 


>  <BOM_3A4>  (2) 
<12,4;Dealkylation;R1><12,H;Dealkylation;R1>/<11,4;Dealkylation;R1><11,H;Dealkylation;R1>

>  <References>  (2) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742 .

>  <FLAG_COMMENTS>  (2) 


>  <ID>  (2) 
Aminophenazone

>  <Comment>  (2) 


>  <smile>  (2) 
Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C

$$$$
Metolazone
     RDKit          3D

 24 26  0  0  1  0  0  0  0  0999 V2000
   -4.7772    1.7921    0.7310 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.4850   -1.2855   -0.2154 S   0  0  0  0  0  6  0  0  0  0  0  0
    0.7238   -1.7093   -0.6592 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6289   -0.4202   -0.4879 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0731   -2.2921   -1.1877 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7379    0.3733   -0.2363 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2858    2.2204    0.3224 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7755   -2.0739    1.2846 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5082    1.8271   -0.3578 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.8286    1.4068    0.2088 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7035    0.0683   -0.1797 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6502   -0.5134   -0.3866 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0940   -0.1162   -0.1002 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4393    2.2768   -1.8212 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8383   -0.7441   -0.3085 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1050    1.9077    0.4992 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1026   -0.2233   -0.0376 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6252   -0.3942    1.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2360    1.1002    0.3719 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8601   -0.3049   -1.2469 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9336   -0.8646    1.2665 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8216   -0.1997    2.4007 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1684   -0.7757   -1.1364 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7054   -1.0554    0.1203 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 19  1  0
  2  4  2  0
  2  5  2  0
  2  8  1  0
  2 17  1  0
  3 12  2  0
  6  9  1  0
  6 12  1  0
  6 13  1  0
  7  9  1  0
  7 10  1  0
  9 14  1  6
 10 11  2  0
 10 16  1  0
 11 12  1  0
 11 15  1  0
 13 18  2  0
 13 20  1  0
 15 17  2  0
 16 19  2  0
 17 19  1  0
 18 21  1  0
 18 22  1  0
 20 23  2  0
 21 24  2  0
 23 24  1  0
M  END
>  <InChIKey>  (3) 
AQCHWTWZEMGIFD-UHFFFAOYSA-N

>  <PubChem_CID>  (3) 
4170

>  <BOM_1A2>  (3) 


>  <BOM_2A6>  (3) 


>  <BOM_2B6>  (3) 


>  <BOM_2C8>  (3) 


>  <BOM_2C9>  (3) 


>  <BOM_2C19>  (3) 


>  <BOM_2D6>  (3) 


>  <BOM_2E1>  (3) 


>  <BOM_3A4>  (3) 


>  <References>  (3) 
Lowenthal, D. T., & Shear, L. (1973). Use of a new diuretic agent (metolazone) in patients with edema and ascites. Archives of Internal Medicine, 132(1), 38-41.

>  <FLAG_COMMENTS>  (3) 
Not substantially metabolized. 70-95% is excreted unchanged in urine via glomerular filtration and active tubular secretion. Undergoes enterohepatic recycling.

>  <ID>  (3) 
Metolazone

>  <Comment>  (3) 


>  <smile>  (3) 
Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N[C@@H]1C

$$$$
Enmetazobactam
     RDKit          3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    2.2106   -0.5497    1.1083 S   0  0  0  0  0  6  0  0  0  0  0  0
    3.0070   -1.7139    0.7652 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1704   -0.0808    2.4804 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2575    2.9919   -0.4002 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9908   -1.5521   -1.9213 O   0  0  0  0  0  1  0  0  0  0  0  0
    0.0127   -1.0589   -2.9598 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4294    0.9716   -0.7191 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8668   -0.2140    0.9706 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3493    0.7827    0.1924 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5817    0.3879   -0.0651 N   0  0  0  0  0  4  0  0  0  0  0  0
    0.4833   -0.8188    0.5017 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.6842    0.7925    0.0183 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.4676   -0.1024   -0.8646 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5391    2.2538    0.4707 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2023    2.2438   -0.2927 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5091   -0.1538    1.4748 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1651   -2.3172    0.4389 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8645   -0.9929   -2.0295 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7854   -1.2131    1.1937 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9117   -0.8172    0.5134 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4805    1.1605   -0.8762 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  2  0
  1 11  1  0
  1 12  1  0
  4 15  2  0
  5 18  1  0
  6 18  2  0
  7 12  1  0
  7 13  1  0
  7 15  1  0
  8  9  1  0
  8 16  1  0
  8 19  1  0
  9 10  2  0
 10 20  1  0
 10 21  1  0
 11 13  1  0
 11 16  1  0
 11 17  1  6
 12 14  1  1
 13 18  1  6
 14 15  1  0
 19 20  2  0
M  CHG  2   5  -1  10   1
M  END
>  <InChIKey>  (4) 
HFZITXBUTWITPT-YWVKMMECSA-N

>  <PubChem_CID>  (4) 
23653540

>  <BOM_1A2>  (4) 


>  <BOM_2A6>  (4) 


>  <BOM_2B6>  (4) 


>  <BOM_2C8>  (4) 


>  <BOM_2C9>  (4) 


>  <BOM_2C19>  (4) 


>  <BOM_2D6>  (4) 


>  <BOM_2E1>  (4) 


>  <BOM_3A4>  (4) 


>  <References>  (4) 
FDA Approved Drug Products: EXBLIFEP (cefepime and enmetazobactam) for injection, for intravenous use

>  <FLAG_COMMENTS>  (4) 
Enmetazobactam is minimally metabolized.

>  <ID>  (4) 
Enmetazobactam

>  <Comment>  (4) 


>  <smile>  (4) 
C[n+]1ccn(C[C@@]2(C)[C@H](C(=O)[O-])N3C(=O)C[C@H]3S2(=O)=O)n1

$$$$
Dacomitinib
     RDKit          3D

 33 36  0  0  0  0  0  0  0  0999 V2000
    5.9098   -3.3062   -2.2272 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.5766   -5.1815    0.0447 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3775   -0.2078    0.9376 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8637    4.5830   -0.7004 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2366   -1.4334    0.4361 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5516    2.0155    0.2023 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9296   -0.3623    0.7308 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7607    3.4664   -0.6025 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4907    1.2762    0.0884 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9447   -2.5471   -1.6577 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4419   -2.3724   -1.8438 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2870   -2.6743   -0.1775 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9037   -1.2299   -0.9808 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6904   -1.5225    0.6327 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6750   -0.3581    1.2533 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1811   -0.2995    1.1347 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5189    0.7935    0.7297 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0282    0.7878    0.6428 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2007    2.3890   -0.0036 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1368    1.8247    0.0456 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7934    1.4629    0.2474 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1066    3.6591   -0.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4792    3.1098   -0.4059 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1972    0.9522    0.2746 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4450    4.0112   -0.6463 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6017   -1.5821    0.5528 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6967    2.5306   -0.3442 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3383   -1.8170   -0.6121 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5390   -2.5702    1.5398 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2527    5.4251    0.3824 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0060   -3.0290   -0.7884 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2064   -3.7823    1.3633 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9400   -4.0116    0.1993 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 31  1  0
  2 33  1  0
  3 18  2  0
  4 22  1  0
  4 30  1  0
  5 13  1  0
  5 14  1  0
  5 15  1  0
  6 18  1  0
  6 19  1  0
  7 24  1  0
  7 26  1  0
  8 23  2  0
  8 27  1  0
  9 24  1  0
  9 27  2  0
 10 11  1  0
 10 12  1  0
 11 13  1  0
 12 14  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 21  2  0
 19 22  1  0
 20 21  1  0
 20 23  1  0
 20 24  2  0
 22 25  2  0
 23 25  1  0
 26 28  2  0
 26 29  1  0
 28 31  1  0
 29 32  2  0
 31 33  2  0
 32 33  1  0
M  END
>  <InChIKey>  (5) 
LVXJQMNHJWSHET-AATRIKPKSA-N

>  <PubChem_CID>  (5) 
11511120

>  <BOM_1A2>  (5) 


>  <BOM_2A6>  (5) 


>  <BOM_2B6>  (5) 


>  <BOM_2C8>  (5) 


>  <BOM_2C9>  (5) 
<30,4;Dealkylation;R1><30,H;Dealkylation;R1>

>  <BOM_2C19>  (5) 


>  <BOM_2D6>  (5) 
<30,4;Dealkylation;R1><30,H;Dealkylation;R1>

>  <BOM_2E1>  (5) 


>  <BOM_3A4>  (5) 


>  <References>  (5) 
Chen X, Jiang J, Giri N, Hu P: Phase 1 study to investigate the pharmacokinetic properties of dacomitinib in healthy adult Chinese subjects genotyped for CYP2D6. Xenobiotica. 2018 May;48(5):459-466. doi: 10.1080/00498254.2017.1342881. Epub 2017 Aug 18.
Sepulveda JM, Sanchez-Gomez P, Vaz Salgado MA, Gargini R, Balana C: Dacomitinib: an investigational drug for the treatment of glioblastoma. Expert Opin Investig Drugs. 2018 Oct;27(10):823-829. doi: 10.1080/13543784.2018.1528225. Epub 2018 Oct 5. 

>  <FLAG_COMMENTS>  (5) 


>  <ID>  (5) 
Dacomitinib

>  <Comment>  (5) 


>  <smile>  (5) 
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1

$$$$
Umeclidinium
     RDKit          3D

 32 36  0  0  0  0  0  0  0  0999 V2000
    3.6881    0.0012   -2.0558 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4049   -0.2330   -0.1517 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7663   -0.7693   -0.7796 N   0  0  2  0  0  4  0  0  0  0  0  0
    1.7740   -0.2546   -0.7135 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0142    0.8256   -1.5054 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1853   -0.3034    0.7087 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5052   -1.6137   -1.3858 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4843    0.5254   -1.5496 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3133   -0.6043    0.6752 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0085   -1.9233   -1.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2717    0.0488   -0.6746 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2569   -1.0712   -0.8185 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9958   -1.0493    0.1229 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6481    1.4429   -0.1461 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0140    0.0599   -0.1509 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3036   -2.2232   -0.5175 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6475    2.2486    0.3369 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3002   -0.8047    1.4383 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9677    1.8185   -0.1819 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9599   -3.2189    0.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9892    3.5133    0.8159 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9567   -1.8004    2.1617 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3093    3.0831    0.2973 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1555    0.7989    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2864   -3.0074    1.5456 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3202    3.9304    0.7960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6106    0.4342    0.4425 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3954    0.8264   -0.6363 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1612   -0.2932    1.4919 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7481    0.4872   -0.6659 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5139   -0.6324    1.4621 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3073   -0.2421    0.3832 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  2 15  1  0
  2 24  1  0
  3  8  1  0
  3  9  1  0
  3 10  1  0
  3 12  1  1
  4  5  1  0
  4  6  1  0
  4  7  1  0
  4 11  1  1
  5  8  1  0
  6  9  1  0
  7 10  1  0
 11 13  1  0
 11 14  1  0
 12 15  1  0
 13 16  2  0
 13 18  1  0
 14 17  2  0
 14 19  1  0
 16 20  1  0
 17 21  1  0
 18 22  2  0
 19 23  2  0
 20 25  2  0
 21 26  2  0
 22 25  1  0
 23 26  1  0
 24 27  1  0
 27 28  2  0
 27 29  1  0
 28 30  1  0
 29 31  2  0
 30 32  2  0
 31 32  1  0
M  CHG  1   3   1
M  END
>  <InChIKey>  (6) 
FVTWTVQXNAJTQP-UHFFFAOYSA-N

>  <PubChem_CID>  (6) 
11519070

>  <BOM_1A2>  (6) 


>  <BOM_2A6>  (6) 


>  <BOM_2B6>  (6) 


>  <BOM_2C8>  (6) 


>  <BOM_2C9>  (6) 


>  <BOM_2C19>  (6) 


>  <BOM_2D6>  (6) 
<2,24;Dealkylation;R1><24,H;Dealkylation;R1>
<32,H;Hydroxylation;R2>

>  <BOM_2E1>  (6) 


>  <BOM_3A4>  (6) 


>  <References>  (6) 
FDA Approved Drug Products: INCRUSE ELLIPTA (umeclidinium inhalation powder) for oral inhalation use
Gao H, Li J, Chen X, Sun Z, Cui G, Cheng M, Ding L: Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects. Front Pharmacol. 2022 Dec 15;13:1064364. doi: 10.3389/fphar.2022.1064364. eCollection 2022. 
CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS REVIEW: Umeclidinium Bromide 

>  <FLAG_COMMENTS>  (6) 


>  <ID>  (6) 
Umeclidinium

>  <Comment>  (6) 


>  <smile>  (6) 
OC(c1ccccc1)(c1ccccc1)[C@]12CC[N@+](CCOCc3ccccc3)(CC1)CC2

$$$$
Leniolisib
     RDKit          3D

 32 35  0  0  1  0  0  0  0  0999 V2000
   -2.4175   -2.5750    1.5903 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5821   -2.4854    1.7754 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6831   -3.2777   -0.0323 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8177   -4.1298    1.0493 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7018   -1.2026   -0.6411 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9916   -2.0949   -0.0312 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7047    0.7018   -0.3650 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3254    2.0404    0.1145 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4716    2.9035   -0.2820 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9534    4.6993    0.2401 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6230    0.8135   -0.9871 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0209    0.1843   -0.6747 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.8344    0.0129    0.6063 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9220   -1.2397   -1.2151 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3683   -1.3317    1.1493 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1392    2.4339    0.1148 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4354    2.0460   -0.1783 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0162    1.4501    0.2658 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7439   -3.4549    0.0211 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4742    3.4873   -0.0878 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9555    3.7919    0.3218 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4162    4.2738    0.6838 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3574   -4.0968   -1.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4221    1.1865   -0.0589 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1639    4.1954   -0.0647 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1524   -5.5796   -1.0927 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4308   -0.0895    0.4938 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5327    1.5867   -0.7841 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5345   -0.9145    0.3066 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5954   -0.4203   -0.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5562   -2.2821    0.8955 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7535   -0.6328   -1.4113 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 31  1  0
  2 31  1  0
  3 31  1  0
  4 19  2  0
  5 30  1  0
  5 32  1  0
  6 14  1  0
  6 15  1  0
  6 19  1  0
 12  7  1  1
  7 17  1  0
  8 18  1  0
  8 20  1  0
  8 24  1  0
  9 17  2  0
  9 25  1  0
 10 21  1  0
 10 25  2  0
 11 28  2  0
 11 30  1  0
 12 13  1  0
 12 14  1  0
 13 15  1  0
 16 17  1  0
 16 18  1  0
 16 21  2  0
 19 23  1  0
 20 22  1  0
 21 22  1  0
 23 26  1  0
 24 27  2  0
 24 28  1  0
 27 29  1  0
 29 30  2  0
 29 31  1  0
M  END
>  <InChIKey>  (7) 
MWKYMZXCGYXLPL-ZDUSSCGKSA-N

>  <PubChem_CID>  (7) 
57495353

>  <BOM_1A2>  (7) 


>  <BOM_2A6>  (7) 


>  <BOM_2B6>  (7) 


>  <BOM_2C8>  (7) 


>  <BOM_2C9>  (7) 


>  <BOM_2C19>  (7) 


>  <BOM_2D6>  (7) 


>  <BOM_2E1>  (7) 


>  <BOM_3A4>  (7) 
<10,N;N-Oxidation;R1>
<12,7;Dealkylation;R2><12,H;Dealkylation;R2>
<32,5;Dealkylation;R3><32,H;Dealkylation;R3>

>  <References>  (7) 
FDA Approved Drug Products: JOENJA (leniolisib) tablets, for oral use
De Buck S, Kucher K, Hara H, Gray C, Woessner R: CYP3A but not P-gp plays a relevant role in the in vivo intestinal and hepatic clearance of the delta-specific phosphoinositide-3 kinase inhibitor leniolisib. Biopharm Drug Dispos. 2018 Sep;39(8):394-402. doi: 10.1002/bdd.2157.
Pearson D, Garnier M, Luneau A, James AD, Walles M: (19)F-NMR-based determination of the absorption, metabolism and excretion of the oral phosphatidylinositol-3-kinase (PI3K) delta inhibitor leniolisib (CDZ173) in healthy volunteers. Xenobiotica. 2019 Aug;49(8):953-960. doi: 10.1080/00498254.2018.1523488. Epub 2018 Nov 29.

>  <FLAG_COMMENTS>  (7) 


>  <ID>  (7) 
Leniolisib

>  <Comment>  (7) 


>  <smile>  (7) 
CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1

$$$$
Ranolazine
     RDKit          3D

 31 33  0  0  1  0  0  0  0  0999 V2000
   -5.4972    2.5115   -1.1596 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8161   -0.0367   -0.2796 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6118    2.2189   -0.5905 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8289   -1.5111   -1.5539 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9315    1.9966   -0.2847 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8472    2.4012    0.4040 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5354    0.3562    0.8366 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8541    1.3891   -1.0756 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4728    3.2489    0.3288 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3887    1.1496   -0.2115 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2306    3.0091    1.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1154    2.2261   -1.1102 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0301    2.1703    1.2308 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3914    2.3266   -0.2710 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.6542    1.0866    0.5808 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1479    1.6100    0.3683 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5402   -0.4896    0.3094 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4223   -1.2516    0.2141 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8614   -0.0472    0.2448 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2093   -1.7665   -0.1449 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8517   -0.8814   -0.2739 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1997   -2.6006   -0.6635 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4266   -1.9887   -0.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2472    1.3151    0.7234 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8031   -2.2694   -0.0883 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0261   -1.7512    1.3681 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5208   -2.1581   -0.7281 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0347   -3.2253    0.0861 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6340   -2.9877    1.8811 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6385   -3.7247    1.2401 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8204   -2.3261   -2.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
 14  1  1  6
  2 15  1  0
  2 18  1  0
  3 16  2  0
  4 23  1  0
  4 31  1  0
  5  8  1  0
  5  9  1  0
  5 12  1  0
  6 10  1  0
  6 11  1  0
  6 13  1  0
  7 16  1  0
  7 17  1  0
  8 10  1  0
  9 11  1  0
 12 14  1  0
 13 16  1  0
 14 15  1  0
 17 19  2  0
 17 20  1  0
 18 23  2  0
 18 26  1  0
 19 21  1  0
 19 24  1  0
 20 22  2  0
 20 25  1  0
 21 27  2  0
 22 27  1  0
 23 28  1  0
 26 29  2  0
 28 30  2  0
 29 30  1  0
M  END
>  <InChIKey>  (8) 
XKLMZUWKNUAPSZ-UHFFFAOYSA-N

>  <PubChem_CID>  (8) 
56959

>  <BOM_1A2>  (8) 


>  <BOM_2A6>  (8) 


>  <BOM_2B6>  (8) 


>  <BOM_2C8>  (8) 


>  <BOM_2C9>  (8) 


>  <BOM_2C19>  (8) 


>  <BOM_2D6>  (8) 
<31,4;Dealkylation;R1><31,H;Dealkylation;R1>
<12,5;Dealkylation;R2><12,H;Dealkylation;R2>
<15,2;Dealkylation;R3><15,H;Dealkylation;R3>
<16,7;Hydrolysis;R4><16,7;Hydrolysis;R4>
<25,H;Hydroxylation;R5>/<24,H;Hydroxylation;R5>
<22,H;Hydroxylation;R6>/<21,H;Hydroxylation;R6>

>  <BOM_2E1>  (8) 


>  <BOM_3A4>  (8) 
<31,4;Dealkylation;R1><31,H;Dealkylation;R1>
<12,5;Dealkylation;R2><12,H;Dealkylation;R2>
<15,2;Dealkylation;R3><15,H;Dealkylation;R3>
<16,7;Hydrolysis;R4><16,7;Hydrolysis;R4>
<25,H;Hydroxylation;R5>/<24,H;Hydroxylation;R5>
<22,H;Hydroxylation;R6>/<21,H;Hydroxylation;R6>

>  <References>  (8) 
FDA Approved Drug Products: Ranexa (ranolazine) extended-release tablets for oral use
Chaitman BR: Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation. 2006 May 23;113(20):2462-72. doi: 10.1161/CIRCULATIONAHA.105.597500. 
Chaitman BR: Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation. 2006 May 23;113(20):2462-72. doi: 10.1161/CIRCULATIONAHA.105.597500.

>  <FLAG_COMMENTS>  (8) 


>  <ID>  (8) 
Ranolazine

>  <Comment>  (8) 


>  <smile>  (8) 
COc1ccccc1OC[C@H](O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1

$$$$
Butyrfentanyl
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -3.4815   -2.7731   -0.1032 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5907   -0.0824   -0.4851 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5947   -0.5753   -0.0738 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2031   -0.9152   -0.2361 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6425   -0.3140   -1.5247 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3792   -0.4507    0.9652 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8577   -0.5825   -1.6563 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1121   -0.7161    0.7514 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0276   -0.3017   -0.6491 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8130    0.3314    0.5001 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9580    0.8354    0.0414 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6344   -1.5518   -0.0203 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0459   -0.9837    0.1081 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2982    0.1319    0.3314 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9911    1.3788    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2382    1.5114   -1.1087 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1183   -2.0730    0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8998   -0.9943    0.8726 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0379    1.0776   -0.3625 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3375    2.7254    1.4011 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5844    2.8581   -0.9984 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5087   -1.4791    0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340    3.4651    0.2565 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2735   -1.1792    0.7165 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4117    0.8926   -0.5187 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0293   -0.2358    0.0207 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  2  0
  2  7  1  0
  2  8  1  0
  2  9  1  0
  3  4  1  0
  3 11  1  0
  3 12  1  0
  4  5  1  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  9 10  1  0
 10 14  1  0
 11 15  2  0
 11 16  1  0
 12 13  1  0
 13 17  1  0
 14 18  2  0
 14 19  1  0
 15 20  1  0
 16 21  2  0
 17 22  1  0
 18 24  1  0
 19 25  2  0
 20 23  2  0
 21 23  1  0
 24 26  2  0
 25 26  1  0
M  END
>  <InChIKey>  (9) 
QQOMYEQLWQJRKK-UHFFFAOYSA-N

>  <PubChem_CID>  (9) 
621174

>  <BOM_1A2>  (9) 


>  <BOM_2A6>  (9) 


>  <BOM_2B6>  (9) 


>  <BOM_2C8>  (9) 


>  <BOM_2C9>  (9) 


>  <BOM_2C19>  (9) 


>  <BOM_2D6>  (9) 
<2,9;Dealkylation;R1><9,H;Dealkylation;R1>
<22,H;Hydroxylation;R4>

>  <BOM_2E1>  (9) 


>  <BOM_3A4>  (9) 
<2,9;Dealkylation;R1><9,H;Dealkylation;R1>
<17,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<22,H;Hydroxylation;R4>

>  <References>  (9) 
Kanamori T, Iwata YT, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Inoue H: Metabolism of Butyrylfentanyl in Fresh Human Hepatocytes: Chemical Synthesis of Authentic Metabolite Standards for Definitive Identification. Biol Pharm Bull. 2019;42(4):623-630. doi: 10.1248/bpb.b18-00765.

>  <FLAG_COMMENTS>  (9) 


>  <ID>  (9) 
Butyrfentanyl

>  <Comment>  (9) 


>  <smile>  (9) 
CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1

$$$$
Ebastine
     RDKit          3D

 35 38  0  0  0  0  0  0  0  0999 V2000
    2.7844    0.0703   -0.3517 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6124    0.8789    2.1213 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3626    3.4824    0.2990 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4549    1.4279   -0.0868 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6248    1.4972    1.1915 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6804    2.0153   -1.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0990    2.9128    1.4356 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    3.4133   -0.9382 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9615    2.8847    0.1435 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9398    3.4976    1.1476 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9985   -0.3048    0.2841 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3452    2.9015    1.0274 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9358   -1.7570    0.7099 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2054    0.0051   -0.5801 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3997    1.4136    1.3442 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5078   -1.7912   -1.1387 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4606    0.5854    0.7029 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4464   -0.9639   -0.4964 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6467   -2.1866    1.8304 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4287    0.3135    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1675   -2.6648   -0.0189 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0924   -0.0180   -1.9701 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1304   -3.2885   -1.3929 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8000   -1.8318   -0.2652 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9025   -1.2199   -2.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6891    1.1586    0.3745 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2249   -0.7623    0.4317 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6820    0.3840   -0.2253 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2178   -1.5370   -0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5893   -3.5242    2.2222 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5388    0.5991   -0.7799 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1100   -4.0024    0.3729 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2024    0.2673   -2.7651 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8210   -4.4320    1.4934 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4257    0.5759   -2.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1 11  1  0
  2 15  2  0
  3  7  1  0
  3  8  1  0
  3  9  1  0
  4  5  1  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  9 10  1  0
 10 12  1  0
 11 13  1  0
 11 14  1  0
 12 15  1  0
 13 19  2  0
 13 21  1  0
 14 20  2  0
 14 22  1  0
 15 17  1  0
 16 18  1  0
 16 23  1  0
 16 24  1  0
 16 25  1  0
 17 26  2  0
 17 27  1  0
 18 28  2  0
 18 29  1  0
 19 30  1  0
 20 31  1  0
 21 32  2  0
 22 33  2  0
 26 28  1  0
 27 29  2  0
 30 34  2  0
 31 35  2  0
 32 34  1  0
 33 35  1  0
M  END
>  <InChIKey>  (10) 
MJJALKDDGIKVBE-UHFFFAOYSA-N

>  <PubChem_CID>  (10) 
3191

>  <BOM_1A2>  (10) 


>  <BOM_2A6>  (10) 


>  <BOM_2B6>  (10) 


>  <BOM_2C8>  (10) 


>  <BOM_2C9>  (10) 


>  <BOM_2C19>  (10) 


>  <BOM_2D6>  (10) 


>  <BOM_2E1>  (10) 


>  <BOM_3A4>  (10) 
<9,3;Dealkylation;R1><9,H;Dealkylation;R1>

>  <References>  (10) 
Hashizume T, Imaoka S, Mise M, Terauchi Y, Fujii T, Miyazaki H, Kamataki T, Funae Y: Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther. 2002 Jan;300(1):298-304.

>  <FLAG_COMMENTS>  (10) 


>  <ID>  (10) 
Ebastine

>  <Comment>  (10) 


>  <smile>  (10) 
CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1

$$$$
Givinostat
     RDKit          3D

 31 33  0  0  0  0  0  0  0  0999 V2000
   -1.0588    1.2298   -0.0395 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9518    2.5118    0.0143 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3866   -0.1567    0.5573 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3690   -2.4200   -0.5137 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4539   -1.4710   -0.3143 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0388    0.1729   -0.0311 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9947   -2.1424   -0.5455 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1698   -0.4239    0.6685 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7262   -0.0496    0.6981 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4893   -0.9079   -1.6630 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7193   -2.1332   -0.0022 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8966    1.3331   -0.1134 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0079    0.6541    0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2528    0.9692   -0.1293 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8524   -0.7174    1.5511 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5018   -0.3690    1.5798 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6516    1.0180    0.7698 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1783    2.0368   -0.0575 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4027    2.3560   -0.9394 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7832   -1.9804   -2.6982 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6779   -2.7757    1.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0521    2.7046   -0.9104 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2656    2.4102   -0.0283 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4210    1.4083   -0.0154 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4240   -0.1077   -0.0159 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3470    0.9376    0.0192 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8681   -1.4299   -0.0348 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1580   -0.6616    0.0164 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7140    0.6606    0.0353 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2350   -1.7069   -0.0186 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5833   -0.9498    0.0327 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 23  1  0
  1 24  1  0
  2 24  2  0
  3 31  2  0
  4  7  1  0
  5  8  1  0
  5 10  1  0
  5 11  1  0
  6 24  1  0
  6 25  1  0
  7 31  1  0
  8  9  1  0
  9 14  2  0
  9 15  1  0
 10 20  1  0
 11 21  1  0
 12 13  2  0
 12 14  1  0
 12 19  1  0
 13 16  1  0
 13 17  1  0
 15 16  2  0
 17 18  2  0
 18 22  1  0
 18 23  1  0
 19 22  2  0
 25 26  2  0
 25 27  1  0
 26 29  1  0
 27 30  2  0
 28 29  2  0
 28 30  1  0
 28 31  1  0
M  END
>  <InChIKey>  (11) 
YALNUENQHAQXEA-UHFFFAOYSA-N

>  <PubChem_CID>  (11) 
9804992

>  <BOM_1A2>  (11) 


>  <BOM_2A6>  (11) 


>  <BOM_2B6>  (11) 


>  <BOM_2C8>  (11) 


>  <BOM_2C9>  (11) 


>  <BOM_2C19>  (11) 


>  <BOM_2D6>  (11) 


>  <BOM_2E1>  (11) 


>  <BOM_3A4>  (11) 


>  <References>  (11) 
FDA Approved Drug Products: Duvyzat (givinostat) suspension for oral administration

>  <FLAG_COMMENTS>  (11) 
The enzymes responsible for the metabolism of givinostat are unclear; its metabolism is not mediated by CYP450 or UGT enzymes.

>  <ID>  (11) 
Givinostat

>  <Comment>  (11) 


>  <smile>  (11) 
CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1

$$$$
Alectinib
     RDKit          3D

 36 41  0  0  0  0  0  0  0  0999 V2000
    9.7817   -0.9829   -0.0244 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0693    2.6096   -0.1161 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8182    0.1709   -0.0548 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0254   -0.2732   -0.0040 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4011   -1.7494    0.0354 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3514   -0.9147    0.0398 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6044   -0.5914   -0.1281 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9755    0.2447   -1.2446 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8868   -0.3108    1.1936 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3842   -0.5708    1.0774 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4745   -0.0220   -1.3556 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8631   -1.4785    0.0148 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4529    0.4809   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8666   -0.3003   -0.0273 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2791   -0.9630    0.0043 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7358   -0.5598   -1.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6338   -1.0251    1.1024 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5195   -0.5566   -0.0241 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2847    1.0519   -0.0701 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0237    1.8017   -0.1024 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6841    0.3518   -0.0372 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6403   -2.2989    1.3047 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6515   -2.3807   -1.2213 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3393    2.0894   -0.1072 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7283    1.4341   -0.0777 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2179   -0.2322   -1.1005 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1180   -0.6853    1.2045 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1106    0.3675   -0.0305 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0004    2.9317   -0.1411 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5312   -0.9643    0.0155 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0920    1.3806   -0.0582 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8814   -1.3326    0.0348 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6233    3.2043    1.2245 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4461    1.0271   -0.0391 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8328   -0.3099    0.0067 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2231   -0.6437    0.0249 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 26  1  0
  1 27  1  0
  2 25  2  0
  3 10  1  0
  3 11  1  0
  3 13  1  0
  4  7  1  0
  4 16  1  0
  4 17  1  0
  5 15  1  0
  5 30  1  0
  6 36  3  0
  7  8  1  0
  7  9  1  0
  8 11  1  0
  9 10  1  0
 12 14  1  0
 12 15  1  0
 12 22  1  0
 12 23  1  0
 13 18  2  0
 13 20  1  0
 14 18  1  0
 14 19  2  0
 15 21  2  0
 16 26  1  0
 17 27  1  0
 19 24  1  0
 19 25  1  0
 20 24  2  0
 20 29  1  0
 21 25  1  0
 21 28  1  0
 28 30  2  0
 28 31  1  0
 29 33  1  0
 30 32  1  0
 31 34  2  0
 32 35  2  0
 34 35  1  0
 35 36  1  0
M  END
>  <InChIKey>  (12) 
KDGFLJKFZUIJMX-UHFFFAOYSA-N

>  <PubChem_CID>  (12) 
49806720

>  <BOM_1A2>  (12) 


>  <BOM_2A6>  (12) 


>  <BOM_2B6>  (12) 


>  <BOM_2C8>  (12) 


>  <BOM_2C9>  (12) 


>  <BOM_2C19>  (12) 


>  <BOM_2D6>  (12) 


>  <BOM_2E1>  (12) 


>  <BOM_3A4>  (12) 
<16,4;Dealkylation;R1><16,H;Dealkylation;R1><26,1;Dealkylation;R1><26,H;Dealkylation;R1>/<17,4;Dealkylation;R1><17,H;Dealkylation;R1><27,1;Dealkylation;R1><27,H;Dealkylation;R1>
<17,4;Dealkylation;R2><16,4;Dealkylation;R2><16,H;Dealkylation;R2><17,H;Oxidation;R2>
<17,H;Dealkylation;R3><17,4;Dealkylation;R3>/<16,4;Dealkylation;R3><16,H;Dealkylation;R3>
<26,1;Dealkylation;R4><26,H;Dealkylation;R4>/<27,1;Dealkylation;R4><27,H;Dealkylation;R4>

>  <References>  (12) 
Sato-Nakai M, Kawashima K, Nakagawa T, Tachibana Y, Yoshida M, Takanashi K, Morcos PN, Binder M, Moore DJ, Yu L: Metabolites of alectinib in human: their identification and pharmacological activity. Heliyon. 2017 Jul 10;3(7):e00354. doi: 10.1016/j.heliyon.2017.e00354. eCollection 2017 Jul.
15 December 2016 EMA/197343/2017/ Committee for Medicinal Products for Human Use (CHMP)

>  <FLAG_COMMENTS>  (12) 


>  <ID>  (12) 
Alectinib

>  <Comment>  (12) 


>  <smile>  (12) 
CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O

$$$$
Eprosartan
     RDKit          3D

 30 32  0  0  0  0  0  0  0  0999 V2000
   -5.0276   -0.5367    1.7173 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6054   -1.6282   -1.4873 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3336   -0.0124   -3.0644 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3091   -4.9062    1.6025 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2975   -5.6627    0.8626 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0590    1.3459   -0.7322 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8670    2.9299    0.8126 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7060    2.1610    0.1545 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2050    2.1427    0.3178 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7820    3.5602    0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6922    0.3828   -1.6075 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2777    1.6116   -0.6329 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3050    3.5349    0.4968 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8111   -0.9644   -0.9475 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3712    2.5920    0.3268 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2098    0.9255   -1.4258 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2303    0.1772   -0.9280 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8871    4.9393    0.5056 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7845   -1.8992   -1.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9465   -1.2778   -0.2004 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5499   -0.0414    0.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8936   -3.1476   -0.4695 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0554   -2.5263    0.4122 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0291   -3.4611    0.2776 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8862    0.5104    0.9872 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1027   -0.4612   -1.9522 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3553    1.8023    0.8945 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1425   -4.7631    0.9159 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6689    1.9343    1.4302 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1539    0.7382    1.9116 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 25  1  0
  1 30  1  0
  2 26  1  0
  3 26  2  0
  4 28  1  0
  5 28  2  0
  6  8  1  0
  6 11  1  0
  6 12  1  0
  7  8  2  0
  7 15  1  0
  8  9  1  0
  9 10  1  0
 10 13  1  0
 11 14  1  0
 12 15  2  0
 12 16  1  0
 13 18  1  0
 14 19  2  0
 14 20  1  0
 16 17  2  0
 17 21  1  0
 17 26  1  0
 19 22  1  0
 20 23  2  0
 21 25  1  0
 22 24  2  0
 23 24  1  0
 24 28  1  0
 25 27  2  0
 27 29  1  0
 29 30  2  0
M  END
>  <InChIKey>  (13) 
OROAFUQRIXKEMV-LDADJPATSA-N

>  <PubChem_CID>  (13) 
5281037

>  <BOM_1A2>  (13) 


>  <BOM_2A6>  (13) 


>  <BOM_2B6>  (13) 


>  <BOM_2C8>  (13) 


>  <BOM_2C9>  (13) 


>  <BOM_2C19>  (13) 


>  <BOM_2D6>  (13) 


>  <BOM_2E1>  (13) 


>  <BOM_3A4>  (13) 


>  <References>  (13) 
Miao, Z., Nucci, G., Amin, N., Sharma, R., Mascitti, V., Tugnait, M., ... & Kalgutkar, A. S. (2013). Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects. Drug Metabolism and Disposition, 41(2), 445-456.

>  <FLAG_COMMENTS>  (13) 
Eprosartan is not metabolized by the cytochrome P450 system. It is mainly eliminated as unchanged drug. Less than 2% of an oral dose is excreted in the urine as a glucuronide.

>  <ID>  (13) 
Eprosartan

>  <Comment>  (13) 


>  <smile>  (13) 
CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1

$$$$
Daprodustat
     RDKit          3D

 28 30  0  0  0  0  0  0  0  0999 V2000
    2.0384   -2.3995   -0.5345 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1471   -0.6125    0.4066 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5293    2.1328    0.3639 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3232    2.1280    1.5446 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3698    2.1475   -0.3560 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0503    4.2659    0.0876 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0880   -1.5408   -0.1668 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8253   -0.1142   -0.1794 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8454    2.7595   -0.6344 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6201   -2.8816   -0.1292 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2626    0.0113   -0.1545 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7446    0.9427   -1.2699 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6614   -3.0768   -1.2338 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2062   -3.1934    1.2504 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7353    0.4953    1.2184 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2491    0.6875    1.2568 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2586    1.1328   -1.2284 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8236   -4.5887    1.2964 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2797   -4.4716   -1.1841 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7278    1.6132    0.1419 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8598   -4.7818    0.1929 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3107   -1.4219   -0.3278 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4045    0.8782   -0.2733 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9766   -0.4806    0.0459 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0649    1.0429    0.0258 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2257    1.9820    0.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7100    3.8728   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1553    3.4708   -0.1719 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  2  0
  2 24  2  0
  3 25  2  0
  4 26  2  0
  5 28  1  0
  6 28  2  0
  7 10  1  0
  7 22  1  0
  7 24  1  0
  8 11  1  0
  8 22  1  0
  8 25  1  0
  9 26  1  0
  9 27  1  0
 10 13  1  0
 10 14  1  0
 11 12  1  0
 11 15  1  0
 12 17  1  0
 13 19  1  0
 14 18  1  0
 15 16  1  0
 16 20  1  0
 17 20  1  0
 18 21  1  0
 19 21  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
 27 28  1  0
M  END
>  <InChIKey>  (14) 
RUEYEZADQJCKGV-UHFFFAOYSA-N

>  <PubChem_CID>  (14) 
91617630

>  <BOM_1A2>  (14) 


>  <BOM_2A6>  (14) 


>  <BOM_2B6>  (14) 


>  <BOM_2C8>  (14) 
<21,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>
<19,H;Hydroxylation;R3>
<16,H;Hydroxylation;R4>
<20,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>

>  <BOM_2C9>  (14) 


>  <BOM_2C19>  (14) 


>  <BOM_2D6>  (14) 


>  <BOM_2E1>  (14) 


>  <BOM_3A4>  (14) 
<21,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>
<19,H;Hydroxylation;R3>
<16,H;Hydroxylation;R4>
<20,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>

>  <References>  (14) 
Johnson BM, Stier BA, Caltabiano S: Effect of food and gemfibrozil on the pharmacokinetics of the novel prolyl hydroxylase inhibitor GSK1278863. Clin Pharmacol Drug Dev. 2014 Mar;3(2):109-17. doi: 10.1002/cpdd.83. Epub 2013 Oct 22. 
Mahar KM, Caltabiano S, Andrews S, Ramanjineyulu B, Chen L, Young G, Pereira A, Lindsay AC, van den Berg F, Cobitz AR: Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination. Clin Pharmacol Drug Dev. 2021 Dec;10(12):1419-1431. doi: 10.1002/cpdd.1029. Epub 2021 Oct 28. 
Licea Perez H, Knecht D, Evans CA: Overcoming bioanalytical challenges associated with the separation and quantitation of GSK1278863, a HIF-prolyl hydroxylase inhibitor, and its 14 stereoisomeric metabolites. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 15;1009-1010:7-16. doi: 10.1016/j.jchromb.2015.11.057. Epub 2015 Dec 4. 
FDA Approved Drug Products: JESDUVROQ (daprodustat) tablets, for oral use

>  <FLAG_COMMENTS>  (14) 
### check og metabolite

>  <ID>  (14) 
Daprodustat

>  <Comment>  (14) 


>  <smile>  (14) 
O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O

$$$$
Bexarotene
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
    6.1672   -1.9222   -1.0330 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6076    0.2152   -1.6689 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1314   -1.8872    0.3159 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2164    0.6104   -1.0813 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6109   -1.6924   -0.0837 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7569   -0.8175   -1.3173 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3563   -0.5638    0.2792 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8550    0.5901   -0.3746 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1403   -2.5110    1.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4536   -2.8848   -0.6495 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1336    1.2814   -2.4732 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2123    1.4127   -0.2146 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0814   -0.4971    0.8849 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0820    1.7723   -0.3381 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3308    0.6770    0.8887 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8356    1.8159    0.2836 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9765    0.6739    1.5319 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0765    3.1034    0.2793 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2654    0.3400    0.8395 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0669    0.9909    2.8514 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9708    1.3584    0.2487 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6792   -0.9684    0.8298 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1688    1.0477   -0.3948 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8773   -1.2792    0.1865 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6221   -0.2711   -0.4259 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8712   -0.5949   -1.0965 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 26  1  0
  2 26  2  0
  3  5  1  0
  3  7  1  0
  3  9  1  0
  3 10  1  0
  4  6  1  0
  4  8  1  0
  4 11  1  0
  4 12  1  0
  5  6  1  0
  7  8  2  0
  7 13  1  0
  8 14  1  0
 13 15  2  0
 14 16  2  0
 15 16  1  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 17 20  2  0
 19 21  2  0
 19 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 24 25  1  0
 25 26  1  0
M  END
>  <InChIKey>  (15) 
NAVMQTYZDKMPEU-UHFFFAOYSA-N

>  <PubChem_CID>  (15) 
82146

>  <BOM_1A2>  (15) 


>  <BOM_2A6>  (15) 


>  <BOM_2B6>  (15) 


>  <BOM_2C8>  (15) 


>  <BOM_2C9>  (15) 
<6,H;Hydroxylation;R1>
<6,H;Oxidation;R2>
<5,H;Oxidation;R3>
<5,H;Hydroxylation;R4>

>  <BOM_2C19>  (15) 
<6,H;Hydroxylation;R1>
<6,H;Oxidation;R2>
<5,H;Oxidation;R3>
<5,H;Hydroxylation;R4>

>  <BOM_2D6>  (15) 


>  <BOM_2E1>  (15) 


>  <BOM_3A4>  (15) 
<6,H;Hydroxylation;R1>
<6,H;Oxidation;R2>
<5,H;Oxidation;R3>
<5,H;Hydroxylation;R4>

>  <References>  (15) 
Howell, Stanley R., et al. "Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors." Drug metabolism and disposition 29.7 (2001): 990-998.

>  <FLAG_COMMENTS>  (15) 


>  <ID>  (15) 
Bexarotene

>  <Comment>  (15) 


>  <smile>  (15) 
C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C

$$$$
Solifenacin
     RDKit          3D

 27 31  0  0  1  0  0  0  0  0999 V2000
    1.2996   -0.8132    0.5466 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0200   -2.8568   -0.4395 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5264   -0.4503   -0.8356 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8045   -1.4232   -0.1954 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3787    0.0726    1.4363 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6894   -1.1066    0.7261 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.3460    1.2966    0.5044 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8507   -0.3127    1.6408 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3662   -1.3490   -0.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0471    0.9488   -0.8185 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4824   -0.6410    0.2777 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5494   -1.7854   -0.0612 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3781   -0.2266    0.4849 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.7098   -2.3871   -0.8274 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8999   -0.1991    0.5256 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9480   -1.7510   -1.4418 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6563   -0.9151   -0.4165 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8198    1.0765   -0.0848 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5666    0.5743    1.4891 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0539   -0.8260   -0.4071 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7079    2.1932    0.7354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4288    1.1329   -1.4175 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9598    0.6451    1.5031 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7024   -0.0505    0.5526 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1980    3.3830    0.2156 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0813    2.3227   -1.9372 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1966    3.4478   -1.1206 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  1  1  6
  1 12  1  0
  2 12  2  0
  3  9  1  0
  3 10  1  0
  3 11  1  0
  4 12  1  0
  4 13  1  0
  4 14  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  6  9  1  0
  7 10  1  0
  8 11  1  0
 13 15  1  0
 13 18  1  6
 14 16  1  0
 15 17  2  0
 15 19  1  0
 16 17  1  0
 17 20  1  0
 18 21  2  0
 18 22  1  0
 19 23  2  0
 20 24  2  0
 21 25  1  0
 22 26  2  0
 23 24  1  0
 25 27  2  0
 26 27  1  0
M  END
>  <InChIKey>  (16) 
FBOUYBDGKBSUES-VXKWHMMOSA-N

>  <PubChem_CID>  (16) 
154059

>  <BOM_1A2>  (16) 


>  <BOM_2A6>  (16) 


>  <BOM_2B6>  (16) 


>  <BOM_2C8>  (16) 


>  <BOM_2C9>  (16) 


>  <BOM_2C19>  (16) 


>  <BOM_2D6>  (16) 
<16,H;Hydroxylation;R1>

>  <BOM_2E1>  (16) 


>  <BOM_3A4>  (16) 
<16,H;Hydroxylation;R1>
<3,N;N-Oxidation;R2>

>  <References>  (16) 
Doroshyenko O, Fuhr U: Clinical pharmacokinetics and pharmacodynamics of solifenacin. Clin Pharmacokinet. 2009;48(5):281-302. doi: 10.2165/00003088-200948050-00001.

>  <FLAG_COMMENTS>  (16) 


>  <ID>  (16) 
Solifenacin

>  <Comment>  (16) 


>  <smile>  (16) 
O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1

$$$$
Nirmatrelvir
     RDKit          3D

 35 37  0  0  1  0  0  0  0  0999 V2000
   -5.2651    0.3853    2.1308 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8314    2.2135    1.0849 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0158    2.1639    2.2891 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.8747   -1.8859   -1.5122 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0035    0.6408    0.8113 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4964    0.3236   -0.6689 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7449    2.9461    1.9493 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6890   -1.0865   -0.5681 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3460   -1.5920    0.7482 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6719    1.4254    0.2686 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2828    3.4118   -0.2800 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1671   -3.1201    1.8606 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4011   -3.4218   -0.4812 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.8334   -3.9081   -0.3288 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4027   -3.1035   -1.5436 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1127   -2.1288    0.0777 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.5341   -1.6173   -1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0815   -5.3814   -0.5422 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7379   -3.3010    0.7122 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5277   -1.8669   -0.3343 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7181    0.2182   -0.0939 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7133    1.1335   -0.7618 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.0657    2.3878   -1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7515   -1.2850    0.6147 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2991    3.2418   -0.3672 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1514    3.2635   -2.0527 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0789    1.9478   -2.4966 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0750    0.1111    1.1604 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6419    1.2203    0.2219 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.9901    0.9930    0.2272 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5427   -2.3102    1.3122 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4285    1.2436   -1.0918 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8964    2.6052    0.7865 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7723    1.4370    1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3538    2.6954   -1.5233 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 34  1  0
  2 34  1  0
  3 34  1  0
  4 20  2  0
  5 21  2  0
  6 30  2  0
  7 33  2  0
  8 16  1  0
  8 17  1  0
  8 21  1  0
  9 20  1  0
  9 24  1  0
 22 10  1  1
 10 30  1  0
 11 33  1  0
 11 35  1  0
 12 31  3  0
 13 14  1  1
 13 15  1  0
 13 16  1  0
 14 15  1  0
 14 18  1  0
 14 19  1  0
 15 17  1  1
 16 20  1  6
 21 22  1  0
 22 23  1  0
 23 25  1  0
 23 26  1  0
 23 27  1  0
 24 28  1  1
 24 31  1  0
 29 28  1  1
 29 32  1  0
 29 33  1  0
 30 34  1  0
 32 35  1  0
M  END
>  <InChIKey>  (17) 
LIENCHBZNNMNKG-OJFNHCPVSA-N

>  <PubChem_CID>  (17) 
155903259

>  <BOM_1A2>  (17) 


>  <BOM_2A6>  (17) 


>  <BOM_2B6>  (17) 


>  <BOM_2C8>  (17) 


>  <BOM_2C9>  (17) 


>  <BOM_2C19>  (17) 


>  <BOM_2D6>  (17) 


>  <BOM_2E1>  (17) 


>  <BOM_3A4>  (17) 
<19,H;Hydroxylation;R1>/<18,H;Hydroxylation;R1>
<35,H;Hydroxylation;R2>
<27,H;Hydroxylation;R3>/<26,H;Hydroxylation;R3>/<25,H;Hydroxylation;R3>

>  <References>  (17) 
Chen, Wujun, et al. "Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection." Journal of Pharmaceutical Analysis 13.3 (2023): 255-261.

>  <FLAG_COMMENTS>  (17) 


>  <ID>  (17) 
Nirmatrelvir

>  <Comment>  (17) 


>  <smile>  (17) 
CC(C)(C)[C@H](NC(=O)C(F)(F)F)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@H](C#N)C[C@@H]1CCNC1=O)C2(C)C

$$$$
Mitapivat
     RDKit          3D

 32 36  0  0  0  0  0  0  0  0999 V2000
   -4.2325    0.9070    1.1190 S   0  0  0  0  0  6  0  0  0  0  0  0
    2.3088    3.7859   -1.1469 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6076    0.5310    0.8487 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8945    1.5465    2.3760 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6150   -0.4785    0.0591 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8251    1.7505   -0.1198 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6382    1.8437   -0.1989 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3995   -1.1961   -0.9999 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7345   -1.6898    0.0384 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0377   -2.1806    1.4236 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4177   -3.0116    0.2334 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3168   -1.6634   -0.4329 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1610   -0.6937    0.0379 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9713    0.7020   -0.7415 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4146    0.5276    0.5791 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2703    1.9486   -0.2043 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9633    2.7294   -0.6201 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5163    2.5010   -0.5111 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1762    2.9386    0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1652    1.8464   -1.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5501    2.7213    0.7211 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5391    1.6291   -1.4339 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2315    2.0666   -0.3049 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2614   -0.5669    0.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4613   -1.4539   -0.0692 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6575   -2.6119   -0.1234 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2972   -0.8028    1.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6873   -2.8492    0.8649 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5089   -1.9451    1.9082 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8583   -3.5053   -1.1842 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8243   -3.2424   -2.1448 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5616   -2.0839   -2.0076 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  2  0
  1  4  2  0
  1  7  1  0
  1 24  1  0
  2 17  2  0
  5 12  1  0
  5 13  1  0
  5 14  1  0
  6 15  1  0
  6 16  1  0
  6 17  1  0
  7 23  1  0
  8 25  2  0
  8 32  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
 10 11  1  0
 13 15  1  0
 14 16  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
 24 25  1  0
 24 27  2  0
 25 26  1  0
 26 28  1  0
 26 30  2  0
 27 29  1  0
 28 29  2  0
 30 31  1  0
 31 32  2  0
M  END
>  <InChIKey>  (18) 
XAYGBKHKBBXDAK-UHFFFAOYSA-N

>  <PubChem_CID>  (18) 
59634741

>  <BOM_1A2>  (18) 


>  <BOM_2A6>  (18) 


>  <BOM_2B6>  (18) 


>  <BOM_2C8>  (18) 


>  <BOM_2C9>  (18) 


>  <BOM_2C19>  (18) 


>  <BOM_2D6>  (18) 


>  <BOM_2E1>  (18) 


>  <BOM_3A4>  (18) 
<12,5;Dealkylation;R1><12,H;Dealkylation;R1>
<15,6;Dealkylation;R2><15,H;Dealkylation;R2><13,5;Dealkylation;R2><13,H;Dealkylation;R2>/<16,6;Dealkylation;R2><16,H;Dealkylation;R2><14,5;Dealkylation;R2><14,H;Dealkylation;R2>

>  <References>  (18) 
Prakash, Chandra, et al. "An innovative phase I study in healthy subjects to determine the mass balance, elimination, metabolism, and absolute bioavailability of mitapivat." Clinical and Translational Science 16.10 (2023): 2021-2032.
U.S. Food and Drug Administration. (2024). Title of the document (216196Orig1s000). Retrieved June 25, 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/216196Orig1s000IntegratedR.pdf

>  <FLAG_COMMENTS>  (18) 


>  <ID>  (18) 
Mitapivat

>  <Comment>  (18) 


>  <smile>  (18) 
O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(CC2CC2)CC1

$$$$
ciprofloxacin
     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
    4.2639    1.4572    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.7940    2.4330    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3921    0.9330    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5261    2.4330    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7940   -0.5670    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2639   -0.5911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5357   -1.5978    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7940   -1.5670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2940   -2.4330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2940   -2.4330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9280   -0.0670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6601   -0.0670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9280    0.9330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0341   -0.6016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1280   -0.0878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3960   -0.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2678   -1.5911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6601    0.9330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7940    1.4330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5319   -0.5978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4037   -2.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0341    1.4677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1280    0.9538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5261    1.4330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 23  1  0
  2 19  2  0
  3 24  1  0
  4 24  2  0
  5  8  1  0
  5 11  1  0
  5 12  1  0
  6 15  1  0
  6 16  1  0
  6 17  1  0
  7 20  1  0
  7 21  1  0
  8  9  1  0
  8 10  1  0
  9 10  1  0
 11 13  2  0
 11 14  1  0
 12 18  2  0
 13 19  1  0
 13 22  1  0
 14 15  2  0
 15 23  1  0
 16 20  1  0
 17 21  1  0
 18 19  1  0
 18 24  1  0
 22 23  2  0
M  END
>  <InChIKey>  (19) 
MYSWGUAQZAJSOK-UHFFFAOYSA-N

>  <PubChem_CID>  (19) 
2764

>  <BOM_1A2>  (19) 
<16,H;Oxidation;R1>/<17,H;Oxidation;R1>
<20,7;Dealkylation;R2><20,H;Dealkylation;R2><16,6;Dealkylation;R2><16,H;Dealkylation;R2>/<21,7;Dealkylation;R2><21,H;Dealkylation;R2><17,6;Dealkylation;R2><17,H;Dealkylation;R2>

>  <BOM_2A6>  (19) 


>  <BOM_2B6>  (19) 


>  <BOM_2C8>  (19) 


>  <BOM_2C9>  (19) 


>  <BOM_2C19>  (19) 


>  <BOM_2D6>  (19) 


>  <BOM_2E1>  (19) 


>  <BOM_3A4>  (19) 


>  <References>  (19) 
Al-Omar, Mohammed A. "Ciprofloxacin: Drug metabolism and pharmacokinetic profile." Profiles of drug Substances, excipients and related methodology. Vol. 31. Academic Press, 2005. 209-214.

>  <FLAG_COMMENTS>  (19) 


>  <ID>  (19) 
ciprofloxacin

>  <Comment>  (19) 


>  <smile>  (19) 
O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O

$$$$
Dextroamphetamine
     RDKit          3D

 10 10  0  0  1  0  0  0  0  0999 V2000
   -3.5842   -0.4594    0.1201 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2228   -0.1767   -0.3441 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.2239   -0.4571    0.7933 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2170   -0.2338    0.4014 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1704    1.2731   -0.8263 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9466   -1.2850   -0.1310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7835    1.0181    0.5807 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2777   -1.0789   -0.4933 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1147    1.2242    0.2181 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8617    0.1756   -0.3189 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  5  1  1
  3  4  1  0
  4  6  2  0
  4  7  1  0
  6  8  1  0
  7  9  2  0
  8 10  2  0
  9 10  1  0
M  END
>  <InChIKey>  (20) 
KWTSXDURSIMDCE-QMMMGPOBSA-N

>  <PubChem_CID>  (20) 
5826

>  <BOM_1A2>  (20) 


>  <BOM_2A6>  (20) 


>  <BOM_2B6>  (20) 


>  <BOM_2C8>  (20) 


>  <BOM_2C9>  (20) 


>  <BOM_2C19>  (20) 


>  <BOM_2D6>  (20) 
<10,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>

>  <BOM_2E1>  (20) 


>  <BOM_3A4>  (20) 


>  <References>  (20) 
de la Torre R, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S: Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin Pharmacokinet. 2004;43(3):157-85. doi: 10.2165/00003088-200443030-00002. 
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742 .

>  <FLAG_COMMENTS>  (20) 


>  <ID>  (20) 
Dextroamphetamine

>  <Comment>  (20) 


>  <smile>  (20) 
C[C@H](N)Cc1ccccc1

$$$$
Copanlisib
     RDKit          3D

 35 39  0  0  0  0  0  0  0  0999 V2000
    9.6798   -2.4739   -0.3732 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1205    1.0023    1.1748 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8600   -0.5682    0.9973 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7930   -1.7489    0.4582 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1338   -1.2024   -0.4251 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8387    2.4046   -0.3103 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0256    4.5426   -0.5343 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5942    0.4960    0.2954 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8367    0.2442   -0.1212 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5399   -3.6345    0.6717 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3114   -1.9771   -0.8983 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6928   -3.7611   -0.2536 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2720   -0.0341   -0.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0686   -1.0052    0.6915 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8777   -1.4839   -1.6607 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1146   -0.0830    0.3992 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9653   -2.2311    0.8393 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7779   -2.6992   -1.4573 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7921    3.2888   -0.2566 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0273    3.1294   -0.6881 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4860    2.7269    0.1153 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1857    1.1122    0.2334 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4881    4.5626   -0.8392 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4492    1.3376    0.3774 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7279    1.0543   -0.0404 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9263    1.5594    0.8256 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7770    0.7690    0.7341 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6558    3.5221    0.2048 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8651    2.9292    0.5619 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7932   -1.1130    0.1356 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1510   -1.4253   -0.1031 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0974   -1.8171    0.0322 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3682   -2.9691    0.7417 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1161   -1.3626   -0.7802 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4535   -3.0912   -0.1551 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  1 18  1  0
  2 22  1  0
  2 26  1  0
  3 27  1  0
  3 31  1  0
  4 30  2  0
  5 13  1  0
  5 14  1  0
  5 15  1  0
  6 19  1  0
  6 20  1  0
  6 25  1  0
  7 19  2  0
  7 23  1  0
  8 24  1  0
  8 25  2  0
  9 25  1  0
  9 30  1  0
 10 33  2  0
 10 35  1  0
 11 34  1  0
 11 35  2  0
 12 35  1  0
 13 16  1  0
 14 17  1  0
 15 18  1  0
 16 22  1  0
 19 21  1  0
 20 23  1  0
 21 24  2  0
 21 28  1  0
 24 27  1  0
 26 27  2  0
 26 29  1  0
 28 29  2  0
 30 32  1  0
 32 33  1  0
 32 34  2  0
M  END
>  <InChIKey>  (21) 
PZBCKZWLPGJMAO-UHFFFAOYSA-N

>  <PubChem_CID>  (21) 
24989044

>  <BOM_1A2>  (21) 


>  <BOM_2A6>  (21) 


>  <BOM_2B6>  (21) 


>  <BOM_2C8>  (21) 


>  <BOM_2C9>  (21) 


>  <BOM_2C19>  (21) 


>  <BOM_2D6>  (21) 


>  <BOM_2E1>  (21) 


>  <BOM_3A4>  (21) 
<15,H;Oxidation;R1>/<14,H;Oxidation;R1>
<22,2;Dealkylation;R2><22,H;Dealkylation;R2>
<1,17;Dealkylation;R3><17,H;Dealkylation;R3><14,5;Dealkylation;R3><14,H;Dealkylation;R3>/<1,18;Dealkylation;R3><18,H;Dealkylation;R3><15,5;Dealkylation;R3><15,H;Dealkylation;R3>
<15,18;Dealkylation;R4><1,18;Dealkylation;R4><15,H;Dealkylation;R4><18,H;Dealkylation;R4>
<13,5;Dealkylation;R5><13,H;Dealkylation;R5>

>  <References>  (21) 
Gerisch M, Schwarz T, Lang D, Rohde G, Reif S, Genvresse I, Reschke S, van der Mey D, Granvil C: Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor
FDA Approved Drug Products: ALIQOPA (copanlisib) for injection, for intravenous use (September 2023)
Gerisch M, Schwarz T, Lang D, Rohde G, Reif S, Genvresse I, Reschke S, van der Mey D, Granvil C: Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor 

>  <FLAG_COMMENTS>  (21) 
## Check

>  <ID>  (21) 
Copanlisib

>  <Comment>  (21) 


>  <smile>  (21) 
COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21

$$$$
Hydrochlorothiazide
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    2.7010   -2.4152   -0.0041 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.3843    1.2390    0.0262 S   0  0  0  0  0  6  0  0  0  0  0  0
    2.9884    0.8025    0.1072 S   0  0  0  0  0  6  0  0  0  0  0  0
   -2.6655    1.5600    1.4114 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1586    2.2718   -0.9652 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8058    2.1097    0.7178 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9631   -0.1273    0.6553 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5780    0.1713   -0.5689 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3503   -1.8587   -0.0568 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2964    1.0065   -1.5598 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9702    0.1815    0.0403 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1247   -1.2131    0.0008 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6052   -1.1526    0.0785 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2871    0.7920    0.0681 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4314    0.0008    0.0573 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0498   -1.9826   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3139   -1.3856    0.0119 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  2  4  2  0
  2  5  2  0
  2  8  1  0
  2 11  1  0
  3  6  2  0
  3  7  2  0
  3 10  1  0
  3 15  1  0
  8 13  1  0
  9 12  1  0
  9 13  1  0
 11 12  2  0
 11 14  1  0
 12 16  1  0
 14 15  2  0
 15 17  1  0
 16 17  2  0
M  END
>  <InChIKey>  (22) 
JZUFKLXOESDKRF-UHFFFAOYSA-N

>  <PubChem_CID>  (22) 
3639

>  <BOM_1A2>  (22) 


>  <BOM_2A6>  (22) 


>  <BOM_2B6>  (22) 


>  <BOM_2C8>  (22) 


>  <BOM_2C9>  (22) 


>  <BOM_2C19>  (22) 


>  <BOM_2D6>  (22) 


>  <BOM_2E1>  (22) 


>  <BOM_3A4>  (22) 


>  <References>  (22) 
FDA Approved Drug Products: Hydrochlorothiazide Oral Tablets

>  <FLAG_COMMENTS>  (22) 
Hydrochlorothiazide is not metabolized.

>  <ID>  (22) 
Hydrochlorothiazide

>  <Comment>  (22) 


>  <smile>  (22) 
NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O

$$$$
Febuxostat
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -2.7288    0.9775   -0.3464 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.6923   -0.2719    0.5275 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2772    2.0829   -0.8784 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5855    0.2868   -0.4454 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6251   -1.4953    0.4000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7635    3.1906    0.6741 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7746   -0.1375   -0.6949 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4160   -0.8308   -0.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6210   -0.3218    0.5664 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5229   -0.6636   -1.9178 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3251   -0.2903    0.4348 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4497   -0.3865    0.2422 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5899    0.8910    0.4562 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6828   -1.5193    0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1991    0.8428    0.3596 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2921   -1.5674    0.2212 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8879   -0.4368    0.1427 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9536   -1.1748    0.1987 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2067    0.1186   -0.2075 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9640   -2.2271    0.4332 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2381    2.1610    0.5766 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4389    0.7720   -0.4998 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  1 19  1  0
  2  8  1  0
  2 11  1  0
  3 22  1  0
  4 22  2  0
  5 17  2  0
  5 18  1  0
  6 21  3  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
 11 13  2  0
 11 14  1  0
 12 15  2  0
 12 16  1  0
 12 17  1  0
 13 15  1  0
 13 21  1  0
 14 16  2  0
 18 19  2  0
 18 20  1  0
 19 22  1  0
M  END
>  <InChIKey>  (23) 
BQSJTQLCZDPROO-UHFFFAOYSA-N

>  <PubChem_CID>  (23) 
134018

>  <BOM_1A2>  (23) 
<7,H;Hydroxylation;R2>

>  <BOM_2A6>  (23) 


>  <BOM_2B6>  (23) 


>  <BOM_2C8>  (23) 
<7,H;Hydroxylation;R2>

>  <BOM_2C9>  (23) 
<10,H;Hydroxylation;R1>/<9,H;Hydroxylation;R1>

>  <BOM_2C19>  (23) 


>  <BOM_2D6>  (23) 


>  <BOM_2E1>  (23) 


>  <BOM_3A4>  (23) 


>  <References>  (23) 
Grabowski BA, Khosravan R, Vernillet L, Mulford DJ: Metabolism and excretion of 
FDA Approved Products: ULORIC (febuxostat) tablets, for oral use (February 2019)

>  <FLAG_COMMENTS>  (23) 


>  <ID>  (23) 
Febuxostat

>  <Comment>  (23) 


>  <smile>  (23) 
Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O

$$$$
Benzocaine
     RDKit          3D

 12 12  0  0  0  0  0  0  0  0999 V2000
   -2.1131   -0.3568    0.0005 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7062    1.9089    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1634   -0.7318   -0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1082    0.3619    0.0009 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0960    1.3466   -0.0001 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4669   -0.9861    0.0012 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8017   -0.3646   -0.0004 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4427    0.9834   -0.0008 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8137   -1.3494    0.0006 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2959    0.7406    0.0008 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5238   -0.1131   -0.0009 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2535   -1.4395   -0.0009 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 11  1  0
  2 10  2  0
  3  7  1  0
  4  5  2  0
  4  6  1  0
  4 10  1  0
  5  8  1  0
  6  9  2  0
  7  8  2  0
  7  9  1  0
 11 12  1  0
M  END
>  <InChIKey>  (24) 
BLFLLBZGZJTVJG-UHFFFAOYSA-N

>  <PubChem_CID>  (24) 
2337

>  <BOM_1A2>  (24) 
<3,N;N-Oxidation;R1>

>  <BOM_2A6>  (24) 


>  <BOM_2B6>  (24) 
<3,N;N-Oxidation;R1>

>  <BOM_2C8>  (24) 


>  <BOM_2C9>  (24) 


>  <BOM_2C19>  (24) 
<3,N;N-Oxidation;R1>

>  <BOM_2D6>  (24) 
<3,N;N-Oxidation;R1>

>  <BOM_2E1>  (24) 
<3,N;N-Oxidation;R1>

>  <BOM_3A4>  (24) 


>  <References>  (24) 
Hartman NR, Mao JJ, Zhou H, Boyne MT 2nd, Wasserman AM, Taylor K, Racoosin JA, Patel V, Colatsky T: More methemoglobin is produced by benzocaine treatment than lidocaine treatment in human in vitro systems. Regul Toxicol Pharmacol. 2014 Oct;70(1):182-8. doi: 10.1016/j.yrtph.2014.07.002. Epub 2014 Jul 8.

>  <FLAG_COMMENTS>  (24) 


>  <ID>  (24) 
Benzocaine

>  <Comment>  (24) 


>  <smile>  (24) 
CCOC(=O)c1ccc(N)cc1

$$$$
Ceftizoxime
     RDKit          3D

 25 27  0  0  1  0  0  0  0  0999 V2000
   -1.7741    0.9202   -2.4039 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.6883   -3.2925    0.2094 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8411    0.2049    2.2164 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3473   -0.7261    1.8291 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1798    1.3029    2.0555 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6872   -2.4433    0.3576 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9629    2.8175    0.0112 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7221    0.4553    0.0477 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2215    1.2688   -0.0872 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3996    1.4984   -0.1739 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0198   -1.1715   -0.4317 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0966   -3.2200   -0.9160 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2538    1.5572   -0.7763 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.1237    1.7214    0.2651 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.9258    0.6862    1.1111 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6823   -0.4087   -0.3503 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4400    0.2620   -2.7834 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0605   -0.5017   -1.6373 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2265    1.1097    0.8513 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2926   -1.3205    0.6185 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5246    0.6368    0.2497 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8294   -0.7918    0.1205 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9716   -1.7678    0.5298 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0577   -2.4855   -0.4374 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9722    3.6883   -0.4755 C   0  0  0  0  0  0  0  0  0  0  0  0
 13  1  1  6
  1 17  1  0
  2 23  1  0
  2 24  1  0
  3 15  2  0
  4 20  1  0
  5 19  2  0
  6 20  2  0
  7 10  1  0
  7 25  1  0
  8 13  1  0
  8 15  1  0
  8 16  1  0
 14  9  1  6
  9 19  1  0
 10 21  2  0
 11 22  1  0
 11 24  2  0
 12 24  1  0
 13 14  1  0
 14 15  1  0
 16 18  2  0
 16 20  1  0
 17 18  1  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
M  END
>  <InChIKey>  (25) 
NNULBSISHYWZJU-LLKWHZGFSA-N

>  <PubChem_CID>  (25) 
6533629

>  <BOM_1A2>  (25) 


>  <BOM_2A6>  (25) 


>  <BOM_2B6>  (25) 


>  <BOM_2C8>  (25) 


>  <BOM_2C9>  (25) 


>  <BOM_2C19>  (25) 


>  <BOM_2D6>  (25) 


>  <BOM_2E1>  (25) 


>  <BOM_3A4>  (25) 


>  <References>  (25) 
Nakashima, N., Suzuki, K., Hashimoto, H., & Nishijima, K. (1981). Phase I Study of Ceftizoxime, a New Cephalosporin. Single?Dose Study. The Journal of Clinical Pharmacology, 21(10), 388-395.

>  <FLAG_COMMENTS>  (25) 
Ceftizoxime is not metabolized and is excreted virtually unchanged by the kidneys in 24 hours.

>  <ID>  (25) 
Ceftizoxime

>  <Comment>  (25) 


>  <smile>  (25) 
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=CCS[C@H]12)c1csc(N)n1

$$$$
Ibandronate
     RDKit          3D

 19 18  0  0  1  0  0  0  0  0999 V2000
    2.5682   -0.6734   -1.2736 P   0  0  0  0  0  5  0  0  0  0  0  0
    1.7834    1.8118    0.5149 P   0  0  0  0  0  5  0  0  0  0  0  0
    3.2202   -0.1722    1.1571 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2865   -2.0745   -0.9080 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8058    0.2810   -1.6914 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1318    2.4778   -0.0747 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8907    2.0685    2.1066 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4755   -0.7592   -2.2966 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5080    2.3013   -0.1065 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3755   -1.6420    1.0038 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0457    0.0048    0.3509 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9388   -0.8499    1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4112   -0.8038    0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6832   -1.5834    0.3505 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1929   -0.1437    0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5706   -0.0623   -0.3489 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9010   -3.0244    1.0714 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0686    1.3811   -0.4212 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4517    1.4626   -1.0471 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1  5  1  0
  1  8  2  0
  1 11  1  0
  2  6  1  0
  2  7  1  0
  2  9  2  0
  2 11  1  0
  3 11  1  0
 10 13  1  0
 10 14  1  0
 10 17  1  0
 11 12  1  0
 12 13  1  0
 14 15  1  0
 15 16  1  0
 16 18  1  0
 18 19  1  0
M  END
>  <InChIKey>  (26) 
MPBVHIBUJCELCL-UHFFFAOYSA-N

>  <PubChem_CID>  (26) 
60852

>  <BOM_1A2>  (26) 


>  <BOM_2A6>  (26) 


>  <BOM_2B6>  (26) 


>  <BOM_2C8>  (26) 


>  <BOM_2C9>  (26) 


>  <BOM_2C19>  (26) 


>  <BOM_2D6>  (26) 


>  <BOM_2E1>  (26) 


>  <BOM_3A4>  (26) 


>  <References>  (26) 
FDA Approved Drug Products: Boniva Ibandronate Oral Tablets 
FDA Approved Drug Products: Boniva Ibandronate Intravenous Injection

>  <FLAG_COMMENTS>  (26) 
Ibanronate is not metabolized in humans.

>  <ID>  (26) 
Ibandronate

>  <Comment>  (26) 


>  <smile>  (26) 
CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O

$$$$
Bexagliflozin
     RDKit          3D

 32 35  0  0  1  0  0  0  0  0999 V2000
   -0.0445   -4.5145   -1.3373 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.4657    0.0791    0.1721 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1245    1.4091   -0.6583 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8901    3.8812    0.2509 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8857    1.9129   -1.6854 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6970    3.4767    0.7653 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0370   -0.5316    0.9193 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9779   -0.3338    1.1848 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6424    2.7951   -0.2930 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.7079    1.6116   -0.5582 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.7338    2.4274    0.7118 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.5089    0.3359   -0.8608 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.9725    2.5251   -1.0466 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4283    1.1255    0.3077 C   0  0  1  0  0  0  0  0  0  0  0  0
   -7.1974    3.5765    0.0002 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2956    3.8590   -1.1655 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6131   -0.8825   -0.9711 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4452    0.6793    1.3535 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8122   -1.2594    0.1071 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890   -1.6258   -2.1512 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8713    0.3182   -0.1333 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9874   -2.3795    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7642   -2.7459   -2.2532 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1452   -2.7511    1.1828 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9633   -3.1228   -1.1751 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9195   -0.8073    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2239   -2.1047    1.1837 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7471   -0.9148    1.1848 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3681   -0.7756    1.5817 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3414   -2.8388    0.7861 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6296   -0.1806    1.5823 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6030   -2.2438    0.7867 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 25  1  0
  2 12  1  0
  2 14  1  0
  3 13  1  0
  3 21  1  0
  9  4  1  1
 10  5  1  6
 11  6  1  6
  7 18  1  0
  8 26  1  0
  8 28  1  0
  9 10  1  0
  9 11  1  0
 10 12  1  0
 11 14  1  0
 12 17  1  1
 13 15  1  0
 13 16  1  0
 14 18  1  1
 15 16  1  0
 17 19  2  0
 17 20  1  0
 19 22  1  0
 20 23  2  0
 21 26  1  0
 22 24  1  0
 22 25  2  0
 23 25  1  0
 24 27  1  0
 27 29  2  0
 27 30  1  0
 28 31  2  0
 28 32  1  0
 29 31  1  0
 30 32  2  0
M  END
>  <InChIKey>  (27) 
BTCRKOKVYTVOLU-SJSRKZJXSA-N

>  <PubChem_CID>  (27) 
25195624

>  <BOM_1A2>  (27) 


>  <BOM_2A6>  (27) 


>  <BOM_2B6>  (27) 


>  <BOM_2C8>  (27) 
<13,3;Dealkylation;R2><13,H;Dealkylation;R2>

>  <BOM_2C9>  (27) 


>  <BOM_2C19>  (27) 


>  <BOM_2D6>  (27) 
<13,3;Dealkylation;R2><13,H;Dealkylation;R2>
<24,H;Hydroxylation;R3>

>  <BOM_2E1>  (27) 


>  <BOM_3A4>  (27) 
<13,3;Dealkylation;R1><13,H;Dealkylation;R1>
<21,3;Oxidation;R1><21,H;Oxidation;R1>
<13,3;Dealkylation;R2><13,H;Dealkylation;R2>
<24,H;Hydroxylation;R3>

>  <References>  (27) 
Zhang W, Li X, Ding H, Lu Y, Stilwell GE, Halvorsen YD, Welihinda A: Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans. Xenobiotica. 2020 May;50(5):559-569. doi: 10.1080/00498254.2019.1654634. Epub 2019 Aug 27.

>  <FLAG_COMMENTS>  (27) 


>  <ID>  (27) 
Bexagliflozin

>  <Comment>  (27) 


>  <smile>  (27) 
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O

$$$$
Oteseconazole
     RDKit          3D

 37 40  0  0  1  0  0  0  0  0999 V2000
   -2.9903   -2.5446    1.9077 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8581   -0.6038    2.8461 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6512    1.3859    2.3496 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8690    4.8229   -0.3707 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.5620    1.7419    0.0828 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.4922    0.1827   -1.4467 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.0910   -0.3141    0.6386 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9749   -0.8318    1.3152 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7988   -0.3113   -0.9206 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9197   -1.2120   -1.6103 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5445   -0.0133    1.5827 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6768   -0.5450   -2.7472 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8538   -0.9896   -2.5656 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8632   -0.4122   -3.3275 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7089   -0.6839    0.6367 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.6318   -1.2388    1.6421 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8036   -1.5683   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4828    0.8067    0.3659 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2011   -1.1410    1.2293 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9772    1.7622    1.2538 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7815    1.2080   -0.7711 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6255   -2.1843    0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7700    3.1189    1.0049 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5744    2.5647   -1.0202 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4187   -0.9170    0.4992 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7098   -2.0624    0.1538 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2480   -1.4783   -1.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0687    3.5201   -0.1321 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7516    0.0696    1.2074 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8087   -0.7607    0.1307 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6286   -1.8827    0.0084 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3297    0.5124   -0.1009 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9693   -1.7315   -0.3452 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6705    0.6635   -0.4544 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4903   -0.4584   -0.5766 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4431    0.8976   -0.5209 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9107    0.6279   -0.3129 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 16  1  0
  2 16  1  0
  3 20  1  0
  4 28  1  0
  5 37  1  0
  6 37  1  0
  7 37  1  0
 15  8  1  1
  9 35  1  0
  9 36  1  0
 10 12  1  0
 10 17  1  0
 10 27  1  0
 11 19  2  0
 11 29  1  0
 12 14  2  0
 13 14  1  0
 13 27  2  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
 16 19  1  0
 18 20  2  0
 18 21  1  0
 19 22  1  0
 20 23  1  0
 21 24  2  0
 22 26  2  0
 23 28  2  0
 24 28  1  0
 25 26  1  0
 25 29  2  0
 25 30  1  0
 30 31  2  0
 30 32  1  0
 31 33  1  0
 32 34  2  0
 33 35  2  0
 34 35  1  0
 36 37  1  0
M  END
>  <InChIKey>  (28) 
IDUYJRXRDSPPRC-NRFANRHFSA-N

>  <PubChem_CID>  (28) 
77050711

>  <BOM_1A2>  (28) 


>  <BOM_2A6>  (28) 


>  <BOM_2B6>  (28) 


>  <BOM_2C8>  (28) 


>  <BOM_2C9>  (28) 


>  <BOM_2C19>  (28) 


>  <BOM_2D6>  (28) 


>  <BOM_2E1>  (28) 


>  <BOM_3A4>  (28) 


>  <References>  (28) 
FDA Approved Drug Products: Vivjoa (oteseconazole) oral capsules

>  <FLAG_COMMENTS>  (28) 
Oteseconazole does not undergo significant metabolism.

>  <ID>  (28) 
Oteseconazole

>  <Comment>  (28) 


>  <smile>  (28) 
O[C@@](Cn1cnnn1)(c1ccc(F)cc1F)C(F)(F)c1ccc(-c2ccc(OCC(F)(F)F)cc2)cn1

$$$$
pazopanib
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    3.7320    2.8450    0.0000 S   0  0  0  0  0  6  0  0  0  0  0  0
    4.7320    2.8450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7320    2.8450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3241   -2.1550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1962   -3.1550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7404   -2.9597    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -0.1550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3301   -1.6550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -1.6550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    3.8450    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7942   -1.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7942   -2.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7404   -1.3503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0622   -2.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9282   -3.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9282   -1.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0622   -1.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0511   -0.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3301   -2.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    1.8450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3241   -2.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    1.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    0.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1962   -4.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    1.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    0.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -1.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -3.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.8450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -2.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  2  0
  1 10  1  0
  1 20  1  0
  4  6  1  0
  4 13  1  0
  4 21  1  0
  5 14  1  0
  5 19  1  0
  5 24  1  0
  6 12  2  0
  7 23  1  0
  7 28  1  0
  8 19  2  0
  8 28  1  0
  9 28  2  0
  9 31  1  0
 11 12  1  0
 11 13  2  0
 11 16  1  0
 12 15  1  0
 13 18  1  0
 14 15  2  0
 14 17  1  0
 16 17  2  0
 19 29  1  0
 20 22  2  0
 20 25  1  0
 22 26  1  0
 22 30  1  0
 23 25  2  0
 23 27  1  0
 26 27  2  0
 29 31  2  0
M  END
>  <InChIKey>  (29) 
CUIHSIWYWATEQL-UHFFFAOYSA-N

>  <PubChem_CID>  (29) 
10113978

>  <BOM_1A2>  (29) 
<24,5;Dealkylation;R1><24,H;Dealkylation;R1>
<18,H;Hydroxylation;R2>
<30,H;Hydroxylation;R3>
<21,4;Dealkylation;R4><21,H;Dealkylation;R4>

>  <BOM_2A6>  (29) 


>  <BOM_2B6>  (29) 


>  <BOM_2C8>  (29) 
<24,5;Dealkylation;R1><24,H;Dealkylation;R1>
<18,H;Hydroxylation;R2>
<30,H;Hydroxylation;R3>
<21,4;Dealkylation;R4><21,H;Dealkylation;R4>

>  <BOM_2C9>  (29) 


>  <BOM_2C19>  (29) 


>  <BOM_2D6>  (29) 


>  <BOM_2E1>  (29) 


>  <BOM_3A4>  (29) 
<24,5;Dealkylation;R1><24,H;Dealkylation;R1>
<18,H;Hydroxylation;R2>
<30,H;Hydroxylation;R3>
<21,4;Dealkylation;R4><21,H;Dealkylation;R4>

>  <References>  (29) 
Thorn, Caroline F., et al. "PharmGKB summary: pazopanib pathway, pharmacokinetics." Pharmacogenetics and genomics 27.8 (2017): 307-312.

>  <FLAG_COMMENTS>  (29) 


>  <ID>  (29) 
pazopanib

>  <Comment>  (29) 


>  <smile>  (29) 
Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O

$$$$
Cabazitaxel
     RDKit          2D

 60 65  0  0  0  0  0  0  0  0999 V2000
    2.1157   -0.3730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890    0.0174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4210    1.1234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5156    2.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4839    2.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9075    1.4581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1731    1.4581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1986    0.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1731    0.1753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1986    2.0902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4486   -0.4664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7839   -0.7437    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4141   -1.1234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1494   -0.7194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4141   -1.8345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7253    2.7874    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0708   -1.2526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6419   -2.9026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6419   -3.7277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3564   -4.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0708   -3.7277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0708   -2.9026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3564   -2.4901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3564   -1.6651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6419   -1.2526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0850    2.9166    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1477    0.3798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1477    1.1234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1477    1.9484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9075    0.1753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9075   -0.6496    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9845    1.2291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9845    0.4041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890    1.4859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890    2.3109    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4210    0.3798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1356   -0.0326    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2700    0.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8460    0.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4349    0.8401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1494    0.4276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1494   -0.3973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4349   -0.8098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7040    0.4276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7040   -0.3973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2750    0.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9895    0.8401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5607    0.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5607    1.6816    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2750   -0.3809    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9895    1.6651    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4183    3.3152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7040    2.9026    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7040    2.0776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4183    1.6651    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5034    2.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5608    3.5907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4183    4.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1329    2.9027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1329    3.7277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  7  2  0
  8  7  1  0
  7 10  1  0
 38  6  1  0
  5  6  1  0
  9  8  1  0
 30 38  1  0
 30  9  1  0
  1 30  1  0
 27  1  1  1
 36  3  1  1
 34  3  1  0
  2 36  1  0
 28 34  1  0
 27  2  1  0
  2 11  1  0
 27 28  1  0
  4 28  1  0
  4  5  1  0
  2 12  1  6
 13 12  1  0
 14 13  1  0
 15 13  2  0
  1 17  1  6
 16  4  2  0
  5 26  1  1
  8 39  1  6
 24 17  1  0
 23 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 23 22  1  0
 23 24  1  0
 24 25  2  0
 28 29  1  1
 30 31  1  1
 38 32  1  0
 38 33  1  0
 34 35  1  1
 36 37  1  0
 11 37  1  0
 48 39  1  0
 40 41  2  0
 40 44  1  0
 41 42  1  0
 42 43  2  0
 43 45  1  0
 47 44  1  0
 45 44  2  0
 47 46  1  0
 48 46  1  0
 46 50  1  6
 47 51  1  6
 48 49  2  0
 54 51  1  0
 53 52  1  0
 53 54  1  0
 54 55  2  0
 35 56  1  0
 26 57  1  0
 52 58  1  0
 52 59  1  0
 52 60  1  0
M  END
>  <InChIKey>  (30) 
BMQGVNUXMIRLCK-OAGWZNDDSA-N

>  <PubChem_CID>  (30) 


>  <BOM_1A2>  (30) 


>  <BOM_2A6>  (30) 


>  <BOM_2B6>  (30) 


>  <BOM_2C8>  (30) 
<26,57;Dealkylation;R1><57,H;Dealkylation;R1>
<35,56;Dealkylation;R2><56,H;Dealkylation;R2>

>  <BOM_2C9>  (30) 


>  <BOM_2C19>  (30) 


>  <BOM_2D6>  (30) 


>  <BOM_2E1>  (30) 


>  <BOM_3A4>  (30) 
<26,57;Dealkylation;R1><57,H;Dealkylation;R1>
<35,56;Dealkylation;R2><56,H;Dealkylation;R2>
<58,H;Hydroxylation;R3>/<59,H;Hydroxylation;R3>/<60,H;Hydroxylation;R3>

>  <References>  (30) 
Kort A, Hillebrand MJ, Cirkel GA, Voest EE, Schinkel AH, Rosing H, Schellens JH, Beijnen JH: Quantification of cabazitaxel, its metabolite docetaxel and the determination of the demethylated metabolites RPR112698 and RPR123142 as docetaxel equivalents in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Apr 15;925:117-23. doi: 10.1016/j.jchromb.2013.02.034. Epub 2013 Mar 5.
Vrignaud P, Semiond D, Benning V, Beys E, Bouchard H, Gupta S. Preclinical profile of cabazitaxel. Drug Des Devel Ther. 2014 Oct 13;8:1851-67. doi: 10.2147/DDDT.S64940. PMID: 25378905; PMCID: PMC4207555.

>  <FLAG_COMMENTS>  (30) 


>  <ID>  (30) 
Cabazitaxel

>  <Comment>  (30) 


>  <smile>  (30) 
CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C

$$$$
Relebactam
     RDKit          3D

 23 25  0  0  1  0  0  0  0  0999 V2000
    4.7770    0.8916    0.2606 S   0  0  0  0  0  6  0  0  0  0  0  0
    3.6987   -0.1390   -0.4478 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5202    0.7809   -2.1714 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9299   -2.5122    0.4208 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1035    2.1895    0.2293 O   0  0  0  0  0  1  0  0  0  0  0  0
    5.9625    0.8147   -0.5920 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9701    0.3397    1.6012 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1471    0.0556   -0.3227 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3855    0.1075   -0.0749 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6286   -0.4778   -0.4695 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9645    2.1788    0.4607 N   0  0  0  0  0  4  0  0  0  0  0  0
    1.8187   -0.6334    1.0424 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.3774   -1.2047   -0.8330 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.4681    0.0572    1.1038 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5491   -2.1197    0.6910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6491   -2.3340   -0.5634 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9959   -0.5168   -0.0029 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3882    0.4434   -1.0046 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7125   -1.4840   -0.2149 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1097    0.0762    1.4053 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9387    0.1881   -0.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8055    1.7050   -0.9458 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9750    1.5932    1.4129 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  1  0
  1  6  2  0
  1  7  2  0
  2  9  1  0
  3 18  2  0
  4 19  2  0
  8 13  1  0
  8 14  1  0
  8 18  1  0
  9 12  1  0
  9 18  1  0
 10 17  1  0
 10 19  1  0
 11 22  1  0
 11 23  1  0
 12 14  1  0
 12 15  1  6
 13 16  1  0
 13 19  1  1
 15 16  1  0
 17 20  1  0
 17 21  1  0
 20 23  1  0
 21 22  1  0
M  CHG  2   5  -1  11   1
M  END
>  <InChIKey>  (31) 
SMOBCLHAZXOKDQ-ZJUUUORDSA-N

>  <PubChem_CID>  (31) 
121301826

>  <BOM_1A2>  (31) 


>  <BOM_2A6>  (31) 


>  <BOM_2B6>  (31) 


>  <BOM_2C8>  (31) 


>  <BOM_2C9>  (31) 


>  <BOM_2C19>  (31) 


>  <BOM_2D6>  (31) 


>  <BOM_2E1>  (31) 


>  <BOM_3A4>  (31) 


>  <References>  (31) 
FDA Approved Drug Products: Recarbrio (imipenem, cilastatin, and relebactam) for intravenous injection

>  <FLAG_COMMENTS>  (31) 
Relebactam does not undergo significant metabolism and can be found mostly unchanged in human plasma.

>  <ID>  (31) 
Relebactam

>  <Comment>  (31) 


>  <smile>  (31) 
O=C(NC1CC[NH2+]CC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)[O-]

$$$$
Desvenlafaxine
     RDKit          3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -1.3482    0.5910   -1.4914 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4342    2.2329   -0.2134 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8230   -2.8292    0.0218 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5751    0.1845   -0.1385 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3801   -0.6638    0.3003 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.6798    1.4509    0.7253 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8757   -0.6325   -0.0723 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9153    2.2860    0.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1063    0.2091   -0.4135 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1931    1.4566    0.4596 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2838   -2.0058   -0.4565 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9198    0.1179    0.1615 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6551    0.3933    1.2953 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3198    0.5261   -1.0936 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9263   -4.0583   -0.7655 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6520   -3.1459    1.4402 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8451    1.1100    1.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5098    1.2427   -1.2209 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2724    1.5346   -0.0901 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  2 19  1  0
  3 11  1  0
  3 15  1  0
  3 16  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  5 11  1  6
  5 12  1  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 10  1  0
 12 13  2  0
 12 14  1  0
 13 17  1  0
 14 18  2  0
 17 19  2  0
 18 19  1  0
M  END
>  <InChIKey>  (32) 
KYYIDSXMWOZKMP-UHFFFAOYSA-N

>  <PubChem_CID>  (32) 
125017

>  <BOM_1A2>  (32) 


>  <BOM_2A6>  (32) 


>  <BOM_2B6>  (32) 


>  <BOM_2C8>  (32) 


>  <BOM_2C9>  (32) 
<16,3;Dealkylation;R1><16,H;Dealkylation;R1>/<15,3;Dealkylation;R1><15,H;Dealkylation;R1>

>  <BOM_2C19>  (32) 
<16,3;Dealkylation;R1><16,H;Dealkylation;R1>/<15,3;Dealkylation;R1><15,H;Dealkylation;R1>

>  <BOM_2D6>  (32) 


>  <BOM_2E1>  (32) 


>  <BOM_3A4>  (32) 
<16,3;Dealkylation;R1><16,H;Dealkylation;R1>/<15,3;Dealkylation;R1><15,H;Dealkylation;R1>

>  <References>  (32) 
Preskorn S, Patroneva A, Silman H, Jiang Q, Isler JA, Burczynski ME, Ahmed S, Paul J, Nichols AI: Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers. J Clin Psychopharmacol. 2009 Feb;29(1):39-43. doi: 10.1097/JCP.0b013e318192e4c1. 
Holliday SM, Benfield P: Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs. 1995 Feb;49(2):280-94.

>  <FLAG_COMMENTS>  (32) 


>  <ID>  (32) 
Desvenlafaxine

>  <Comment>  (32) 


>  <smile>  (32) 
CN(C)C[C@@H](c1ccc(O)cc1)C1(O)CCCCC1

$$$$
rivoglitazone
     RDKit          2D

 28 31  0  0  1  0  0  0  0  0999 V2000
   12.5872   -1.3686    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.4939    0.4110    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    2.2770    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6576    0.1836    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2258   -3.0322    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4103    2.0817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4103    0.4723    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1964   -1.5377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4939    0.4110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9939   -0.4551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641    1.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9939    1.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4939    0.4110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641    0.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9939    1.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9885   -0.5596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    2.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9939   -0.4551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9939    1.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4939    0.4110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7210    3.0322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    0.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9939   -0.4551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9939    1.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    1.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3303   -2.0377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 27  1  0
  2 15  1  0
  2 20  1  0
  3 25  1  0
  3 28  1  0
  4 16  2  0
  5 27  2  0
  6 11  1  0
  6 12  1  0
  6 21  1  0
  7 12  2  0
  7 14  1  0
  8 16  1  0
  8 27  1  0
  9 10  1  0
  9 13  1  0
 10 16  1  0
 11 14  2  0
 11 17  1  0
 12 15  1  0
 13 18  2  0
 13 19  1  0
 14 22  1  0
 17 25  2  0
 18 23  1  0
 19 24  2  0
 20 23  2  0
 20 24  1  0
 22 26  2  0
 25 26  1  0
M  END
>  <InChIKey>  (33) 
XMSXOLDPMGMWTH-UHFFFAOYSA-N

>  <PubChem_CID>  (33) 
3055168

>  <BOM_1A2>  (33) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2><21,H;Dealkylation;R2>
<28,3;Dealkylation;R3><28,H;Dealkylation;R3>

>  <BOM_2A6>  (33) 


>  <BOM_2B6>  (33) 


>  <BOM_2C8>  (33) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2><21,H;Dealkylation;R2>
<28,3;Dealkylation;R3><28,H;Dealkylation;R3>

>  <BOM_2C9>  (33) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2><21,H;Dealkylation;R2>
<28,3;Dealkylation;R3><28,H;Dealkylation;R3>

>  <BOM_2C19>  (33) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2><21,H;Dealkylation;R2>
<28,3;Dealkylation;R3><28,H;Dealkylation;R3>

>  <BOM_2D6>  (33) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2><21,H;Dealkylation;R2>
<28,3;Dealkylation;R3><28,H;Dealkylation;R3>

>  <BOM_2E1>  (33) 


>  <BOM_3A4>  (33) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2><21,H;Dealkylation;R2>
<28,3;Dealkylation;R3><28,H;Dealkylation;R3>

>  <References>  (33) 
Uchiyama, Minoru, et al. "In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor r agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytes." Drug metabolism and disposition 39.7 (2011): 1311-1319.

>  <FLAG_COMMENTS>  (33) 


>  <ID>  (33) 
rivoglitazone

>  <Comment>  (33) 


>  <smile>  (33) 
COc1ccc2nc(COc3ccc(CC4SC(=O)NC4=O)cc3)n(C)c2c1

$$$$
Primidone
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -1.4743   -2.3135   -0.3835 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5353    2.2626   -0.4939 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4865   -1.1694    1.6021 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5346    1.2083    1.5420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6261   -0.0119   -0.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9206   -0.0462   -1.9167 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9084    0.0005   -0.2344 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2430   -1.2811    0.2449 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2840    1.2655    0.1822 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1950    0.0446    2.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4107   -0.0275   -2.1847 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6009   -1.2020   -0.1747 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5785    1.2138   -0.1465 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9875   -1.1908   -0.0243 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9652    1.2248    0.0038 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6696    0.0224    0.0648 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  8  2  0
  2  9  2  0
  3  8  1  0
  3 10  1  0
  4  9  1  0
  4 10  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  5  9  1  0
  6 11  1  0
  7 12  2  0
  7 13  1  0
 12 14  1  0
 13 15  2  0
 14 16  2  0
 15 16  1  0
M  END
>  <InChIKey>  (34) 
DQMZLTXERSFNPB-UHFFFAOYSA-N

>  <PubChem_CID>  (34) 
4909

>  <BOM_1A2>  (34) 


>  <BOM_2A6>  (34) 


>  <BOM_2B6>  (34) 


>  <BOM_2C8>  (34) 


>  <BOM_2C9>  (34) 
<10,H;Oxidation;R1>
<10,4;Dealkylation;R1><10,3;Dealkylation;R1><10,H;Dealkylation;R1>

>  <BOM_2C19>  (34) 
<10,H;Oxidation;R1>
<10,4;Dealkylation;R1><10,3;Dealkylation;R1><10,H;Dealkylation;R1>

>  <BOM_2D6>  (34) 


>  <BOM_2E1>  (34) 
<10,H;Oxidation;R1>
<10,4;Dealkylation;R1><10,3;Dealkylation;R1><10,H;Dealkylation;R1>

>  <BOM_3A4>  (34) 


>  <References>  (34) 
Hedera P, Cibulcik F, Davis TL: Pharmacotherapy of essential tremor. J Cent Nerv Syst Dis. 2013 Dec 22;5:43-55. doi: 10.4137/JCNSD.S6561.
Marvanova M: Pharmacokinetic characteristics of antiepileptic drugs (AEDs). Ment Health Clin. 2016 Mar 8;6(1):8-20. doi: 10.9740/mhc.2015.01.008. eCollection 2016 Jan.
El-Masri HA, Portier CJ: Physiologically based pharmacokinetics model of primidone and its metabolites phenobarbital and phenylethylmalonamide in humans, rats, and mice. Drug Metab Dispos. 1998 Jun;26(6):585-94.
Zaccara G, Perucca E: Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord. 2014 Dec;16(4):409-31. doi: 10.1684/epd.2014.0714.

>  <FLAG_COMMENTS>  (34) 


>  <ID>  (34) 
Primidone

>  <Comment>  (34) 


>  <smile>  (34) 
CCC1(c2ccccc2)C(=O)NCNC1=O

$$$$
Vaborbactam
     RDKit          2D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -4.8946    4.3527    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8946    3.5277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6091    3.1152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3235    3.5277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3235    4.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6091    4.7652    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0380    4.7652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0380    5.5902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7525    6.0027    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3235    6.0027    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1801    3.1152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1801    2.2902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8946    1.8777    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4656    1.8777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4656    1.0527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7982    0.5678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0531   -0.2169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8781   -0.2169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1331    0.5678    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1801    4.7652    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  5  7  1  1
  7  8  1  0
  8  9  2  0
  8 10  1  0
  2 11  1  1
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 15 19  1  0
  1 20  1  0
M  END
>  <InChIKey>  (35) 
IOOWNWLVCOUUEX-WPRPVWTQSA-N

>  <PubChem_CID>  (35) 


>  <BOM_1A2>  (35) 


>  <BOM_2A6>  (35) 


>  <BOM_2B6>  (35) 


>  <BOM_2C8>  (35) 


>  <BOM_2C9>  (35) 


>  <BOM_2C19>  (35) 


>  <BOM_2D6>  (35) 


>  <BOM_2E1>  (35) 


>  <BOM_3A4>  (35) 


>  <References>  (35) 
VABOMERE (meropenem and vaborbactam) for injection FDA label

>  <FLAG_COMMENTS>  (35) 
Vaborbactam does not undergo metabolism.

>  <ID>  (35) 
Vaborbactam

>  <Comment>  (35) 


>  <smile>  (35) 
O=C(O)C[C@@H]1CC[C@H](NC(=O)Cc2cccs2)B(O)O1

$$$$
Ketorolac
     RDKit          3D

 19 21  0  0  1  0  0  0  0  0999 V2000
   -4.5944    1.6943    0.6581 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0057    1.7621   -0.9844 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8162   -2.3545    0.6129 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9658   -0.7134    0.2798 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2588   -0.2292    0.3050 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.7181   -0.3010    1.7575 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1799   -0.2786    1.6455 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0966   -0.6898   -0.4819 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1018   -1.1450   -0.4209 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7643   -1.1233   -1.7385 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3638   -1.4107   -1.6995 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5900    1.1738   -0.0871 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4276   -1.2829    0.0913 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4503   -0.1751    0.0484 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0821    1.0190   -0.5097 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6908   -0.4242    0.5705 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0277    2.0436   -0.5492 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6363    0.6006    0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3046    1.8344   -0.0288 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  2 12  2  0
  3 13  2  0
  4  7  1  0
  4  8  1  0
  4  9  1  0
  5  6  1  0
  5  8  1  0
  5 12  1  6
  6  7  1  0
  8 10  2  0
  9 11  2  0
  9 13  1  0
 10 11  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 15 17  1  0
 16 18  2  0
 17 19  2  0
 18 19  1  0
M  END
>  <InChIKey>  (36) 
OZWKMVRBQXNZKK-UHFFFAOYSA-N

>  <PubChem_CID>  (36) 
3826

>  <BOM_1A2>  (36) 


>  <BOM_2A6>  (36) 


>  <BOM_2B6>  (36) 


>  <BOM_2C8>  (36) 
<19,H;Hydroxylation;R1>

>  <BOM_2C9>  (36) 
<19,H;Hydroxylation;R1>

>  <BOM_2C19>  (36) 


>  <BOM_2D6>  (36) 


>  <BOM_2E1>  (36) 


>  <BOM_3A4>  (36) 


>  <References>  (36) 
Allegaert K, van Calsteren K, Hendrickx S, Kelchtermans J, Smits A, Kulo A, van de Velde M: Paracetamol and ketorolac pharmacokinetics and metabolism at delivery and during postpartum. Acta Anaesthesiol Belg. 2012;63(3):121-5. 
Valitalo PA, Kemppainen H, Kulo A, Smits A, van Calsteren K, Olkkola KT, de Hoon J, Knibbe CAJ, Allegaert K: Body weight, gender and pregnancy affect enantiomer-specific ketorolac pharmacokinetics. Br J Clin Pharmacol. 2017 Sep;83(9):1966-1975.

>  <FLAG_COMMENTS>  (36) 


>  <ID>  (36) 
Ketorolac

>  <Comment>  (36) 


>  <smile>  (36) 
O=C(c1ccccc1)c1ccc2n1CC[C@H]2C(=O)O

$$$$
Piperaquine
     RDKit          3D

 37 42  0  0  0  0  0  0  0  0999 V2000
   -7.4578    4.9057    0.7856 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.3180    0.4757   -2.0371 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.2288   -2.5514    0.5903 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1041   -2.2527    0.8047 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6227   -1.1930   -0.1736 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0619   -0.1916    0.5259 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3433    0.3928   -1.3581 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7427    3.0597    0.4702 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8579   -2.6632    1.0869 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4699   -3.5391    0.5186 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0210   -3.3727    0.0552 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2680   -1.7480   -0.6376 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0979   -1.9492    1.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4688   -2.4523    1.3082 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1339   -1.4139   -0.3996 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6900   -1.6699   -1.1992 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5472   -1.8790    1.1224 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1231   -1.1157    1.6653 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7447   -0.0427   -0.1001 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8510   -0.6416   -0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9706    0.8721    0.4925 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2328    0.6866   -0.2326 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2499    0.7741   -0.1136 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7557   -1.4248   -1.2878 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6155    2.0952    1.0816 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4913    1.1632   -0.6555 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1054    1.8957   -0.1013 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3684    1.5183    0.4993 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6609   -0.4253   -0.7194 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9646   -0.8708   -1.6575 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5201    3.1370    1.0439 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8413    2.4697   -0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3548    1.7729   -0.7030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7441    2.8209    0.8150 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9160   -0.5202   -1.3136 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9821    3.2969    0.4016 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7638    0.5806   -1.3053 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 36  1  0
  2 37  1  0
  3  9  1  0
  3 12  1  0
  3 13  1  0
  4 10  1  0
  4 14  1  0
  4 15  1  0
  5 16  1  0
  5 17  1  0
  5 20  1  0
  6 18  1  0
  6 19  1  0
  6 21  1  0
  7 26  2  0
  7 30  1  0
  8 27  2  0
  8 31  1  0
  9 11  1  0
 10 11  1  0
 12 16  1  0
 13 17  1  0
 14 18  1  0
 15 19  1  0
 20 22  2  0
 20 24  1  0
 21 23  2  0
 21 25  1  0
 22 26  1  0
 22 28  1  0
 23 27  1  0
 23 29  1  0
 24 30  2  0
 25 31  2  0
 26 32  1  0
 27 33  1  0
 28 34  2  0
 29 35  2  0
 32 36  2  0
 33 37  2  0
 34 36  1  0
 35 37  1  0
M  END
>  <InChIKey>  (37) 
UCRHFBCYFMIWHC-UHFFFAOYSA-N

>  <PubChem_CID>  (37) 
122262

>  <BOM_1A2>  (37) 


>  <BOM_2A6>  (37) 


>  <BOM_2B6>  (37) 


>  <BOM_2C8>  (37) 


>  <BOM_2C9>  (37) 


>  <BOM_2C19>  (37) 


>  <BOM_2D6>  (37) 


>  <BOM_2E1>  (37) 


>  <BOM_3A4>  (37) 
<10,4;Dealkylation;R1><10,H;Dealkylation;R1>
<8,N;N-Oxidation;R2>

>  <References>  (37) 
Tarning J, Bergqvist Y, Day NP, Bergquist J, Arvidsson B, White NJ, Ashton M, Lindegardh N: Characterization of human urinary metabolites of the antimalarial piperaquine. Drug Metab Dispos. 2006 Dec;34(12):2011-9. doi: 10.1124/dmd.106.011494. Epub 2006 Sep 6. 
Lee, Tina Ming-Na, et al. "In vitro metabolism of piperaquine is primarily mediated by CYP3A4." Xenobiotica 42.11 (2012): 1088-1095.

>  <FLAG_COMMENTS>  (37) 


>  <ID>  (37) 
Piperaquine

>  <Comment>  (37) 


>  <smile>  (37) 
Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1

$$$$
Phentermine
     RDKit          3D

 11 11  0  0  0  0  0  0  0  0999 V2000
    3.3888    0.0526   -0.5981 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0831    0.0002    0.0827 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9797   -0.0013   -1.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9984    1.2309    0.9959 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0660   -1.2787    0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4494   -0.0010   -0.5158 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0899   -1.2087   -0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0902    1.2072   -0.2966 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4089   -1.2084    0.1598 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090    1.2076    0.1574 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0685   -0.0003    0.3855 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  7  9  1  0
  8 10  2  0
  9 11  2  0
 10 11  1  0
M  END
>  <InChIKey>  (38) 
DHHVAGZRUROJKS-UHFFFAOYSA-N

>  <PubChem_CID>  (38) 
4771

>  <BOM_1A2>  (38) 


>  <BOM_2A6>  (38) 


>  <BOM_2B6>  (38) 


>  <BOM_2C8>  (38) 


>  <BOM_2C9>  (38) 


>  <BOM_2C19>  (38) 


>  <BOM_2D6>  (38) 


>  <BOM_2E1>  (38) 


>  <BOM_3A4>  (38) 
<11,H;Hydroxylation;R1>
<1,N;N-Oxidation;R2>

>  <References>  (38) 
Choi YJ, Sim A, Kim MK, Suh S, In MK, Kim JY: Determination of phentermine, N-hydroxyphentermine and mephentermine in urine using dilute and shoot liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 1;1029-1030:22-27. doi: 10.1016/j.jchromb.2016.06.045. Epub 2016 Jun 27. 
FDA Approved Drug Products: Qsymia (phentermine and topiramate), extended-release capsules for oral use

>  <FLAG_COMMENTS>  (38) 


>  <ID>  (38) 
Phentermine

>  <Comment>  (38) 


>  <smile>  (38) 
CC(C)(N)Cc1ccccc1

$$$$
Vortioxetine
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.2033    0.1846   -1.4480 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4973    0.2127    0.0879 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1984    2.5037    0.0051 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4665    0.3711   -1.0049 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8047    0.9443    1.3217 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7785    1.8497   -1.2333 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1419    2.4023    1.0104 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7660   -0.9788    0.1516 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5215   -1.1453   -0.4938 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2763   -2.0692    0.8859 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1793   -2.3483   -0.4081 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5756   -3.2722    0.9717 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7411    0.4319   -0.5753 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3477   -3.4117    0.3247 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9778    0.2792   -1.2056 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6894    0.7876    0.7739 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1578    0.4813   -0.4894 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1035    0.8364    0.8584 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8693    0.9897    1.4899 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0882   -0.1013   -2.6476 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3646    1.0524    1.6247 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0
  1 13  1  0
  2  4  1  0
  2  5  1  0
  2  8  1  0
  3  6  1  0
  3  7  1  0
  4  6  1  0
  5  7  1  0
  8  9  1  0
  8 10  2  0
  9 11  2  0
 10 12  1  0
 11 14  1  0
 12 14  2  0
 13 15  2  0
 13 16  1  0
 15 17  1  0
 15 20  1  0
 16 19  2  0
 17 18  2  0
 18 19  1  0
 18 21  1  0
M  END
>  <InChIKey>  (39) 
YQNWZWMKLDQSAC-UHFFFAOYSA-N

>  <PubChem_CID>  (39) 
9966051

>  <BOM_1A2>  (39) 


>  <BOM_2A6>  (39) 
<1,S;S-Oxidation;R4>

>  <BOM_2B6>  (39) 
<3,N;N-Oxidation;R3>

>  <BOM_2C8>  (39) 
<1,S;S-Oxidation;R4>

>  <BOM_2C9>  (39) 
<14,H;Hydroxylation;R1>
<21,H;Hydroxylation;R2>
<3,N;N-Oxidation;R3>

>  <BOM_2C19>  (39) 
<3,N;N-Oxidation;R3>

>  <BOM_2D6>  (39) 
<14,H;Hydroxylation;R1>
<21,H;Hydroxylation;R2>

>  <BOM_2E1>  (39) 


>  <BOM_3A4>  (39) 
<1,S;S-Oxidation;R4>

>  <References>  (39) 
Hvenegaard MG, Bang-Andersen B, Pedersen H, Jorgensen M, Puschl A, Dalgaard L: Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004. Drug Metab Dispos. 2012 Jul;40(7):1357-65. doi: 10.1124/dmd.112.044610. Epub 2012 Apr 11.

>  <FLAG_COMMENTS>  (39) 


>  <ID>  (39) 
Vortioxetine

>  <Comment>  (39) 


>  <smile>  (39) 
Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1

$$$$
Belinostat
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -2.8405   -0.4591   -1.2818 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0613   -1.2489   -1.3913 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1444   -0.0693   -2.5019 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7765   -1.2033    0.1710 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7754    1.0582   -0.9261 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1936    0.9442   -0.3464 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3934    0.8437   -0.8315 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7293   -1.3361   -0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3568   -1.1103   -0.3659 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5304   -1.8115    0.4509 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2144   -2.2630    0.6628 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0902    1.7154    0.1598 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0450   -2.7382    1.3737 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3273   -2.9639    1.4796 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1810    2.2786   -0.7276 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9457    1.8898    1.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9617   -1.5769    0.3406 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1111    3.0269   -0.2366 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8759    2.6383    2.0219 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0414    3.2068    1.1379 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5328   -0.4797   -0.2049 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0148   -0.3416   -0.2554 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  2  0
  1  6  1  0
  1  8  1  0
  4 22  2  0
  5  7  1  0
  6 12  1  0
  7 22  1  0
  8  9  2  0
  8 11  1  0
  9 10  1  0
 10 13  2  0
 10 17  1  0
 11 14  2  0
 12 15  2  0
 12 16  1  0
 13 14  1  0
 15 18  1  0
 16 19  2  0
 17 21  2  0
 18 20  2  0
 19 20  1  0
 21 22  1  0
M  END
>  <InChIKey>  (40) 
NCNRHFGMJRPRSK-MDZDMXLPSA-N

>  <PubChem_CID>  (40) 
6918638

>  <BOM_1A2>  (40) 


>  <BOM_2A6>  (40) 
<22,7;Hydrolysis;R1>
<7,5;Reduction;R2>

>  <BOM_2B6>  (40) 


>  <BOM_2C8>  (40) 


>  <BOM_2C9>  (40) 
<22,7;Hydrolysis;R1>
<7,5;Reduction;R2>

>  <BOM_2C19>  (40) 


>  <BOM_2D6>  (40) 


>  <BOM_2E1>  (40) 


>  <BOM_3A4>  (40) 
<22,7;Hydrolysis;R1>
<7,5;Reduction;R2>

>  <References>  (40) 
Dunn, A., Takebe, N., Chen, A. et al. The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers. Cancer Chemother Pharmacol (2024). https://doi.org/10.1007/s00280-024-04651-x

>  <FLAG_COMMENTS>  (40) 


>  <ID>  (40) 
Belinostat

>  <Comment>  (40) 


>  <smile>  (40) 
O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO

$$$$
Cyazofamid
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.0923   -3.7384   -0.7328 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.1173    1.4107    0.6062 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4870    1.8835    0.6696 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2932    1.3985    1.7995 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2667   -0.2637    0.1779 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2809    2.1878   -0.6830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2156   -2.1431   -0.2859 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8098    0.0931    0.3359 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2353   -1.0666   -0.0473 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1640   -0.7139    0.0174 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4301   -0.8878    0.0401 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8495   -2.2613   -0.3415 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8164   -0.2448   -1.1216 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8594   -0.8436    1.2185 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9077    2.1408   -2.0279 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292    3.5110   -0.3995 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8648   -0.0340    0.1417 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1676    0.0954   -1.0594 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2107   -0.5034    1.2808 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3098    0.3292    0.2089 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7365   -0.3493    0.2025 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  2  6  1  0
  5  9  1  0
  5 11  1  0
  6 15  1  0
  6 16  1  0
  7 11  2  0
  7 12  1  0
  8 21  3  0
  9 10  1  0
  9 12  2  0
 10 13  2  0
 10 14  1  0
 11 21  1  0
 13 18  1  0
 14 19  2  0
 17 18  2  0
 17 19  1  0
 17 20  1  0
M  END
>  <InChIKey>  (41) 
YXKMMRDKEKCERS-UHFFFAOYSA-N

>  <PubChem_CID>  (41) 
9862076

>  <BOM_1A2>  (41) 


>  <BOM_2A6>  (41) 


>  <BOM_2B6>  (41) 
<20,H;Hydroxylation;R1>

>  <BOM_2C8>  (41) 


>  <BOM_2C9>  (41) 
<20,H;Hydroxylation;R1>

>  <BOM_2C19>  (41) 
<20,H;Hydroxylation;R1>

>  <BOM_2D6>  (41) 


>  <BOM_2E1>  (41) 


>  <BOM_3A4>  (41) 


>  <References>  (41) 
Lee, H., et al. "Biotransformation and molecular docking of cyazofamid by human liver microsomes and cDNA-expressed human recombinant P450s." Applied Biological Chemistry 59 (2016): 649-653.

>  <FLAG_COMMENTS>  (41) 


>  <ID>  (41) 
Cyazofamid

>  <Comment>  (41) 


>  <smile>  (41) 
Cc1ccc(-c2c(Cl)nc(C#N)n2S(=O)(=O)N(C)C)cc1

$$$$
Hydroxychloroquine
     RDKit          3D

 23 24  0  0  1  0  0  0  0  0999 V2000
   -4.9068   -1.9876   -1.6099 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.2693   -2.9958    0.4835 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9165   -1.2358   -0.1070 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0406    2.4644   -0.3071 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1893   -0.0466    2.2104 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3087    1.6277    0.0766 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3903    0.8671   -1.2528 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4002    2.8618   -0.0060 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.3526   -0.3158   -1.1511 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5550   -1.7055   -0.3698 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8790    3.8197   -1.0921 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8345   -2.3716   -0.0046 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7079    1.6265    0.4999 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0583   -2.5775    0.7722 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2422   -1.9109    0.3332 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7118    0.7631   -0.0086 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4750    1.6215    1.8831 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4298   -0.0583    0.8856 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9890    0.7252   -1.3856 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2286    0.7826    2.6787 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4099   -0.8967    0.3615 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9747   -0.1228   -1.8825 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6858   -0.9346   -1.0076 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 23  1  0
  2 14  1  0
  3  9  1  0
  3 10  1  0
  3 12  1  0
  4  8  1  0
  4 13  1  0
  5 18  2  0
  5 20  1  0
  6  7  1  0
  6  8  1  0
  7  9  1  0
  8 11  1  6
 10 14  1  0
 12 15  1  0
 13 16  2  0
 13 17  1  0
 16 18  1  0
 16 19  1  0
 17 20  2  0
 18 21  1  0
 19 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <InChIKey>  (42) 
XXSMGPRMXLTPCZ-UHFFFAOYSA-N

>  <PubChem_CID>  (42) 
3652

>  <BOM_1A2>  (42) 
<10,3;Dealkylation;R1><10,H;Dealkylation;R1>
<12,3;Dealkylation;R2><12,H;Dealkylation;R2>

>  <BOM_2A6>  (42) 


>  <BOM_2B6>  (42) 


>  <BOM_2C8>  (42) 
<10,3;Dealkylation;R1><10,H;Dealkylation;R1>
<12,3;Dealkylation;R2><12,H;Dealkylation;R2>

>  <BOM_2C9>  (42) 


>  <BOM_2C19>  (42) 
<10,3;Dealkylation;R1><10,H;Dealkylation;R1>
<12,3;Dealkylation;R2><12,H;Dealkylation;R2>

>  <BOM_2D6>  (42) 
<10,3;Dealkylation;R1><10,H;Dealkylation;R1>
<12,3;Dealkylation;R2><12,H;Dealkylation;R2>

>  <BOM_2E1>  (42) 


>  <BOM_3A4>  (42) 
<10,3;Dealkylation;R1><10,H;Dealkylation;R1>
<12,3;Dealkylation;R2><12,H;Dealkylation;R2>

>  <References>  (42) 
Rendic, Slobodan, and Frederick P. Guengerich. "Metabolism and interactions of chloroquine and hydroxychloroquine with human cytochrome P450 enzymes and drug transporters." Current drug metabolism 21.14 (2020): 1127-1135.

>  <FLAG_COMMENTS>  (42) 


>  <ID>  (42) 
Hydroxychloroquine

>  <Comment>  (42) 


>  <smile>  (42) 
CCN(CCO)CCC[C@@H](C)Nc1ccnc2cc(Cl)ccc12

$$$$
alpha-Asarone
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -1.2981   -2.3856    0.3322 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1218    1.8956   -0.2951 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0979   -0.7055   -0.3520 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9573   -0.0103    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4669   -1.3158    0.1777 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2787    0.8366   -0.1419 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7690   -0.4689   -0.1693 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0844    1.0659    0.0452 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8962   -1.5451   -0.0093 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3762    0.2558    0.4009 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0515    1.3271   -0.0696 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8725   -2.9346   -0.8516 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5409    3.1976   -0.2548 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5083    1.5639    0.1644 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9106   -0.7767    0.8181 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1 12  1  0
  2  6  1  0
  2 13  1  0
  3  7  1  0
  3 15  1  0
  4  5  2  0
  4  8  1  0
  4 10  1  0
  5  9  1  0
  6  7  1  0
  6  8  2  0
  7  9  2  0
 10 11  2  0
 11 14  1  0
M  END
>  <InChIKey>  (43) 
RKFAZBXYICVSKP-AATRIKPKSA-N

>  <PubChem_CID>  (43) 
636822

>  <BOM_1A2>  (43) 
<14,H;Hydroxylation;R2>

>  <BOM_2A6>  (43) 
<15,3;Dealkylation;R3><15,H;Dealkylation;R3>
<13,2;Dealkylation;R4><13,H;Dealkylation;R4>
<12,1;Dealkylation;R5><12,H;Dealkylation;R5>

>  <BOM_2B6>  (43) 
<11,10;Epoxidation;R1>
<14,H;Hydroxylation;R2>
<15,3;Dealkylation;R3><15,H;Dealkylation;R3>
<13,2;Dealkylation;R4><13,H;Dealkylation;R4>
<12,1;Dealkylation;R5><12,H;Dealkylation;R5>

>  <BOM_2C8>  (43) 
<14,H;Hydroxylation;R2>

>  <BOM_2C9>  (43) 
<14,H;Hydroxylation;R2>

>  <BOM_2C19>  (43) 
<14,H;Hydroxylation;R2>
<15,3;Dealkylation;R3><15,H;Dealkylation;R3>
<13,2;Dealkylation;R4><13,H;Dealkylation;R4>
<12,1;Dealkylation;R5><12,H;Dealkylation;R5>

>  <BOM_2D6>  (43) 
<14,H;Hydroxylation;R2>

>  <BOM_2E1>  (43) 
<14,H;Hydroxylation;R2>

>  <BOM_3A4>  (43) 
<11,10;Epoxidation;R1>
<14,H;Hydroxylation;R2>
<15,3;Dealkylation;R3><15,H;Dealkylation;R3>
<13,2;Dealkylation;R4><13,H;Dealkylation;R4>
<12,1;Dealkylation;R5><12,H;Dealkylation;R5>

>  <References>  (43) 
Cartus, Alexander T., and Dieter Schrenk. "Metabolism of carcinogenic alpha-asarone by human cytochrome P450 enzymes." Naunyn-Schmiedeberg's archives of pharmacology 393 (2020): 213-223.

>  <FLAG_COMMENTS>  (43) 


>  <ID>  (43) 
alpha-Asarone

>  <Comment>  (43) 


>  <smile>  (43) 
C/C=C/c1cc(OC)c(OC)cc1OC

$$$$
Cannabichromene
     RDKit          3D

 23 24  0  0  1  0  0  0  0  0999 V2000
    0.9446    0.7586    1.5355 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7155    2.7109   -2.5771 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3068    1.1383    1.2440 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.1215   -0.1606    1.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5248    1.8744   -0.0571 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0422    1.0797    0.6468 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7649    2.0247    2.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6680   -1.0792    0.1039 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1861    1.7627   -0.5494 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060    0.9691    0.1441 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5351    2.1702   -0.9021 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7871    0.5463    0.5148 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3371    0.6836    0.9925 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1796   -0.8553    0.0126 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8908    2.0469   -1.3979 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1831    1.6509   -1.0502 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6259   -1.2258    0.3559 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4633   -2.3540    0.1016 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9847   -2.6117   -0.1814 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5772   -2.6286   -0.6031 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4308   -2.9695    0.1224 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3278   -3.9294   -0.5599 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1626   -1.6022   -1.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  6  1  0
  2 15  1  0
  3  4  1  0
  3  5  1  0
  3  7  1  1
  4  8  1  0
  5 11  2  0
  6  9  2  0
  6 13  1  0
  8 18  1  0
  9 11  1  0
  9 15  1  0
 10 12  1  0
 10 13  2  0
 10 16  1  0
 12 14  1  0
 14 17  1  0
 15 16  2  0
 17 19  1  0
 18 20  2  0
 19 21  1  0
 20 22  1  0
 20 23  1  0
M  END
>  <InChIKey>  (44) 
UVOLYTDXHDXWJU-UHFFFAOYSA-N

>  <PubChem_CID>  (44) 
30219

>  <BOM_1A2>  (44) 


>  <BOM_2A6>  (44) 


>  <BOM_2B6>  (44) 


>  <BOM_2C8>  (44) 
<20,18;Epoxidation;R1>
<22,H;Hydroxylation;R2>/<23,H;Hydroxylation;R2>

>  <BOM_2C9>  (44) 
<20,18;Epoxidation;R1>
<22,H;Hydroxylation;R2>/<23,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <BOM_2C19>  (44) 


>  <BOM_2D6>  (44) 
<20,18;Epoxidation;R1>
<22,H;Hydroxylation;R2>/<23,H;Hydroxylation;R2>

>  <BOM_2E1>  (44) 


>  <BOM_3A4>  (44) 
<20,18;Epoxidation;R1>

>  <References>  (44) 
Roy, Pritam, et al. "Elucidating the Mechanism of Metabolism of Cannabichromene by Human Cytochrome P450s." Journal of Natural Products 87.4 (2024): 639-651.

>  <FLAG_COMMENTS>  (44) 


>  <ID>  (44) 
Cannabichromene

>  <Comment>  (44) 


>  <smile>  (44) 
CCCCCc1cc(O)c2c(c1)O[C@@](C)(CCC=C(C)C)C=C2

$$$$
6:2 FTOH
     RDKit          3D

 22 21  0  0  0  0  0  0  0  0999 V2000
    0.9437    1.1022   -1.6890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7652   -0.1654   -2.0926 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3043    2.1860   -0.8844 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0027    1.7201    0.7786 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1511   -1.8085   -0.0485 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.3951   -1.5418   -1.5478 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5378    1.4186    1.3954 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4752   -0.4712    1.4191 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.1927   -0.2137    1.7047 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2921   -1.9203    0.9345 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.5393    1.4259   -0.0914 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790   -0.2875   -0.7935 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8075    0.3228    1.2979 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1537   -1.3195   -0.3531 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0334    0.2878   -1.0837 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8102    1.1473   -0.1513 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7681   -0.9148   -0.5087 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9667    0.4835    0.5831 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7968   -0.6962    0.5905 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0679   -0.1513   -0.2569 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9693    0.1896    0.2484 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1875   -0.7938    0.5486 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 15  1  0
  2 15  1  0
  3 16  1  0
  4 16  1  0
  5 17  1  0
  6 17  1  0
  7 18  1  0
  8 18  1  0
  9 19  1  0
 10 19  1  0
 11 21  1  0
 12 21  1  0
 13 21  1  0
 14 22  1  0
 15 16  1  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
M  END
>  <InChIKey>  (45) 
GRJRKPMIRMSBNK-UHFFFAOYSA-N

>  <PubChem_CID>  (45) 
69537

>  <BOM_1A2>  (45) 


>  <BOM_2A6>  (45) 
<22,14;Oxidation;R1>

>  <BOM_2B6>  (45) 


>  <BOM_2C8>  (45) 


>  <BOM_2C9>  (45) 


>  <BOM_2C19>  (45) 


>  <BOM_2D6>  (45) 


>  <BOM_2E1>  (45) 


>  <BOM_3A4>  (45) 
<22,14;Oxidation;R1>

>  <References>  (45) 
Merino, Nancy, et al. "Roles of various enzymes in the biotransformation of 6: 2 fluorotelomer alcohol (6: 2 FTOH) by a white-rot fungus." Journal of Hazardous Materials 450 (2023): 131007.

>  <FLAG_COMMENTS>  (45) 


>  <ID>  (45) 
6:2 FTOH

>  <Comment>  (45) 


>  <smile>  (45) 
OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

$$$$
4-Hydroxyretinoic acid
     RDKit          3D

 23 23  0  0  1  0  0  0  0  0999 V2000
   -5.0553   -2.7301   -0.6226 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1870   -1.5042   -1.1263 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2616    0.1183    0.4708 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6335    1.0551   -0.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8554    0.2106   -0.9472 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2854   -0.7909    0.1129 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5456    0.1755    0.1647 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1451   -1.7562    0.4190 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.7836   -1.1008    0.5615 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1069    2.1289    0.5117 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1158    1.7703   -1.7674 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2498    0.8118    0.3325 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7720   -2.0250    1.2048 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0859    0.1741    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2527    0.7461    0.2753 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3470    2.1936    0.7009 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3980    0.0639    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7668    0.5338    0.1747 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8261   -0.2560   -0.0741 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2429    0.1160    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5587    1.5363    0.4122 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1624   -0.8257   -0.2733 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6311   -0.6455   -0.2381 C   0  0  0  0  0  0  0  0  0  0  0  0
  8  1  1  6
  2 23  1  0
  3 23  2  0
  4  5  1  0
  4  7  1  0
  4 10  1  0
  4 11  1  0
  5  6  1  0
  6  8  1  0
  7  9  2  0
  7 12  1  0
  8  9  1  0
  9 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 22 23  1  0
M  END
>  <InChIKey>  (46) 
KGUMXGDKXYTTEY-FRCNGJHJSA-N

>  <PubChem_CID>  (46) 
6438629

>  <BOM_1A2>  (46) 


>  <BOM_2A6>  (46) 
<1,8;Oxidation;R1>

>  <BOM_2B6>  (46) 
<1,8;Oxidation;R1>

>  <BOM_2C8>  (46) 
<1,8;Oxidation;R1>

>  <BOM_2C9>  (46) 


>  <BOM_2C19>  (46) 


>  <BOM_2D6>  (46) 


>  <BOM_2E1>  (46) 


>  <BOM_3A4>  (46) 


>  <References>  (46) 
Marill, J., Cresteil, T., Lanotte, M., et al. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol. Pharmacol. 58(6), 1341-1348 (2000).
Thatcher, J.E., Buttrick, B., Shaffer, S.A., et al. Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase. Mol. Pharmacol. 80(2), 228-239 (2011).

>  <FLAG_COMMENTS>  (46) 


>  <ID>  (46) 
4-Hydroxyretinoic acid

>  <Comment>  (46) 


>  <smile>  (46) 
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CC[C@H]1O

$$$$
Flualprazolam
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -0.5908    4.5876    0.9367 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.8725   -2.1273    1.3469 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2483   -0.5160   -0.1031 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3621   -1.7153    0.9292 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8968   -2.6109    0.1112 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7740   -1.9745   -0.7328 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5170    0.6793    0.0735 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1618    0.6712    0.4583 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0047   -1.7268    0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6975   -0.5603    0.4629 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9470   -1.9111    1.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3923   -0.7215   -0.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1814    1.9033   -0.1072 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0568   -0.4717   -0.1492 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4729    1.8935    0.7413 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5264    3.1072    0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2073    3.1019    0.5932 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0315    0.2407   -1.7517 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0822   -1.2726    0.3354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2760    0.4130   -1.1965 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3508   -1.1868   -0.2382 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5448    0.4984   -1.7699 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5821   -0.3015   -1.2908 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  2 19  1  0
  3  7  1  0
  3  9  1  0
  3 12  1  0
  4 10  2  0
  4 11  1  0
  5  6  1  0
  5  9  2  0
  6 12  2  0
  7  8  2  0
  7 13  1  0
  8 10  1  0
  8 15  1  0
  9 11  1  0
 10 14  1  0
 12 18  1  0
 13 16  2  0
 14 19  2  0
 14 20  1  0
 15 17  2  0
 16 17  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <InChIKey>  (47) 
MPZVLJCMGPYWQQ-UHFFFAOYSA-N

>  <PubChem_CID>  (47) 
10359044

>  <BOM_1A2>  (47) 


>  <BOM_2A6>  (47) 


>  <BOM_2B6>  (47) 
<18,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <BOM_2C8>  (47) 


>  <BOM_2C9>  (47) 
<18,H;Hydroxylation;R1>

>  <BOM_2C19>  (47) 
<18,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <BOM_2D6>  (47) 


>  <BOM_2E1>  (47) 


>  <BOM_3A4>  (47) 
<18,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <References>  (47) 
Wagmann, Lea, et al. "Toxicokinetics and analytical toxicology of flualprazolam: metabolic fate, isozyme mapping, human plasma concentration and main urinary excretion products." Journal of Analytical Toxicology 44.6 (2020): 549-558.

>  <FLAG_COMMENTS>  (47) 


>  <ID>  (47) 
Flualprazolam

>  <Comment>  (47) 


>  <smile>  (47) 
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2

$$$$
asenapine
     RDKit          2D

 20 23  0  0  1  0  0  0  0  0999 V2000
    7.9254   -1.3034    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.0438    1.5572    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4295   -1.7948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5438   -0.6334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6428   -0.1995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4078   -1.6182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9577   -0.9198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4447   -0.1995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4203    0.7754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9956   -2.6958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6673    0.7754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0438    1.5572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1973   -0.9197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3880    0.9147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6578    1.0977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6782    2.5326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1950   -0.6204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.8814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4268    0.3951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6494    2.6958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  2 11  1  0
  2 12  1  0
  3  6  1  0
  3  7  1  0
  3 10  1  0
  4  5  1  0
  4  6  1  6
  4  8  1  0
  5  7  1  1
  5  9  1  0
  8 11  2  0
  8 13  1  0
  9 12  2  0
  9 14  1  0
 11 15  1  0
 12 16  1  0
 13 17  2  0
 14 18  2  0
 15 19  2  0
 16 20  2  0
 17 19  1  0
 18 20  1  0
M  END
>  <InChIKey>  (48) 
VSWBSWWIRNCQIJ-GJZGRUSLSA-N

>  <PubChem_CID>  (48) 
3036780

>  <BOM_1A2>  (48) 
<3,N;N-Oxidation;R1>
<10,3;Dealkylation;R2><10,H;Dealkylation;R2>
<18,H;Hydroxylation;R3>

>  <BOM_2A6>  (48) 


>  <BOM_2B6>  (48) 


>  <BOM_2C8>  (48) 


>  <BOM_2C9>  (48) 


>  <BOM_2C19>  (48) 


>  <BOM_2D6>  (48) 
<3,N;N-Oxidation;R1>

>  <BOM_2E1>  (48) 


>  <BOM_3A4>  (48) 
<10,3;Dealkylation;R2><10,H;Dealkylation;R2>
<18,H;Hydroxylation;R3>

>  <References>  (48) 
Danek, Przemysaw J., et al. "Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects." Neurochemistry International 151 (2021): 105209.
Danek, Przemysaw J., et al. "Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects." Neurochemistry International 151 (2021): 105209.

>  <FLAG_COMMENTS>  (48) 


>  <ID>  (48) 
asenapine

>  <Comment>  (48) 


>  <smile>  (48) 
CN1C[C@H]2c3ccccc3Oc3ccc(Cl)cc3[C@@H]2C1

$$$$
osilodrostat
     RDKit          2D

 17 19  0  0  1  0  0  0  0  0999 V2000
    4.9344    0.0823    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.5472    1.8776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0771    2.3776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0511   -3.1867    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5962    1.5686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0084    2.3776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5962    3.1867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5472    2.8776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2872    0.6176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4935    1.5729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4935    3.1824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9563   -0.1256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3090    0.4097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6473   -1.0766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.5414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6691   -1.2846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3601   -2.2356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  2  5  1  0
  2  8  1  0
  2 10  1  0
  3 10  2  0
  3 11  1  0
  4 17  3  0
  5  6  1  0
  5  9  1  1
  6  7  1  0
  7  8  1  0
  8 11  2  0
  9 12  2  0
  9 13  1  0
 12 14  1  0
 13 15  2  0
 14 16  2  0
 15 16  1  0
 16 17  1  0
M  END
>  <InChIKey>  (49) 
USUZGMWDZDXMDG-CYBMUJFWSA-N

>  <PubChem_CID>  (49) 
44139752

>  <BOM_1A2>  (49) 


>  <BOM_2A6>  (49) 


>  <BOM_2B6>  (49) 
<7,H;Hydroxylation;R1>

>  <BOM_2C8>  (49) 


>  <BOM_2C9>  (49) 


>  <BOM_2C19>  (49) 


>  <BOM_2D6>  (49) 
<7,H;Hydroxylation;R1>

>  <BOM_2E1>  (49) 


>  <BOM_3A4>  (49) 
<7,H;Hydroxylation;R1>

>  <References>  (49) 
EMA Summary of Product Characteristics: Isturisa (osilodrostat) oral tablets

>  <FLAG_COMMENTS>  (49) 


>  <ID>  (49) 
osilodrostat

>  <Comment>  (49) 


>  <smile>  (49) 
N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1

$$$$
Suvorexant
     RDKit          3D

 32 36  0  0  1  0  0  0  0  0999 V2000
    7.9362   -0.8750   -2.5467 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.6968    0.4528    1.1887 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3558    1.0957    1.9753 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2757    0.7657    0.9380 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5582   -0.4738    1.3431 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2151   -1.1726   -0.3155 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9474    0.8284   -1.3480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9811    0.9632   -2.6836 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9649    1.9374   -0.5913 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6667    1.9029    1.6595 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8461    1.7974    1.9415 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2845    0.4281    2.4703 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4479    0.0040   -0.0151 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3819   -1.0658    0.6992 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9667    3.2113    0.9194 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6314    0.4855    1.1896 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7984   -0.4467    0.6985 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2634   -0.6227    0.4649 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8938   -0.4267   -0.7639 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2236   -1.8960    1.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4967   -0.7226   -0.5214 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7951    0.2725    0.3977 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8139   -2.9734    0.3723 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4843   -1.5041   -1.4245 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4442   -2.7775   -0.8565 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4726   -1.0964   -1.4563 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0088    0.9450    0.4703 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7713   -4.3349    0.9794 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7111   -0.4398   -1.4143 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9714    0.5602   -0.4692 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0254    2.2931   -2.8027 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0154    2.8849   -1.5317 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 29  1  0
  2 17  1  0
  2 22  1  0
  3 16  2  0
  4 10  1  0
  4 13  1  0
  4 16  1  0
  5 12  1  0
  5 14  1  0
  5 17  1  0
  6 17  2  0
  6 21  1  0
  7  8  1  0
  7  9  1  0
  7 19  1  0
  8 31  2  0
  9 32  2  0
 10 11  1  0
 10 15  1  6
 11 12  1  0
 13 14  1  0
 16 18  1  0
 18 19  1  0
 18 20  2  0
 19 24  2  0
 20 23  1  0
 21 22  2  0
 21 26  1  0
 22 27  1  0
 23 25  2  0
 23 28  1  0
 24 25  1  0
 26 29  2  0
 27 30  2  0
 29 30  1  0
 31 32  1  0
M  END
>  <InChIKey>  (50) 
JYTNQNCOQXFQPK-MRXNPFEDSA-N

>  <PubChem_CID>  (50) 
24965990

>  <BOM_1A2>  (50) 


>  <BOM_2A6>  (50) 


>  <BOM_2B6>  (50) 


>  <BOM_2C8>  (50) 


>  <BOM_2C9>  (50) 
<28,H;Hydroxylation;R1>

>  <BOM_2C19>  (50) 
<28,H;Hydroxylation;R1>

>  <BOM_2D6>  (50) 
<28,H;Hydroxylation;R1>

>  <BOM_2E1>  (50) 


>  <BOM_3A4>  (50) 
<28,H;Hydroxylation;R1>
<15,H;Hydroxylation;R2>
<30,H;Hydroxylation;R3>

>  <References>  (50) 
Skillman, Britni, and Sarah Kerrigan. "CYP450-Mediated metabolism of suvorexant and investigation of metabolites in forensic case specimens." Forensic science international 312 (2020): 110307.

>  <FLAG_COMMENTS>  (50) 


>  <ID>  (50) 
Suvorexant

>  <Comment>  (50) 


>  <smile>  (50) 
Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1

$$$$
Luseogliflozin
     RDKit          3D

 30 32  0  0  1  0  0  0  0  0999 V2000
   -3.5191    0.1962    1.1693 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4710   -1.1141   -2.0765 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8957   -3.4153   -1.3774 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4373   -3.0510   -0.2889 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2847    0.2442    2.1993 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1469    2.6394   -1.8732 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8901   -2.0702   -0.2227 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1837   -1.2018   -0.8330 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.3992   -2.1079   -1.0663 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.5454    0.2226   -0.3775 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.3392   -2.2349    0.1379 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.8808   -0.8886    0.6330 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3314    1.1231   -0.2057 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8493   -1.0433    1.8072 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3523    0.7728    0.7215 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1974    2.2849   -0.9627 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7663    1.5883    0.8925 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9032    2.7521    0.1357 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0787    3.1004   -0.7918 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8044    1.1958    1.8919 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0920    3.6407    0.3009 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9013    0.3192    1.3238 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9268    3.8447   -2.6031 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5602   -0.7401    0.5024 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2186    0.5983    1.6406 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5706   -1.5476   -0.0199 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2289   -0.2093    1.1183 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9049   -1.2822    0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1572   -1.4569   -0.4551 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8412   -2.1595   -1.6084 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 12  1  0
  8  2  1  6
  9  3  1  1
 11  4  1  6
  5 14  1  0
  6 16  1  0
  6 23  1  0
  7 28  1  0
  7 29  1  0
  8  9  1  0
  8 10  1  0
  9 11  1  0
 10 13  1  1
 11 12  1  0
 12 14  1  1
 13 15  2  0
 13 16  1  0
 15 17  1  0
 16 19  2  0
 17 18  2  0
 17 20  1  0
 18 19  1  0
 18 21  1  0
 20 22  1  0
 22 24  2  0
 22 25  1  0
 24 26  1  0
 25 27  2  0
 26 28  2  0
 27 28  1  0
 29 30  1  0
M  END
>  <InChIKey>  (51) 
WHSOLWOTCHFFBK-ZQGJOIPISA-N

>  <PubChem_CID>  (51) 
11988953

>  <BOM_1A2>  (51) 


>  <BOM_2A6>  (51) 


>  <BOM_2B6>  (51) 


>  <BOM_2C8>  (51) 


>  <BOM_2C9>  (51) 


>  <BOM_2C19>  (51) 


>  <BOM_2D6>  (51) 
<29,7;Dealkylation;R1><29,H;Dealkylation;R1>
<23,6;Dealkylation;R2><23,H;Dealkylation;R2>

>  <BOM_2E1>  (51) 


>  <BOM_3A4>  (51) 
<29,7;Dealkylation;R1><29,H;Dealkylation;R1>
<23,6;Dealkylation;R2><23,H;Dealkylation;R2>

>  <References>  (51) 
Samukawa, Y.; Haneda, M.; Seino, Y.; Sasaki, T.; Fukatsu, A.; Kubo, Y.; Sato, Y.; Sakai, S. Pharmacokinetics and pharmacodynamicsof luseogliflozin, a selective SGLT2 Inhibitor, in Japanese patients with Type 2 Diabetes with mild to severe renal impairment.Clin. Pharmacol. Drug Dev. 2018, 7, 820828.

>  <FLAG_COMMENTS>  (51) 


>  <ID>  (51) 
Luseogliflozin

>  <Comment>  (51) 


>  <smile>  (51) 
CCOc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)cc2C)cc1

$$$$
Trimethoprim
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -2.6987    2.5018    0.5331 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7534   -2.1358   -0.6625 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9726    0.3515   -0.6609 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8404   -0.9052   -0.7646 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8224    1.4185   -0.1267 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2723   -2.4149    0.1769 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3815    0.6079   -1.6816 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0829   -0.3313    1.7553 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2528   -0.1509    1.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2494   -0.1025    0.8154 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8913   -1.2361    0.5168 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8638    1.1031    1.1202 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1131    1.2718    0.5231 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1406   -1.0674   -0.0803 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7514    0.1866   -0.0773 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8016   -1.1049    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7843    1.1476    0.6914 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2945    0.3616   -0.8148 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4122    3.3649   -0.5656 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6094   -2.9217    0.1643 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0701    0.0555   -2.0521 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0
  1 19  1  0
  2 14  1  0
  2 20  1  0
  3 15  1  0
  3 21  1  0
  4 16  2  0
  4 18  1  0
  5 17  1  0
  5 18  2  0
  6 16  1  0
  7 18  1  0
  8  9  1  0
  8 10  1  0
  9 11  2  0
  9 12  1  0
 10 16  1  0
 10 17  2  0
 11 14  1  0
 12 13  2  0
 13 15  1  0
 14 15  2  0
M  END
>  <InChIKey>  (52) 
IEDVJHCEMCRBQM-UHFFFAOYSA-N

>  <PubChem_CID>  (52) 
5578

>  <BOM_1A2>  (52) 
<5,N;N-Oxidation;R1>

>  <BOM_2A6>  (52) 


>  <BOM_2B6>  (52) 


>  <BOM_2C8>  (52) 


>  <BOM_2C9>  (52) 
<20,2;Dealkylation;R3><20,H;Dealkylation;R3>/<19,1;Dealkylation;R3><19,H;Dealkylation;R3>

>  <BOM_2C19>  (52) 
<4,N;N-Oxidation;R2>

>  <BOM_2D6>  (52) 


>  <BOM_2E1>  (52) 


>  <BOM_3A4>  (52) 
<4,N;N-Oxidation;R2>
<21,3;Dealkylation;R4><21,H;Dealkylation;R4>
<8,H;Hydroxylation;R5>

>  <References>  (52) 
Goldman JL, Leeder JS, Van Haandel L, Pearce RE: In Vitro Hepatic Oxidative Biotransformation of Trimethoprim. Drug Metab Dispos. 2015 Sep;43(9):1372-80. doi: 10.1124/dmd.115.065193. Epub 2015 Jul 2.

>  <FLAG_COMMENTS>  (52) 


>  <ID>  (52) 
Trimethoprim

>  <Comment>  (52) 


>  <smile>  (52) 
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC

$$$$
Tandospirone
     RDKit          3D

 28 32  0  0  1  0  0  0  0  0999 V2000
   -3.8176   -2.2080    1.0732 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2923    0.8896   -2.3316 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7310   -0.7426   -0.7493 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3344    0.6991   -0.3375 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1131    0.1922    0.0886 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9797   -1.2112   -0.2604 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2533    0.9843    0.6949 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1885   -0.2359    1.5685 C   0  0  1  0  0  0  0  0  0  0  0  0
   -6.4162    1.2574   -0.0745 C   0  0  2  0  0  0  0  0  0  0  0  0
   -5.7910   -1.0365    0.3135 C   0  0  1  0  0  0  0  0  0  0  0  0
   -5.9473   -0.0083   -0.8175 C   0  0  2  0  0  0  0  0  0  0  0  0
   -5.6672    1.1700    1.2582 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7105   -0.0013    1.5227 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8676    1.0288    0.3888 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3359   -1.4291    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5712    0.1221   -1.4209 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3344   -0.9150   -1.0992 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4209    0.0360   -0.3329 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0537   -0.1265   -0.7159 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9331    0.8635    0.0472 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1748    1.6934    0.3413 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8019   -0.6542   -0.0138 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6358    1.5684   -0.0968 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2512   -0.8579   -0.4626 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4937   -0.0185    0.1776 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3146   -1.3804   -0.1607 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5797    0.7477    0.7653 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1722   -0.4270    0.3488 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 15  2  0
  2 16  2  0
  3 15  1  0
  3 16  1  0
  3 17  1  0
  4 20  1  0
  4 21  1  0
  4 22  1  0
  5 23  1  0
  5 24  1  0
  5 25  1  0
  6 25  2  0
  6 26  1  0
  7 25  1  0
  7 27  2  0
  8 10  1  0
  8 12  1  0
  8 13  1  6
  9 11  1  0
  9 12  1  0
  9 14  1  1
 10 11  1  0
 10 15  1  1
 11 16  1  1
 13 14  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 21 23  1  0
 22 24  1  0
 26 28  2  0
 27 28  1  0
M  END
>  <InChIKey>  (53) 
CEIJFEGBUDEYSX-FZDBZEDMSA-N 

>  <PubChem_CID>  (53) 
91273

>  <BOM_1A2>  (53) 


>  <BOM_2A6>  (53) 


>  <BOM_2B6>  (53) 


>  <BOM_2C8>  (53) 


>  <BOM_2C9>  (53) 


>  <BOM_2C19>  (53) 


>  <BOM_2D6>  (53) 
<20,4;Dealkylation;R1><20,H;Dealkylation;R1>
<28,H;Hydroxylation;R2>
<26,H;Hydroxylation;R3>/<27,H;Hydroxylation;R3>
<12,H;Hydroxylation;R4>
<13,H;Hydroxylation;R5>
<14,H;Hydroxylation;R6>

>  <BOM_2E1>  (53) 


>  <BOM_3A4>  (53) 
<20,4;Dealkylation;R1><20,H;Dealkylation;R1>
<28,H;Hydroxylation;R2>
<26,H;Hydroxylation;R3>/<27,H;Hydroxylation;R3>
<12,H;Hydroxylation;R4>
<13,H;Hydroxylation;R5>
<14,H;Hydroxylation;R6>

>  <References>  (53) 
Natsui, K., Mizuno, Y., Tani, N., Yabuki, M., & Komuro, S. (2007). Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics, 32(3), 131137. doi:10.1007/bf03190475 

>  <FLAG_COMMENTS>  (53) 


>  <ID>  (53) 
Tandospirone

>  <Comment>  (53) 


>  <smile>  (53) 
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1

$$$$
Vilanterol
     RDKit          2D

 32 33  0  0  0  0  0  0  0  0999 V2000
    2.8295    1.2219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8295    0.3968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1149   -0.0156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4003    0.3968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4003    1.2219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1149    1.6345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6748    1.6410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0353    1.2309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7321    1.6334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4359    1.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1359    1.6315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8378    1.2261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5388    1.6309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2439    1.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2486    0.4110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5496    0.0021    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6748    2.4661    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8460    0.4030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1470   -0.0057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4435    0.3950    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7444   -0.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7490   -0.8236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500   -1.2324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0546   -2.0574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7715   -2.4661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4705   -2.0571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4659   -1.2320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1912   -0.8078    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6701   -0.8221    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.5441    1.6345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2486    1.2276    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5441   -0.0156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  7 17  1  6
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 22 27  1  0
 27 28  1  0
 23 29  1  0
  1 30  1  0
 30 31  1  0
  2 32  1  0
M  END
>  <InChIKey>  (54) 
DAFYYTQWSAWIGS-DEOSSOPVSA-N

>  <PubChem_CID>  (54) 


>  <BOM_1A2>  (54) 


>  <BOM_2A6>  (54) 


>  <BOM_2B6>  (54) 


>  <BOM_2C8>  (54) 


>  <BOM_2C9>  (54) 


>  <BOM_2C19>  (54) 


>  <BOM_2D6>  (54) 


>  <BOM_2E1>  (54) 


>  <BOM_3A4>  (54) 
<21,20;Dealkylation;R1><21,H;Dealkylation;R1>
<8,9;Dealkylation;R2><8,H;Dealkylation;R2>
<18,16;Dealkylation;R3><18,H;Dealkylation;R3>
<19,20;Dealkylation;R4><19,H;Dealkylation;R4>
<30,H;Oxidation;R5>

>  <References>  (54) 
Harrell AW, Siederer SK, Bal J, Patel NH, Young GC, Felgate CC, Pearce SJ, Roberts AD, Beaumont C, Emmons AJ, Pereira AI, Kempsford RD: Metabolism and disposition of vilanterol, a long-acting beta(2)-adrenoceptor agonist for inhalation use in humans. Drug Metab Dispos. 2013 Jan;41(1):89-100. doi: 10.1124/dmd.112.048603. Epub 2012 Oct 4.

>  <FLAG_COMMENTS>  (54) 


>  <ID>  (54) 
Vilanterol

>  <Comment>  (54) 


>  <smile>  (54) 
OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O

$$$$
loxapine
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    2.0000   -1.4271    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.8374   -2.7541    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9036    0.3375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0358    2.1394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3374   -0.5635    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9064    0.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4669    1.1637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4725    1.3132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0330    2.0647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3374   -0.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6019    3.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7139   -1.3453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9364   -2.3202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9609   -1.3453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7234   -1.0230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7384   -2.3202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1839   -3.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9544   -1.7255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1862   -2.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9514   -1.0230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4909   -3.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7204   -1.7256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4886   -2.7411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0
  2 13  1  0
  2 16  1  0
  3  6  1  0
  3  7  1  0
  3 10  1  0
  4  8  1  0
  4  9  1  0
  4 11  1  0
  5 10  2  0
  5 14  1  0
  6  8  1  0
  7  9  1  0
 10 12  1  0
 12 13  2  0
 12 15  1  0
 13 17  1  0
 14 16  2  0
 14 20  1  0
 15 18  2  0
 16 21  1  0
 17 19  2  0
 18 19  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <InChIKey>  (55) 
XJGVXQDUIWGIRW-UHFFFAOYSA-N

>  <PubChem_CID>  (55) 
3964

>  <BOM_1A2>  (55) 
<11,4;Dealkylation;R2><11,H;Dealkylation;R2>
<22,H;Hydroxylation;R3>

>  <BOM_2A6>  (55) 


>  <BOM_2B6>  (55) 


>  <BOM_2C8>  (55) 


>  <BOM_2C9>  (55) 


>  <BOM_2C19>  (55) 
<11,4;Dealkylation;R2><11,H;Dealkylation;R2>

>  <BOM_2D6>  (55) 
<23,H;Hydroxylation;R1>

>  <BOM_2E1>  (55) 


>  <BOM_3A4>  (55) 
<11,4;Dealkylation;R2><11,H;Dealkylation;R2>

>  <References>  (55) 
Investigation of the disposition of loxapine, amoxapine and their hydroxylated metabolites in different brain regions, CSF and plasma of rat by LC-MS/MS.

>  <FLAG_COMMENTS>  (55) 


>  <ID>  (55) 
loxapine

>  <Comment>  (55) 


>  <smile>  (55) 
CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1

$$$$
Macitentan
     RDKit          3D

 32 34  0  0  0  0  0  0  0  0999 V2000
   -0.0649   -5.0070   -1.1447 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -8.8883   -1.4674    0.2919 Br  0  0  0  0  0  0  0  0  0  0  0  0
    5.2020    0.8230   -0.5475 S   0  0  0  0  0  6  0  0  0  0  0  0
   -0.8684    1.4171    0.4085 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1345    0.0689   -1.3660 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4298    2.2369   -0.3136 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6264    1.2493   -0.0371 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0739    0.0449    0.9853 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6211    0.5826   -1.1958 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9011    2.7235   -0.5348 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6649    3.1339    0.2641 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4200    0.5750    1.2541 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3296    0.1149   -1.1097 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0721   -1.4339    1.0069 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3213    0.9132   -0.3931 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5679    1.4252   -0.6892 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9414   -1.9434    2.4369 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9940   -0.4850   -0.5706 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4003    1.8231    0.0851 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9502   -3.4632    2.5233 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1982   -1.3873    0.4735 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4741   -0.9308   -1.7858 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7555    2.4172    0.8942 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8828   -2.7351    0.3023 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1587   -2.2787   -1.9570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9163    3.5105   -0.0612 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1066    1.7872    1.1729 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3630   -3.1808   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8410    0.6201    0.0392 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6155   -0.0494    1.2923 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5277   -0.4954   -0.9989 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2237   -0.6090    0.1874 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 28  1  0
  2 32  1  0
  3  5  2  0
  3  6  2  0
  3  8  1  0
  3  9  1  0
  4 19  1  0
  4 23  1  0
  7 27  1  0
  7 29  1  0
  8 14  1  0
  9 16  1  0
 10 16  2  0
 10 26  1  0
 11 19  1  0
 11 26  2  0
 12 29  2  0
 12 30  1  0
 13 29  1  0
 13 31  2  0
 14 17  1  0
 15 16  1  0
 15 18  1  0
 15 19  2  0
 17 20  1  0
 18 21  2  0
 18 22  1  0
 21 24  1  0
 22 25  2  0
 23 27  1  0
 24 28  2  0
 25 28  1  0
 30 32  2  0
 31 32  1  0
M  END
>  <InChIKey>  (56) 
JGCMEBMXRHSZKX-UHFFFAOYSA-N

>  <PubChem_CID>  (56) 
16004692

>  <BOM_1A2>  (56) 


>  <BOM_2A6>  (56) 


>  <BOM_2B6>  (56) 


>  <BOM_2C8>  (56) 
<14,8;Dealkylation;R1><14,H;Dealkylation;R1>

>  <BOM_2C9>  (56) 
<14,8;Dealkylation;R1><14,H;Dealkylation;R1>
<27,7;Dealkylation;R2><27,H;Dealkylation;R2>

>  <BOM_2C19>  (56) 
<14,8;Dealkylation;R1><14,H;Dealkylation;R1>

>  <BOM_2D6>  (56) 


>  <BOM_2E1>  (56) 


>  <BOM_3A4>  (56) 
<14,8;Dealkylation;R1><14,H;Dealkylation;R1>

>  <References>  (56) 
Sidharta PN, Treiber A, Dingemanse J: Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentan. Clin Pharmacokinet. 2015 May;54(5):457-71. doi: 10.1007/s40262-015-0255-5.
FDA Approved Drug Products: OPSUMIT (macitentan) tablets

>  <FLAG_COMMENTS>  (56) 


>  <ID>  (56) 
Macitentan

>  <Comment>  (56) 


>  <smile>  (56) 
CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1

$$$$
Tadalafil
     RDKit          3D

 29 34  0  0  1  0  0  0  0  0999 V2000
   -0.7505    3.2326    2.1493 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0223    1.4582   -2.6928 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1891   -1.9061    1.9257 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4332   -3.9194    0.6238 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5469    1.3952   -0.8731 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3085   -0.9817   -1.2692 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0182    3.3792    0.2087 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1512    2.2619    0.1205 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0017    0.0674   -1.2873 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1537    1.5441    1.0528 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3768   -0.1217   -0.7593 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9386    0.5430    0.3025 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9172    2.9669    0.9595 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2662    0.0650    0.4633 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5591    1.9613   -1.6698 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9118   -1.0199   -0.8058 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9573    3.3523   -1.2418 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4736   -0.8911   -0.5372 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3172    0.3467    1.3588 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6084   -0.8550    0.3907 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0510   -2.1908   -1.5669 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6844   -1.5770   -0.6848 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2253    3.8354    0.8778 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4347   -1.8841    0.7931 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5328   -0.3333    1.2221 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8946   -3.2178   -1.1369 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7116   -1.2793    0.2151 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5740   -3.0337    0.0498 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8194   -3.1983    1.8114 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  2  0
  2 15  2  0
  3 24  1  0
  3 29  1  0
  4 28  1  0
  4 29  1  0
  5  8  1  0
  5  9  1  0
  5 15  1  0
  6 11  1  0
  6 18  1  0
  7 13  1  0
  7 17  1  0
  7 23  1  0
  8 10  1  1
  8 13  1  0
  9 11  1  0
  9 16  1  1
 10 12  1  0
 11 12  2  0
 12 14  1  0
 14 18  2  0
 14 19  1  0
 15 17  1  0
 16 20  1  0
 16 21  2  0
 18 22  1  0
 19 25  2  0
 20 24  2  0
 21 26  1  0
 22 27  2  0
 24 28  1  0
 25 27  1  0
 26 28  2  0
M  END
>  <InChIKey>  (57) 
WOXKDUGGOYFFRN-IIBYNOLFSA-N

>  <PubChem_CID>  (57) 
110635

>  <BOM_1A2>  (57) 


>  <BOM_2A6>  (57) 


>  <BOM_2B6>  (57) 


>  <BOM_2C8>  (57) 


>  <BOM_2C9>  (57) 


>  <BOM_2C19>  (57) 


>  <BOM_2D6>  (57) 


>  <BOM_2E1>  (57) 


>  <BOM_3A4>  (57) 
<29,4;Dealkylation;R1><29,3;Dealkylation;R1><29,H;Dealkylation;R1>

>  <References>  (57) 
Dalvie D, Obach RS, Kang P, Prakash C, Loi CM, Hurst S, Nedderman A, Goulet L, Smith E, Bu HZ, Smith DA: Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites. Chem Res Toxicol. 2009 Feb;22(2):357-68. doi: 10.1021/tx8004357. 
FDA Approved Drug Products: Cialis (tadalafil) tablets 
FDA Approved Drug Products: Adcirca (tadalafil) tablets
Forgue ST, Patterson BE, Bedding AW, Payne CD, Phillips DL, Wrishko RE, Mitchell MI: Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006 Mar;61(3):280-8. doi: 10.1111/j.1365-2125.2005.02553.x. 

>  <FLAG_COMMENTS>  (57) 


>  <ID>  (57) 
Tadalafil

>  <Comment>  (57) 


>  <smile>  (57) 
CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O

$$$$
Etrasimod
     RDKit          3D

 33 37  0  0  1  0  0  0  0  0999 V2000
   -4.2440   -3.0258   -1.2614 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9330   -2.5027    0.0041 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8860   -1.8467   -2.0625 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3639   -0.3281    1.0488 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4697   -1.1296   -1.7811 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3131    1.0511   -1.1478 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0994   -0.5047    1.6854 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6064    0.4092   -0.2243 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7801    0.6328    0.0421 C   0  0  1  0  0  0  0  0  0  0  0  0
   -7.2168    0.7060    1.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2137    1.4548   -1.1824 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2810    1.6902   -1.0146 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4797    0.2073    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3799    0.6158   -0.0967 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7602    1.4020   -1.2865 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4560    1.5374    0.8616 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0154    2.4071   -0.3025 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0943    0.3875   -0.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2385    0.1367    0.5673 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5251   -0.5182   -0.6177 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7123   -0.5690    1.6904 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3866   -0.7627   -0.5465 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8507    0.2185    0.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4075    1.5401    0.1845 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8479   -1.1929    2.5974 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9817   -0.4032    1.2527 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8462   -0.0772   -1.1915 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9920   -0.7602   -0.5142 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3053    0.3923   -0.1323 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0129    1.5425    0.2172 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4739   -1.0966    2.3572 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1004   -2.0085   -0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8051    0.3951   -0.0984 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 32  1  0
  2 32  1  0
  3 32  1  0
  4 26  1  0
  4 33  1  0
  5 27  1  0
  6 27  2  0
  7 13  1  0
  7 21  1  0
  8 10  1  0
  8 11  1  0
  8 18  1  0
  9 12  1  0
  9 13  1  0
  9 20  1  6
 10 16  1  0
 11 17  1  0
 12 15  1  0
 13 14  2  0
 14 15  1  0
 14 19  1  0
 16 17  1  0
 18 22  2  0
 18 24  1  0
 19 21  2  0
 19 23  1  0
 20 27  1  0
 21 25  1  0
 22 28  1  0
 22 32  1  0
 23 26  2  0
 24 30  2  0
 25 31  2  0
 26 31  1  0
 28 29  2  0
 29 30  1  0
 29 33  1  0
M  END
>  <InChIKey>  (58) 
MVGWUTBTXDYMND-QGZVFWFLSA-N

>  <PubChem_CID>  (58) 
44623998

>  <BOM_1A2>  (58) 


>  <BOM_2A6>  (58) 


>  <BOM_2B6>  (58) 


>  <BOM_2C8>  (58) 
<17,H;Hydroxylation;R1>/<16,H;Hydroxylation;R1>

>  <BOM_2C9>  (58) 
<17,H;Hydroxylation;R1>/<16,H;Hydroxylation;R1>

>  <BOM_2C19>  (58) 
<17,H;Hydroxylation;R1>/<16,H;Hydroxylation;R1>

>  <BOM_2D6>  (58) 


>  <BOM_2E1>  (58) 


>  <BOM_3A4>  (58) 
<17,H;Hydroxylation;R1>/<16,H;Hydroxylation;R1>

>  <References>  (58) 
Lee, Caroline A., et al. "Disposition and mass balance of etrasimod in healthy subjects and in vitro determination of the enzymes responsible for Its oxidative metabolism." Clinical Pharmacology in Drug Development 12.6 (2023): 553-571.

>  <FLAG_COMMENTS>  (58) 


>  <ID>  (58) 
Etrasimod

>  <Comment>  (58) 


>  <smile>  (58) 
O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21

$$$$
M396
     RDKit          3D

 28 31  0  0  0  0  0  0  0  0999 V2000
    2.7529   -1.7378    1.2167 S   0  0  0  0  0  6  0  0  0  0  0  0
   -4.2484   -1.8618   -1.4666 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1772   -1.9478    1.0357 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1164   -2.1450    2.4546 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9737    0.2422   -0.4852 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1746    2.3520    1.0319 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9118   -2.4089   -0.1286 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8650    0.0488   -0.9074 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1335    1.2515    0.1713 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3430    0.6728   -0.7639 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8431    1.8548    1.3827 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9974    1.2765    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5450   -1.0157   -0.9164 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1355   -1.3759   -0.7126 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5414   -2.0596   -0.3266 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4581   -0.0056    1.0028 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1918   -1.0826   -1.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7406   -2.0112    0.4648 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1467   -1.4244   -1.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4022   -2.3530    0.6579 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0549    0.6909   -0.0446 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7830    2.0698   -0.1645 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6125    0.6285    1.9162 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9322    2.7079    0.7539 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3490    1.9868    1.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3837    2.7716   -1.2184 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2189    2.1127   -2.1091 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4249    0.7625   -1.9109 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  2  0
  1  4  2  0
  1  7  1  0
  1 16  1  0
  2 13  2  0
  5  9  1  0
  5 10  1  0
  5 13  1  0
  6 11  1  0
  6 12  1  0
  7 15  1  0
  8 21  2  0
  8 28  1  0
  9 11  1  0
 10 12  1  0
 13 14  1  0
 14 17  2  0
 14 18  1  0
 15 19  2  0
 15 20  1  0
 16 21  1  0
 16 23  2  0
 17 19  1  0
 18 20  2  0
 21 22  1  0
 22 24  1  0
 22 26  2  0
 23 25  1  0
 24 25  2  0
 26 27  1  0
 27 28  2  0
M  END
>  <InChIKey>  (59) 
RVGADWBBGNTVBK-UHFFFAOYSA-N

>  <PubChem_CID>  (59) 
59634912

>  <BOM_1A2>  (59) 


>  <BOM_2A6>  (59) 


>  <BOM_2B6>  (59) 


>  <BOM_2C8>  (59) 


>  <BOM_2C9>  (59) 


>  <BOM_2C19>  (59) 


>  <BOM_2D6>  (59) 


>  <BOM_2E1>  (59) 


>  <BOM_3A4>  (59) 
<11,6;Dealkylation;R1><11,H;Dealkylation;R1>/<12,6;Dealkylation;R1><12,H;Dealkylation;R1>
<9,5;Dealkylation;R2><9,H;Dealkylation;R2>/<10,5;Dealkylation;R2><10,H;Dealkylation;R2>

>  <References>  (59) 
Prakash, Chandra, et al. "An innovative phase I study in healthy subjects to determine the mass balance, elimination, metabolism, and absolute bioavailability of mitapivat." Clinical and Translational Science 16.10 (2023): 2021-2032.

>  <FLAG_COMMENTS>  (59) 


>  <ID>  (59) 
M396

>  <Comment>  (59) 


>  <smile>  (59) 
O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1)N1CCNCC1

$$$$
norketamine
     RDKit          3D

 15 16  0  0  1  0  0  0  0  0999 V2000
    0.2316   -2.3211    0.2924 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.7536   -0.2919   -2.1235 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8780    2.0969   -0.0734 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6194    0.6583    0.1162 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2295    0.1930    1.4618 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7571    0.1911    1.4887 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3038   -0.6678    0.3568 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8500   -0.1563   -0.9991 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3414   -0.0046   -1.0775 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8819    0.3188    0.1053 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3345   -0.9981    0.1818 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7969    1.3674    0.0164 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7033   -1.2665    0.1694 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1657    1.0990    0.0041 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6189   -0.2180    0.0806 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  2  9  2  0
  4  3  1  6
  4  5  1  0
  4  9  1  0
  4 10  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  2  0
 10 12  1  0
 11 13  1  0
 12 14  2  0
 13 15  2  0
 14 15  1  0
M  END
>  <InChIKey>  (60) 
BEQZHFIKTBVCAU-UHFFFAOYSA-N

>  <PubChem_CID>  (60) 
123767

>  <BOM_1A2>  (60) 


>  <BOM_2A6>  (60) 
<5,H;Hydroxylation;R1>
<6,H;Hydroxylation;R2>
<7,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>

>  <BOM_2B6>  (60) 
<5,H;Hydroxylation;R1>
<6,H;Hydroxylation;R2>
<7,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>
<7,8;Dehydrogenation;R5>

>  <BOM_2C8>  (60) 


>  <BOM_2C9>  (60) 


>  <BOM_2C19>  (60) 


>  <BOM_2D6>  (60) 


>  <BOM_2E1>  (60) 


>  <BOM_3A4>  (60) 


>  <References>  (60) 
Pelletier, Romain, et al. "Arylcyclohexylamine derivatives: pharmacokinetic, pharmacodynamic, clinical and forensic aspects." International Journal of Molecular Sciences 23.24 (2022): 15574.

>  <FLAG_COMMENTS>  (60) 


>  <ID>  (60) 
norketamine

>  <Comment>  (60) 


>  <smile>  (60) 
N[C@@]1(c2ccccc2Cl)CCCCC1=O

$$$$
lenvatinib
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    8.0437    3.5272    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.6705    1.0574    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3465    0.5074    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -2.5272    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -1.0272    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5192    2.5673    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7872    2.5473    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3580   -2.5619    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    0.4728    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3909    2.0774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9009    1.2172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3908    2.0890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6590    2.0574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9270    2.0373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0553    2.5273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9386    1.0374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -1.0272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2067    1.0174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3580   -0.4926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -2.0272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1951    2.0173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0784    0.5274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -0.5272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -1.0272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -2.0272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -2.5272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2641   -1.0064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2641   -2.0480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -0.5272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -3.5272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 15  1  0
  2 13  2  0
  3 18  1  0
  3 19  1  0
  4 25  1  0
  4 30  1  0
  5 29  2  0
  6 10  1  0
  6 13  1  0
  7 13  1  0
  7 14  1  0
  8 20  2  0
  8 28  1  0
  9 29  1  0
 10 11  1  0
 10 12  1  0
 11 12  1  0
 14 15  2  0
 14 16  1  0
 15 21  1  0
 16 22  2  0
 17 19  2  0
 17 20  1  0
 17 23  1  0
 18 21  2  0
 18 22  1  0
 19 27  1  0
 20 26  1  0
 23 24  2  0
 24 25  1  0
 24 29  1  0
 25 26  2  0
 27 28  2  0
M  END
>  <InChIKey>  (61) 
WOSKHXYHFSIKNG-UHFFFAOYSA-N

>  <PubChem_CID>  (61) 
9823820

>  <BOM_1A2>  (61) 
<30,4;Dealkylation;R2><30,H;Dealkylation;R2>

>  <BOM_2A6>  (61) 
<30,4;Dealkylation;R2><30,H;Dealkylation;R2>

>  <BOM_2B6>  (61) 
<30,4;Dealkylation;R2><30,H;Dealkylation;R2>
<10,6;Dealkylation;R3><10,H;Dealkylation;R3>

>  <BOM_2C8>  (61) 


>  <BOM_2C9>  (61) 


>  <BOM_2C19>  (61) 
<30,4;Dealkylation;R2><30,H;Dealkylation;R2>

>  <BOM_2D6>  (61) 


>  <BOM_2E1>  (61) 


>  <BOM_3A4>  (61) 
<8,N;N-Oxidation;R1>
<30,4;Dealkylation;R2><30,H;Dealkylation;R2>
<10,6;Dealkylation;R3><10,H;Dealkylation;R3>

>  <References>  (61) 
Vavrov, Katarna, et al. "The impact of individual human cytochrome P450 enzymes on oxidative metabolism of anticancer drug lenvatinib." Biomedicine & Pharmacotherapy 145 (2022): 112391.

>  <FLAG_COMMENTS>  (61) 


>  <ID>  (61) 
lenvatinib

>  <Comment>  (61) 


>  <smile>  (61) 
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O

$$$$
Duloxetine
     RDKit          3D

 21 23  0  0  1  0  0  0  0  0999 V2000
   -1.5366   -1.8702    1.6645 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1372    0.3493   -0.8990 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6900    1.9586   -0.4704 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2748    0.2805   -0.0442 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.3929    1.1277   -0.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6658    1.1498    0.1816 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6367   -1.1784    0.1187 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9939    0.9109   -0.3784 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1925    0.1853   -0.2824 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3379    0.8106    0.2652 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0462   -2.0393   -0.8478 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9254    2.2338    0.0597 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2796   -1.1470   -0.7181 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2509    2.1430    0.7008 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0518    2.8488    0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5366    0.0852    0.3611 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2935   -3.3338   -0.3065 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0558   -3.3816    1.0495 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9228    1.9570    0.3039 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4787   -1.8527   -0.6150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6051   -1.2377   -0.0764 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0
  1 18  1  0
  2  4  1  0
  2  8  1  0
  3  6  1  0
  3 19  1  0
  4  5  1  6
  4  7  1  0
  5  6  1  0
  7 11  2  0
  8  9  1  0
  8 12  2  0
  9 10  2  0
  9 13  1  0
 10 14  1  0
 10 16  1  0
 11 17  1  0
 12 15  1  0
 13 20  2  0
 14 15  2  0
 16 21  2  0
 17 18  2  0
 20 21  1  0
M  END
>  <InChIKey>  (62) 
ZEUITGRIYCTCEM-KRWDZBQOSA-N

>  <PubChem_CID>  (62) 
60835

>  <BOM_1A2>  (62) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>

>  <BOM_2A6>  (62) 


>  <BOM_2B6>  (62) 


>  <BOM_2C8>  (62) 


>  <BOM_2C9>  (62) 
<16,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>

>  <BOM_2C19>  (62) 


>  <BOM_2D6>  (62) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>

>  <BOM_2E1>  (62) 


>  <BOM_3A4>  (62) 


>  <References>  (62) 
Knadler MP, Lobo E, Chappell J, Bergstrom R: Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2011 May;50(5):281-94. doi: 10.2165/11539240-000000000-00000.

>  <FLAG_COMMENTS>  (62) 


>  <ID>  (62) 
Duloxetine

>  <Comment>  (62) 


>  <smile>  (62) 
CNCC[C@H](Oc1cccc2ccccc12)c1cccs1

$$$$
Indapamide
     RDKit          3D

 24 26  0  0  1  0  0  0  0  0999 V2000
    5.8085   -0.5802   -0.0632 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7693    1.8229    0.6627 S   0  0  0  0  0  6  0  0  0  0  0  0
   -0.4949   -2.2165   -1.3957 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6958    2.4401    1.4249 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0836    1.6535    1.2612 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2513   -0.7668    0.1711 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8943   -0.6089    0.2300 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9406    2.6466   -0.8230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9572   -1.4353    1.2699 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.4318   -0.9560    1.1909 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2971    0.2985    0.3881 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0203    0.3568   -0.1833 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8415   -2.9474    1.1455 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2416    1.2854    0.1651 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6657    1.4262   -0.9923 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8858    2.3642   -0.6450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6073    2.4344   -1.2191 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0840   -1.3803   -0.5947 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3807   -1.1677   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8382    0.0581   -0.0219 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2128    0.2567    0.1063 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2350   -2.2040   -0.7719 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0986   -0.7750   -0.2044 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6097   -2.0054   -0.6435 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 23  1  0
  2  4  2  0
  2  5  2  0
  2  8  1  0
  2 21  1  0
  3 18  2  0
  6  7  1  0
  6  9  1  0
  6 12  1  0
  7 18  1  0
  9 10  1  0
  9 13  1  6
 10 11  1  0
 11 12  2  0
 11 14  1  0
 12 15  1  0
 14 16  2  0
 15 17  2  0
 16 17  1  0
 18 19  1  0
 19 20  2  0
 19 22  1  0
 20 21  1  0
 21 23  2  0
 22 24  2  0
 23 24  1  0
M  END
>  <InChIKey>  (63) 
NDDAHWYSQHTHNT-UHFFFAOYSA-N

>  <PubChem_CID>  (63) 
3702

>  <BOM_1A2>  (63) 


>  <BOM_2A6>  (63) 


>  <BOM_2B6>  (63) 


>  <BOM_2C8>  (63) 
<10,9;Dehydrogenation;R1>

>  <BOM_2C9>  (63) 


>  <BOM_2C19>  (63) 
<10,9;Dehydrogenation;R1>

>  <BOM_2D6>  (63) 


>  <BOM_2E1>  (63) 


>  <BOM_3A4>  (63) 
<10,9;Dehydrogenation;R1>
<16,H;Hydroxylation;R2>
<14,16;Epoxidation;R3>

>  <References>  (63) 
Zisaki A, Miskovic L, Hatzimanikatis V: Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches. Curr Pharm Des. 2015;21(6):806-22. 
Caruso FS, Szabadi RR, Vukovich RA: Pharmacokinetics and clinical pharmacology of indapamide. Am Heart J. 1983 Jul;106(1 Pt 2):212-20. doi: 10.1016/0002-8703(83)90119-9.
Sun H, Moore C, Dansette PM, Kumar S, Halpert JR, Yost GS: Dehydrogenation of the indoline-containing drug 4-chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (indapamide) by CYP3A4: correlation with in silico predictions. Drug Metab Dispos. 2009 Mar;37(3):672-84. doi: 10.1124/dmd.108.022707. Epub 2008 Dec 12. 
Zisaki A, Miskovic L, Hatzimanikatis V: Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches. Curr Pharm Des. 2015;21(6):806-22.

>  <FLAG_COMMENTS>  (63) 


>  <ID>  (63) 
Indapamide

>  <Comment>  (63) 


>  <smile>  (63) 
C[C@@H]1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1

$$$$
Sunitinib
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
    7.3421   -1.9332    2.0237 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1676    1.7851   -0.8482 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1660    1.2214   -1.8222 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8561   -0.7407   -0.0641 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750    1.7829    0.9513 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1485   -0.4445   -0.2615 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4453    0.6024   -1.8711 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5025   -0.4874    0.4124 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1875    0.9254    0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1856   -0.0763    0.0942 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9279    0.4914    0.6216 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4965   -0.7178   -0.7057 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6279    2.0648    0.6329 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8331   -0.4842    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9840   -2.1164   -0.5491 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5446    0.8201   -0.3592 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2742    0.0935    0.0284 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2519    0.0047    0.8814 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6466   -0.3695    0.2033 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3372   -1.4640   -0.3924 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3142   -0.0357   -0.9788 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1962    3.4047    0.8793 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1617    0.7243   -1.3294 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7189    0.9391    1.5152 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3720   -2.3738   -1.1106 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3108   -1.0109    1.2317 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6499   -0.3230   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6648   -1.3116    1.0487 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3278   -0.9709   -0.1455 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 28  1  0
  2 16  2  0
  3 23  2  0
  4  8  1  0
  4 14  1  0
  4 15  1  0
  5 11  1  0
  5 13  1  0
  6 12  1  0
  6 16  1  0
  7 21  1  0
  7 23  1  0
  8 12  1  0
  9 10  1  0
  9 13  2  0
  9 16  1  0
 10 11  2  0
 10 20  1  0
 11 18  1  0
 13 22  1  0
 14 24  1  0
 15 25  1  0
 17 18  2  0
 17 19  1  0
 17 23  1  0
 19 21  2  0
 19 26  1  0
 21 27  1  0
 26 28  2  0
 27 29  2  0
 28 29  1  0
M  END
>  <InChIKey>  (64) 
WINHZLLDWRZWRT-ATVHPVEESA-N

>  <PubChem_CID>  (64) 
5329102

>  <BOM_1A2>  (64) 
<14,4;Dealkylation;R1><14,H;Dealkylation;R1>/<15,4;Dealkylation;R1><15,H;Dealkylation;R1>
<28,1;Dehalogenation;R2>

>  <BOM_2A6>  (64) 


>  <BOM_2B6>  (64) 


>  <BOM_2C8>  (64) 


>  <BOM_2C9>  (64) 


>  <BOM_2C19>  (64) 


>  <BOM_2D6>  (64) 


>  <BOM_2E1>  (64) 


>  <BOM_3A4>  (64) 
<14,4;Dealkylation;R1><14,H;Dealkylation;R1>/<15,4;Dealkylation;R1><15,H;Dealkylation;R1>
<28,1;Dehalogenation;R2>

>  <References>  (64) 
Amaya, Gracia M., et al. "Cytochromes P450 1A2 and 3A4 catalyze the metabolic activation of sunitinib." Chemical research in toxicology 31.7 (2018): 570-584.

>  <FLAG_COMMENTS>  (64) 


>  <ID>  (64) 
Sunitinib

>  <Comment>  (64) 


>  <smile>  (64) 
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C

$$$$
Danicamtiv
     RDKit          3D

 29 31  0  0  1  0  0  0  0  0999 V2000
    2.5574   -0.6188   -0.9910 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.8690    0.8178    1.0529 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.9791    2.5940   -0.0992 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8185    2.4725    0.0365 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.6151    0.4415   -1.9794 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2946   -1.9850   -1.4034 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5559   -1.0035   -1.5135 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2933   -0.6643    0.4210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8187    0.3329   -0.7719 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8608   -1.2571    1.0125 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9365    0.4338    0.2664 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0988    0.0385    0.7461 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0293   -0.7090   -0.1547 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0646    0.3825   -0.3647 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3480   -0.1613    0.2582 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6109   -0.6804   -1.2402 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9099    0.8593    0.7194 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9194   -0.1555   -1.8215 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2324    1.3439    0.1227 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0428   -1.3585    1.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1056   -0.6458   -0.1351 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1451   -0.1514   -0.7215 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0232    0.4065    0.0449 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6799   -1.7158    0.5069 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9147    1.7947   -0.4383 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8221   -2.0214    1.7708 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3029    0.1733    0.5373 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0479    0.7990    1.5517 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2918    0.2374    1.4359 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  2  0
  1  6  2  0
  1 15  1  0
  1 21  1  0
  2 15  1  0
  3 25  1  0
  4 25  1  0
  7 22  2  0
  8 13  1  0
  8 29  1  0
  9 18  1  0
  9 19  1  0
  9 22  1  0
 10 12  1  0
 10 24  1  0
 10 26  1  0
 11 22  1  0
 11 27  1  0
 12 23  2  0
 13 27  2  0
 14 15  1  0
 14 16  1  0
 14 17  1  0
 15 20  1  1
 16 18  1  0
 17 19  1  0
 21 23  1  0
 21 24  2  0
 23 25  1  0
 27 28  1  0
 28 29  2  0
M  END
>  <InChIKey>  (65) 
NREKKBAMVWQRES-MRXNPFEDSA-N

>  <PubChem_CID>  (65) 
122424426

>  <BOM_1A2>  (65) 
<22,9;Hydrolysis;R1>
<19,9;Dealkylation;R2><19,9;Dealkylation;R2>/<18,9;Dealkylation;R2><18,9;Dealkylation;R2>

>  <BOM_2A6>  (65) 


>  <BOM_2B6>  (65) 


>  <BOM_2C8>  (65) 
<22,9;Hydrolysis;R1>

>  <BOM_2C9>  (65) 
<22,9;Hydrolysis;R1>
<26,10;Dealkylation;R3><26,10;Dealkylation;R3>

>  <BOM_2C19>  (65) 
<22,9;Hydrolysis;R1>

>  <BOM_2D6>  (65) 
<22,9;Hydrolysis;R1>

>  <BOM_2E1>  (65) 
<22,9;Hydrolysis;R1>

>  <BOM_3A4>  (65) 
<22,9;Hydrolysis;R1>
<19,9;Dealkylation;R2><19,9;Dealkylation;R2>/<18,9;Dealkylation;R2><18,9;Dealkylation;R2>
<26,10;Dealkylation;R3><26,10;Dealkylation;R3>

>  <References>  (65) 
Grillo, Mark P., et al. "Preclinical in vitro and in vivo pharmacokinetic properties of danicamtiv, a new targeted myosin activator for the treatment of dilated cardiomyopathy." Xenobiotica 51.2 (2021): 222-238.

>  <FLAG_COMMENTS>  (65) 
## The CYP-mediated isoxazole ring-opened and oxidized derivatives, M4 and M5, could not be structurally characterized and thus were not included in the labeling.

>  <ID>  (65) 
Danicamtiv

>  <Comment>  (65) 


>  <smile>  (65) 
Cn1cc(S(=O)(=O)[C@@](C)(F)C2CCN(C(=O)Nc3ccon3)CC2)c(C(F)F)n1

$$$$
Abemaciclib
     RDKit          3D

 37 41  0  0  0  0  0  0  0  0999 V2000
    5.8656    0.8872    2.4062 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.2571   -2.4484   -1.1817 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2163   -0.3322    0.7640 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8798    1.7361   -0.3823 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9741    3.0976   -0.3553 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5538    3.2786    1.1976 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8391   -1.7310    0.5915 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0280   -3.6948   -0.4417 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7695   -2.1493   -0.2138 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1499   -4.3095   -1.2116 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5304   -0.0084    1.3325 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6291    0.8511    0.1234 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4675    0.5527    0.2575 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5665    1.4110   -0.9521 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3227   -0.8634    1.7914 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7735    2.2691   -1.4086 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1788   -1.6383    1.1934 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1113    2.6754   -0.8144 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9744    3.4918   -1.3221 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3321    1.8105   -0.0455 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3645   -2.9245    0.6986 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9081   -1.0914    1.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7310    3.9377    0.4129 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3194    1.9503    0.9259 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5844    2.9809   -0.9353 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    3.0381   -2.7355 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8906    0.5739   -0.5173 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4917   -0.5618    0.0354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2890   -3.6146    0.1504 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9125    0.7987    1.4702 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0581   -2.9793    0.1207 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6026    5.4073    0.3328 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4849   -0.4537    1.0116 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0745   -1.8694   -0.4115 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3804   -3.3691   -0.6313 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9669   -2.7457   -0.9945 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4433   -3.9633   -1.3788 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 30  1  0
  2 36  1  0
  3 11  1  0
  3 12  1  0
  3 15  1  0
  4 13  1  0
  4 14  1  0
  4 16  1  0
  5 19  1  0
  5 20  1  0
  5 23  1  0
  6 23  2  0
  6 24  1  0
  7 22  2  0
  7 31  1  0
  8 31  1  0
  8 35  1  0
  9 34  2  0
  9 35  1  0
 10 35  2  0
 10 37  1  0
 11 13  1  0
 12 14  1  0
 15 17  1  0
 16 18  1  0
 17 21  2  0
 17 22  1  0
 19 25  1  0
 19 26  1  0
 20 24  2  0
 20 27  1  0
 21 29  1  0
 23 32  1  0
 24 30  1  0
 27 28  2  0
 28 33  1  0
 28 34  1  0
 29 31  2  0
 30 33  2  0
 34 36  1  0
 36 37  2  0
M  END
>  <InChIKey>  (66) 
UZWDCWONPYILKI-UHFFFAOYSA-N 

>  <PubChem_CID>  (66) 
46220502

>  <BOM_1A2>  (66) 


>  <BOM_2A6>  (66) 


>  <BOM_2B6>  (66) 


>  <BOM_2C8>  (66) 


>  <BOM_2C9>  (66) 


>  <BOM_2C19>  (66) 


>  <BOM_2D6>  (66) 


>  <BOM_2E1>  (66) 


>  <BOM_3A4>  (66) 
<16,4;Dealkylation;R1><16,H;Dealkylation;R1>
<32,H;Hydroxylation;R2>

>  <References>  (66) 
Martnez-Chvez, Alejandra, et al. "Simultaneous quantification of abemaciclib and its active metabolites in human and mouse plasma by UHPLCMS/MS." Journal of Pharmaceutical and Biomedical Analysis 203 (2021): 114225.

>  <FLAG_COMMENTS>  (66) 


>  <ID>  (66) 
Abemaciclib

>  <Comment>  (66) 


>  <smile>  (66) 
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1

$$$$
Ribavirin
     RDKit          3D

 17 18  0  0  1  0  0  0  0  0999 V2000
    1.3923   -0.5531   -1.0023 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8880    2.3434    1.0678 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8653    1.0931   -0.3151 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8679   -3.2215   -0.2838 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4406   -1.8540    0.5635 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4685    0.7913   -0.4022 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1659   -0.3029   -0.0614 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5350    1.5008   -0.3852 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8037   -0.0596    0.2197 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0429    0.2641    0.5061 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.7292    0.9690    0.7805 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5982   -0.9473   -0.3074 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.9865    0.7451   -0.5279 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2793   -2.1586    0.5578 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2891    1.8588   -0.5931 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4105    0.1792   -0.0652 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5364   -0.6477    0.2482 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  1 13  1  0
 11  2  1  6
 10  3  1  6
  4 14  1  0
  5 17  2  0
  6  7  1  0
 13  6  1  1
  6 15  1  0
  7 16  2  0
  8 15  2  0
  8 16  1  0
  9 17  1  0
 10 11  1  0
 10 12  1  0
 11 13  1  0
 12 14  1  1
 16 17  1  0
M  END
>  <InChIKey>  (67) 
IWUCXVSUMQZMFG-AFCXAGJDSA-N

>  <PubChem_CID>  (67) 
37542

>  <BOM_1A2>  (67) 


>  <BOM_2A6>  (67) 


>  <BOM_2B6>  (67) 


>  <BOM_2C8>  (67) 


>  <BOM_2C9>  (67) 


>  <BOM_2C19>  (67) 


>  <BOM_2D6>  (67) 


>  <BOM_2E1>  (67) 


>  <BOM_3A4>  (67) 


>  <References>  (67) 
FDA Approved Drug Products: Rebetol (ribavirin) oral capsules

>  <FLAG_COMMENTS>  (67) 
 In vitro studies indicate that ribavirin is not a substrate of CYP450 enzymes

>  <ID>  (67) 
Ribavirin

>  <Comment>  (67) 


>  <smile>  (67) 
NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1

$$$$
Erlotinib
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    2.1434    0.4125    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
    2.1434   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    1.4289   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.4289   -1.6500    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    0.7145   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    0.7145   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.4289   -3.3000    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    2.1434   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.8579   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    3.5724   -2.8875    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    4.2868   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.0000   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -0.7145   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -1.4289   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -1.4289   -4.1250    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -2.1434   -4.5375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -2.1434   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -2.8579   -5.7750    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -3.5724   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -3.5724   -4.5375    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -2.8579   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -2.8579   -6.6000    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -2.8579   -7.4250    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -2.1434   -2.8875    0.0000 N   0  0  0  0  0  0  0  0  0 25  0  0
   -2.1434   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -1.4289   -1.6500    0.0000 N   0  0  0  0  0  0  0  0  0 27  0  0
   -0.7145   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    0.0000   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 17 22  1  0
 19 23  1  0
 23 24  3  0
 15 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 14 28  1  0
 28 29  2  0
  6 29  1  0
M  END
>  <InChIKey>  (68) 
AAKJLRGGTJKAMG-UHFFFAOYSA-N

>  <PubChem_CID>  (68) 


>  <BOM_1A2>  (68) 
<1,2;Dealkylation;R1><1,H;Dealkylation;R1>

>  <BOM_2A6>  (68) 


>  <BOM_2B6>  (68) 


>  <BOM_2C8>  (68) 


>  <BOM_2C9>  (68) 


>  <BOM_2C19>  (68) 


>  <BOM_2D6>  (68) 


>  <BOM_2E1>  (68) 


>  <BOM_3A4>  (68) 
<1,2;Dealkylation;R1><1,H;Dealkylation;R1>
<11,12;Dealkylation;R2><12,H;Dealkylation;R2>

>  <References>  (68) 
(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423
Rakhit, A., Pantze, M. P., Fettner, S., Jones, H. M., Charoin, J. E., Riek, M., ... & Hamilton, M. (2008). The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP?) predicts in vivo metabolic inhibition. European journal of clinical pharmacology, 64(1), 31-41.

>  <FLAG_COMMENTS>  (68) 


>  <ID>  (68) 
Erlotinib

>  <Comment>  (68) 


>  <smile>  (68) 
[CH3:1][O:2][CH2:3][CH2:4][O:5][c:6]1[c:7]([O:8][CH2:9][CH2:10][O:11][CH3:12])[cH:13][c:14]2[c:15]([NH:16][c:17]3[cH:18][c:19]([C:23]#[CH:24])[cH:20][cH:21][cH:22]3)[n:25][cH:26][n:27][c:28]2[cH:29]1

$$$$
leflunomide
     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
    1.4289   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.4289   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.0964   -2.9599    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    1.8414   -3.7445    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.0164   -3.7445    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
    0.7615   -2.9599    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    2.8810   -2.7050    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.4941   -3.2570    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    3.0525   -1.8980    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    3.8372   -1.6431    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    4.0087   -0.8361    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    4.7933   -0.5812    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    5.4064   -1.1332    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    5.2349   -1.9402    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    4.4502   -2.1951    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    6.1910   -0.8783    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    6.9756   -0.6233    0.0000 F   0  0  0  0  0  0  0  0  0 17  0  0
    6.4460   -1.6629    0.0000 F   0  0  0  0  0  0  0  0  0 18  0  0
    5.9361   -0.0936    0.0000 F   0  0  0  0  0  0  0  0  0 19  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  2  6  1  0
  3  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 10 15  1  0
 13 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
M  END
>  <InChIKey>  (69) 
VHOGYURTWQBHIL-UHFFFAOYSA-N

>  <PubChem_CID>  (69) 


>  <BOM_1A2>  (69) 
<5,6;Reduction;R1><4,5;Reduction;R1>

>  <BOM_2A6>  (69) 


>  <BOM_2B6>  (69) 


>  <BOM_2C8>  (69) 


>  <BOM_2C9>  (69) 
<5,6;Reduction;R1><4,5;Reduction;R1>

>  <BOM_2C19>  (69) 


>  <BOM_2D6>  (69) 


>  <BOM_2E1>  (69) 


>  <BOM_3A4>  (69) 
<5,6;Reduction;R1><4,5;Reduction;R1>

>  <References>  (69) 
PMID: 19754423

>  <FLAG_COMMENTS>  (69) 
## <5,6;Cleavage;R1> to <5,6;Reduction;R1>, Reductive Isoxazole ring opening

>  <ID>  (69) 
leflunomide

>  <Comment>  (69) 


>  <smile>  (69) 
[CH3:1][c:2]1[c:3]([C:7](=[O:8])[NH:9][c:10]2[cH:11][cH:12][c:13]([C:16]([F:17])([F:18])[F:19])[cH:14][cH:15]2)[cH:4][n:5][o:6]1

$$$$
paraxanthine
     RDKit          2D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.3984    0.7541    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.1435   -0.0305    0.0000 N   0  0  0  0  0  0  0  0  0  2  0  0
   -0.6284   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.1435   -1.3654    0.0000 N   0  0  0  0  0  0  0  0  0  4  0  0
    0.6411   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.6411   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    1.3556    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.3556    0.9521    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    2.0701   -0.2854    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    2.0701   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.7845   -1.5229    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    1.3556   -1.5229    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    2.7845    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  2  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  5 12  1  0
  9 13  1  0
M  END
>  <InChIKey>  (70) 
QUNWUDVFRNGTCO-UHFFFAOYSA-N

>  <PubChem_CID>  (70) 


>  <BOM_1A2>  (70) 
<1,2;Dealkylation;R1><1,H;Dealkylation;R1>

>  <BOM_2A6>  (70) 
<3,H;Oxidation;R2>

>  <BOM_2B6>  (70) 


>  <BOM_2C8>  (70) 


>  <BOM_2C9>  (70) 


>  <BOM_2C19>  (70) 


>  <BOM_2D6>  (70) 


>  <BOM_2E1>  (70) 


>  <BOM_3A4>  (70) 


>  <References>  (70) 
PMID: 8162667;PMID: 19754423

>  <FLAG_COMMENTS>  (70) 


>  <ID>  (70) 
paraxanthine

>  <Comment>  (70) 


>  <smile>  (70) 
[CH3:1][n:2]1[cH:3][n:4][c:5]2[c:6]1[c:7](=[O:8])[n:9]([CH3:13])[c:10](=[O:11])[nH:12]2

$$$$
Azinphos-methyl
     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -1.4289   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -1.4289   -3.3000    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
   -0.7145   -2.8875    0.0000 P   0  0  0  0  0  5  0  0  0  3  0  0
   -0.3020   -3.6020    0.0000 S   0  0  0  0  0  0  0  0  0  4  0  0
   -1.1270   -2.1730    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
   -0.7145   -1.4586    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    0.0000   -2.4750    0.0000 S   0  0  0  0  0  0  0  0  0  7  0  0
    0.0000   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    0.7145   -1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    0.7145   -0.4125    0.0000 N   0  0  0  0  0  0  0  0  0 10  0  0
    1.4289    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
    2.1434   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    2.8579    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.5724   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.5724   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    2.8579   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.1434   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.4289   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    1.4289   -2.4750    0.0000 O   0  0  0  0  0  0  0  0  0 19  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 12 17  1  0
 17 18  1  0
  9 18  1  0
 18 19  2  0
M  END
>  <InChIKey>  (71) 
CJJOSEISRRTUQB-UHFFFAOYSA-N

>  <PubChem_CID>  (71) 


>  <BOM_1A2>  (71) 
<4,3;Desulfuration;R1>

>  <BOM_2A6>  (71) 


>  <BOM_2B6>  (71) 
<4,3;Desulfuration;R1>

>  <BOM_2C8>  (71) 
<4,3;Desulfuration;R1>

>  <BOM_2C9>  (71) 


>  <BOM_2C19>  (71) 
<4,3;Desulfuration;R1>

>  <BOM_2D6>  (71) 
<4,3;Desulfuration;R1>

>  <BOM_2E1>  (71) 


>  <BOM_3A4>  (71) 
<4,3;Desulfuration;R1>

>  <References>  (71) 
PMID: 21782601;PMID: 12898643 
Buratti, Franca M., et al. "CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes." Toxicology and applied pharmacology 186.3 (2003): 143-154.

>  <FLAG_COMMENTS>  (71) 


>  <ID>  (71) 
Azinphos-methyl

>  <Comment>  (71) 


>  <smile>  (71) 
[CH3:1][O:2][P:3](=[S:4])([O:5][CH3:6])[S:7][CH2:8][n:9]1[n:10][n:11][c:12]2[cH:13][cH:14][cH:15][cH:16][c:17]2[c:18]1=[O:19]

$$$$
3-Hydroxylidocaine
     RDKit          2D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.7145   -1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
    1.5395   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    1.9520   -0.5230    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    1.9520   -1.9520    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    2.7770   -1.9520    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
    3.1895   -2.6664    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.0145   -2.6664    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.1895   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    4.0145   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    0.3020   -0.5230    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.5230   -0.5230    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.9355    0.1914    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -0.5230    0.9059    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.3020    0.9059    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.7145    1.6204    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
    0.7145    0.1914    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    1.5395    0.1914    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -0.9355   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  1 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 10 16  1  0
 16 17  1  0
 11 18  1  0
M  END
>  <InChIKey>  (72) 
PMGUCIDDSCRAMY-UHFFFAOYSA-N

>  <PubChem_CID>  (72) 


>  <BOM_1A2>  (72) 
<5,8;Dealkylation;R1><8,H;Dealkylation;R1>
<5,6;Dealkylation;R2><6,H;Dealkylation;R2>

>  <BOM_2A6>  (72) 


>  <BOM_2B6>  (72) 


>  <BOM_2C8>  (72) 


>  <BOM_2C9>  (72) 


>  <BOM_2C19>  (72) 


>  <BOM_2D6>  (72) 
<5,8;Dealkylation;R1><8,H;Dealkylation;R1>
<5,6;Dealkylation;R2><6,H;Dealkylation;R2>

>  <BOM_2E1>  (72) 


>  <BOM_3A4>  (72) 
<5,8;Dealkylation;R1><8,H;Dealkylation;R1>
<5,6;Dealkylation;R2><6,H;Dealkylation;R2>

>  <References>  (72) 
(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693

>  <FLAG_COMMENTS>  (72) 


>  <ID>  (72) 
3-Hydroxylidocaine

>  <Comment>  (72) 


>  <smile>  (72) 
[NH:1]([C:2](=[O:3])[CH2:4][N:5]([CH2:6][CH3:7])[CH2:8][CH3:9])[c:10]1[c:11]([CH3:18])[cH:12][cH:13][c:14]([OH:15])[c:16]1[CH3:17]

$$$$
(R)-mianserin_ 8-hydroxy
     RDKit          2D

 21 24  0  0  1  0  0  0  0  0999 V2000
    5.9401    1.6553    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    5.1517    1.8985    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    4.5470    1.3373    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    4.7305    0.5330    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    5.5189    0.2898    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    6.1237    0.8510    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.2162   -0.1120    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.3912   -0.1120    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    2.8768    0.5330    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    3.0604    1.3373    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.4556    1.8985    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.6673    1.6553    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    1.4837    0.8510    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.6953    0.6078    0.0000 O   0  0  0  0  0  0  0  0  0 14  0  0
    2.0884    0.2898    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.8037    1.6953    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.9787   -0.8265    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.3912   -1.5409    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    4.2162   -1.5409    0.0000 N   0  0  0  0  0  0  0  0  0 19  0  0
    4.6287   -2.2554    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    4.6287   -0.8265    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
  9 15  1  0
 10 16  1  0
  3 16  1  0
  8 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
  7 21  1  6
M  END
>  <InChIKey>  (73) 
IXAPYQICIDTITB-SFHVURJKSA-N

>  <PubChem_CID>  (73) 


>  <BOM_1A2>  (73) 
<19,20;Dealkylation;R1>
<20,H;Dealkylation;R1>

>  <BOM_2A6>  (73) 


>  <BOM_2B6>  (73) 


>  <BOM_2C8>  (73) 


>  <BOM_2C9>  (73) 


>  <BOM_2C19>  (73) 


>  <BOM_2D6>  (73) 
<19,20;Dealkylation;R1><20,H;Dealkylation;R1>

>  <BOM_2E1>  (73) 


>  <BOM_3A4>  (73) 
<19,20;Dealkylation;R1><20,H;Dealkylation;R1>

>  <References>  (73) 
(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423

>  <FLAG_COMMENTS>  (73) 


>  <ID>  (73) 
(R)-mianserin_ 8-hydroxy

>  <Comment>  (73) 


>  <smile>  (73) 
[cH:1]1[cH:2][c:3]2[c:4]([cH:5][cH:6]1)[C@H:7]1[N:8]([c:9]3[c:10]([cH:11][cH:12][c:13]([OH:14])[cH:15]3)[CH2:16]2)[CH2:17][CH2:18][N:19]([CH3:20])[CH2:21]1

$$$$
Carbosulfan
     RDKit          2D

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.4275    1.2927    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    0.1574    2.0723    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.6975    2.6959    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    1.5077    2.5400    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.9063    3.2623    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    1.3425    3.8646    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    2.0005    4.3624    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    0.9163    4.5710    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    0.5955    3.5146    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    1.7777    1.7605    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.5878    1.6046    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    2.3178    0.2014    0.0000 O   0  0  0  0  0  0  0  0  0 13  0  0
    3.6680    0.6691    0.0000 N   0  0  0  0  0  0  0  0  0 14  0  0
    3.9381   -0.1105    0.0000 S   0  0  0  0  0  0  0  0  0 15  0  0
    4.7482   -0.2664    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
    5.0182   -1.0459    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    5.8284   -1.2018    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    6.0984   -1.9814    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    6.9086   -2.1373    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    5.2883    0.3573    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    6.0984    0.2014    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    6.6385    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    7.4486    0.6691    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    4.2081    1.2927    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.2376    1.1368    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  3  9  1  0
  4 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 16 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 14 25  1  0
 10 26  2  0
  1 26  1  0
M  END
>  <InChIKey>  (74) 
JLQUFIHWVLZVTJ-UHFFFAOYSA-N

>  <PubChem_CID>  (74) 


>  <BOM_1A2>  (74) 
<14,15;S-N-Cleavage;R1>

>  <BOM_2A6>  (74) 
<14,15;S-N-Cleavage;R1>

>  <BOM_2B6>  (74) 
<14,15;S-N-Cleavage;R1>
<15,S;S-Oxidation;R2>

>  <BOM_2C8>  (74) 
<14,15;S-N-Cleavage;R1>

>  <BOM_2C9>  (74) 


>  <BOM_2C19>  (74) 
<14,15;S-N-Cleavage;R1>
<15,S;S-Oxidation;R2>

>  <BOM_2D6>  (74) 


>  <BOM_2E1>  (74) 


>  <BOM_3A4>  (74) 
<14,15;S-N-Cleavage;R1>
<15,S;S-Oxidation;R2>

>  <References>  (74) 
(R1) Abass, K. et al. (2010). Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chem. Biol. Interact., Vol. 185, No. 3, (163-173).

>  <FLAG_COMMENTS>  (74) 


>  <ID>  (74) 
Carbosulfan

>  <Comment>  (74) 


>  <smile>  (74) 
[cH:1]1[cH:2][c:3]2[c:4]([c:10]([O:11][C:12](=[O:13])[N:14]([S:15][N:16]([CH2:17][CH2:18][CH2:19][CH3:20])[CH2:21][CH2:22][CH2:23][CH3:24])[CH3:25])[cH:26]1)[O:5][C:6]([CH3:7])([CH3:8])[CH2:9]2

$$$$
Dimethoate
     RDKit          2D

 12 11  0  0  0  0  0  0  0  0999 V2000
    0.8250    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
    1.2375   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.8250   -1.4289    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    2.0625   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    2.4750   -1.4289    0.0000 S   0  0  0  0  0  0  0  0  0  5  0  0
    3.3000   -1.4289    0.0000 P   0  0  0  0  0  5  0  0  0  6  0  0
    3.3000   -2.2539    0.0000 S   0  0  0  0  0  0  0  0  0  7  0  0
    4.1250   -1.4289    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    4.5375   -2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    3.3000   -0.6039    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
    4.0145   -0.1914    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.0670    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  6 10  1  0
 10 11  1  0
  1 12  1  0
M  END
>  <InChIKey>  (75) 
MCWXGJITAZMZEV-UHFFFAOYSA-N

>  <PubChem_CID>  (75) 


>  <BOM_1A2>  (75) 
<7,6;Desulfuration;R1>

>  <BOM_2A6>  (75) 
<7,6;Desulfuration;R1>

>  <BOM_2B6>  (75) 
<7,6;Desulfuration;R1>

>  <BOM_2C8>  (75) 
<7,6;Desulfuration;R1>

>  <BOM_2C9>  (75) 
<7,6;Desulfuration;R1>

>  <BOM_2C19>  (75) 
<7,6;Desulfuration;R1>

>  <BOM_2D6>  (75) 


>  <BOM_2E1>  (75) 


>  <BOM_3A4>  (75) 
<7,6;Desulfuration;R1>

>  <References>  (75) 
(R1) Buratti, F.M. and Testai, E. (2007). Evidences for CYP3A4 autoactivation in the desulfuration of dimethoate by the human liver. Toxicology, Vol. 241, No. 1-2, (33-46).

>  <FLAG_COMMENTS>  (75) 


>  <ID>  (75) 
Dimethoate

>  <Comment>  (75) 
In paper (https://doi.org/10.1016/j.tox.2007.08.081), it says DIM can be detoxified by esterase-dependent hydrolytic cleavage of the Csingle bondN bond, to yield DIM carboxylic acid. However, it's not clear if the reaction is catalyzed by a CYP450 enzyme or which CYP450 isoform it is. 

>  <smile>  (75) 
[NH:1]([C:2](=[O:3])[CH2:4][S:5][P:6](=[S:7])([O:8][CH3:9])[O:10][CH3:11])[CH3:12]

$$$$
Disulfoton
     RDKit          2D

 14 13  0  0  0  0  0  0  0  0999 V2000
    5.3625   -3.5724    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    4.9500   -2.8579    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    4.1250   -2.8579    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    3.7125   -2.1434    0.0000 P   0  0  0  0  0  5  0  0  0  4  0  0
    4.4270   -1.7309    0.0000 S   0  0  0  0  0  0  0  0  0  5  0  0
    2.9980   -2.5559    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    2.2836   -2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.5691   -2.5559    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    3.3000   -1.4289    0.0000 S   0  0  0  0  0  0  0  0  0  9  0  0
    2.4750   -1.4289    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.0625   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.2375   -0.7145    0.0000 S   0  0  0  0  0  0  0  0  0 12  0  0
    0.8250    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
M  END
>  <InChIKey>  (76) 
DOFZAZXDOSGAJZ-UHFFFAOYSA-N

>  <PubChem_CID>  (76) 


>  <BOM_1A2>  (76) 
<12,S;S-Oxidation;R1>

>  <BOM_2A6>  (76) 


>  <BOM_2B6>  (76) 
<12,S;S-Oxidation;R1>

>  <BOM_2C8>  (76) 


>  <BOM_2C9>  (76) 
<12,S;S-Oxidation;R1>

>  <BOM_2C19>  (76) 
<12,S;S-Oxidation;R1>

>  <BOM_2D6>  (76) 
<12,S;S-Oxidation;R1>

>  <BOM_2E1>  (76) 


>  <BOM_3A4>  (76) 
<12,S;S-Oxidation;R1>

>  <References>  (76) 
(R1) Usmani, K.A.; (2004b). In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab. Dispos., Vol. 32, No. 3, (333-339).

>  <FLAG_COMMENTS>  (76) 


>  <ID>  (76) 
Disulfoton

>  <Comment>  (76) 


>  <smile>  (76) 
[CH3:1][CH2:2][O:3][P:4](=[S:5])([O:6][CH2:7][CH3:8])[S:9][CH2:10][CH2:11][S:12][CH2:13][CH3:14]

$$$$
N-Desmethylclomipramine
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -3.3367    3.8358    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -4.1251    3.5927    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -4.3087    2.7884    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -3.7039    2.2272    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -2.9155    2.4704    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.7320    3.2747    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.2339    2.0056    0.0000 N   0  0  0  0  0  0  0  0  0  7  0  0
   -2.1722    1.1830    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -2.7770    0.6218    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -2.5934   -0.1825    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -1.8051   -0.4257    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -1.2003    0.1355    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -0.4120   -0.1077    0.0000 Cl  0  0  0  0  0  0  0  0  0 13  0  0
   -1.3839    0.9398    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.5928    0.7448    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -4.0053    1.4592    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -1.5194    2.4181    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -0.8050    2.0056    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -0.0905    2.4181    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    0.6240    2.0056    0.0000 N   0  0  0  0  0  0  0  0  0 20  0  0
    1.3385    2.4181    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
  8 14  1  0
  9 15  1  0
 15 16  1  0
  4 16  1  0
  7 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
M  END
>  <InChIKey>  (77) 
VPIXQGUBUKFLRF-UHFFFAOYSA-N

>  <PubChem_CID>  (77) 


>  <BOM_1A2>  (77) 
<20,21;Dealkylation;R1><21,H;Dealkylation;R1>

>  <BOM_2A6>  (77) 


>  <BOM_2B6>  (77) 


>  <BOM_2C8>  (77) 


>  <BOM_2C9>  (77) 


>  <BOM_2C19>  (77) 
<20,21;Dealkylation;R1><21,H;Dealkylation;R1>

>  <BOM_2D6>  (77) 
<2,H;Hydroxylation;R1>

>  <BOM_2E1>  (77) 


>  <BOM_3A4>  (77) 
<20,21;Dealkylation;R1><21,H;Dealkylation;R1>

>  <References>  (77) 
(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423
Yokono, A., Morita, S., Someya, T., Hirokane, G., Okawa, M., & Shimoda, K. (2001). The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients. Journal of clinical psychopharmacology, 21(6), 549-555.

>  <FLAG_COMMENTS>  (77) 


>  <ID>  (77) 
N-Desmethylclomipramine

>  <Comment>  (77) 


>  <smile>  (77) 
[cH:1]1[cH:2][cH:3][c:4]2[c:5]([cH:6]1)[N:7]([CH2:17][CH2:18][CH2:19][NH:20][CH3:21])[c:8]1[c:9]([cH:10][cH:11][c:12]([Cl:13])[cH:14]1)[CH2:15][CH2:16]2

$$$$
Fenthion
     RDKit          2D

 16 16  0  0  0  0  0  0  0  0999 V2000
   -4.7989    2.0187    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -4.0845    1.6062    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -3.3700    2.0187    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -3.3700    2.8437    0.0000 P   0  0  0  0  0  5  0  0  0  4  0  0
   -2.5450    2.8437    0.0000 S   0  0  0  0  0  0  0  0  0  5  0  0
   -3.3700    3.6687    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
   -2.6555    4.0812    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -4.1950    2.8437    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
   -4.6075    3.5582    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -4.0845    0.7812    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -4.7989    0.3687    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -5.5134    0.7812    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -6.2279    0.3687    0.0000 S   0  0  0  0  0  0  0  0  0 13  0  0
   -6.2279   -0.4563    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -5.5134    1.6062    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -4.7989   -0.4563    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  1  0
  2 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  2  0
  1 15  1  0
 11 16  1  0
M  END
>  <InChIKey>  (78) 
PNVJTZOFSHSLTO-UHFFFAOYSA-N

>  <PubChem_CID>  (78) 


>  <BOM_1A2>  (78) 
<5,4;Desulfuration;R1>

>  <BOM_2A6>  (78) 


>  <BOM_2B6>  (78) 
<5,4;Desulfuration;R1>

>  <BOM_2C8>  (78) 


>  <BOM_2C9>  (78) 
<5,4;Desulfuration;R1>

>  <BOM_2C19>  (78) 
<5,4;Desulfuration;R1>

>  <BOM_2D6>  (78) 


>  <BOM_2E1>  (78) 


>  <BOM_3A4>  (78) 
<5,4;Desulfuration;R1>

>  <References>  (78) 
(R1) Leoni, C. et al. (2008). The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol. Appl. Pharmacol., Vol. 233, No. 2, (343-352).

>  <FLAG_COMMENTS>  (78) 


>  <ID>  (78) 
Fenthion

>  <Comment>  (78) 


>  <smile>  (78) 
[cH:1]1[c:2]([O:3][P:4](=[S:5])([O:6][CH3:7])[O:8][CH3:9])[cH:10][c:11]([CH3:16])[c:12]([S:13][CH3:14])[cH:15]1

$$$$
Monoethylglycinexylidide
     RDKit          2D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -3.7052   -0.3446    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -2.9907    0.0679    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -2.9907    0.8929    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -2.2762   -0.3446    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.5618    0.0679    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
   -0.8473   -0.3446    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -0.1328    0.0679    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -4.4196    0.0679    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -5.1341   -0.3446    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -5.8486    0.0679    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -5.8486    0.8929    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -5.1341    1.3054    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.4196    0.8929    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.7052    1.3054    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -5.1341   -1.1696    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  1  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  8 13  1  0
 13 14  1  0
  9 15  1  0
M  END
>  <InChIKey>  (79) 
WRMRXPASUROZGT-UHFFFAOYSA-N

>  <PubChem_CID>  (79) 


>  <BOM_1A2>  (79) 
<5,6;Dealkylation;R1><6,H;Dealkylation;R1>
<10,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <BOM_2A6>  (79) 


>  <BOM_2B6>  (79) 


>  <BOM_2C8>  (79) 


>  <BOM_2C9>  (79) 


>  <BOM_2C19>  (79) 


>  <BOM_2D6>  (79) 
<10,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <BOM_2E1>  (79) 


>  <BOM_3A4>  (79) 
<5,6;Dealkylation;R1><6,H;Dealkylation;R1>
<10,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <References>  (79) 
(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693
Wang, B., & Zhou, S. F. (2009). Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Current medicinal chemistry, 16(31), 4066-4218.

>  <FLAG_COMMENTS>  (79) 


>  <ID>  (79) 
Monoethylglycinexylidide

>  <Comment>  (79) 


>  <smile>  (79) 
[NH:1]([C:2](=[O:3])[CH2:4][NH:5][CH2:6][CH3:7])[c:8]1[c:9]([CH3:15])[cH:10][cH:11][cH:12][c:13]1[CH3:14]

$$$$
N-Desmethyldiphenhydramine
     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -5.9602    0.6027    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -5.2457    1.0152    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -4.5313    0.6027    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -4.5313   -0.2223    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.2457   -0.6348    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.9602   -0.2223    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -3.8168   -0.6348    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -3.1023   -0.2223    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
   -2.3878   -0.6348    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.6734   -0.2223    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.9589   -0.6348    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
   -0.2444   -0.2223    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -3.8168   -1.4598    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.1023   -1.8723    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.1023   -2.6973    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.8168   -3.1098    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -4.5313   -2.6973    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -4.5313   -1.8723    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 13 18  1  0
M  END
>  <InChIKey>  (80) 
AGSLYHYWLYGAOU-UHFFFAOYSA-N

>  <PubChem_CID>  (80) 


>  <BOM_1A2>  (80) 
<11,12;Dealkylation;R1><12,H;Dealkylation;R1>

>  <BOM_2A6>  (80) 


>  <BOM_2B6>  (80) 


>  <BOM_2C8>  (80) 


>  <BOM_2C9>  (80) 
<11,12;Dealkylation;R1><12,H;Dealkylation;R1>

>  <BOM_2C19>  (80) 
<11,12;Dealkylation;R1><12,H;Dealkylation;R1>

>  <BOM_2D6>  (80) 
<11,12;Dealkylation;R1><12,H;Dealkylation;R1>

>  <BOM_2E1>  (80) 


>  <BOM_3A4>  (80) 


>  <References>  (80) 
(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423

>  <FLAG_COMMENTS>  (80) 


>  <ID>  (80) 
N-Desmethyldiphenhydramine

>  <Comment>  (80) 


>  <smile>  (80) 
[cH:1]1[cH:2][cH:3][c:4]([CH:7]([O:8][CH2:9][CH2:10][NH:11][CH3:12])[c:13]2[cH:14][cH:15][cH:16][cH:17][cH:18]2)[cH:5][cH:6]1

$$$$
Sulprofos
     RDKit          2D

 18 18  0  0  1  0  0  0  0  0999 V2000
   -5.9150    1.4830    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -5.2005    1.0705    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -5.2005    0.2455    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -4.4861   -0.1670    0.0000 S   0  0  0  0  0  0  0  0  0  4  0  0
   -4.4861   -0.9920    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.9150   -0.1670    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -6.6295    0.2455    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -6.6295    1.0705    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.3439    1.4830    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -7.3439    2.3080    0.0000 P   0  0  0  0  0  5  0  0  0 10  0  0
   -6.5189    2.3080    0.0000 S   0  0  0  0  0  0  0  0  0 11  0  0
   -8.1689    2.3080    0.0000 O   0  0  0  0  0  0  0  0  0 12  0  0
   -8.5814    3.0225    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -9.4064    3.0225    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -7.3439    3.1330    0.0000 S   0  0  0  0  0  0  0  0  0 15  0  0
   -8.0584    3.5455    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -8.0584    4.3705    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -8.7729    4.7830    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  2  0
  6  7  1  0
  7  8  2  0
  1  8  1  0
  8  9  1  0
 10  9  1  6
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 10 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
M  END
>  <InChIKey>  (81) 
JXHJNEJVUNHLKO-HNNXBMFYSA-N

>  <PubChem_CID>  (81) 


>  <BOM_1A2>  (81) 
<4,S;S-Oxidation;R1>

>  <BOM_2A6>  (81) 


>  <BOM_2B6>  (81) 


>  <BOM_2C8>  (81) 


>  <BOM_2C9>  (81) 
<4,S;S-Oxidation;R1>

>  <BOM_2C19>  (81) 
<4,S;S-Oxidation;R1>

>  <BOM_2D6>  (81) 
<4,S;S-Oxidation;R1>

>  <BOM_2E1>  (81) 


>  <BOM_3A4>  (81) 
<4,S;S-Oxidation;R1>

>  <References>  (81) 
(R1) Usmani, K.A.; (2004b). In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab. Dispos., Vol. 32, No. 3, (333-339).

>  <FLAG_COMMENTS>  (81) 


>  <ID>  (81) 
Sulprofos

>  <Comment>  (81) 


>  <smile>  (81) 
[cH:1]1[cH:2][c:3]([S:4][CH3:5])[cH:6][cH:7][c:8]1[O:9][P@:10](=[S:11])([O:12][CH2:13][CH3:14])[S:15][CH2:16][CH2:17][CH3:18]

$$$$
nisoldipine
     RDKit          2D

 28 29  0  0  0  0  0  0  0  0999 V2000
  -12.4813    0.9083    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
  -11.9421    0.2264    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
  -11.9557   -0.5985    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
  -11.2481   -1.0227    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
  -10.5270   -0.6220    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  -10.5134    0.2028    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
  -11.2209    0.6271    0.0000 N   0  0  0  0  0  0  0  0  0  7  0  0
   -9.9315    0.8500    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -9.6484   -0.8725    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -9.2922   -1.6684    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
   -8.7795   -0.6817    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
   -7.9703   -1.0186    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -7.1989   -0.6817    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -6.5349   -1.1713    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -7.1069    0.1382    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
  -11.2617   -1.8476    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
  -10.5542   -2.2718    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
  -10.5678   -3.0967    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
  -11.2889   -3.4974    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
  -11.9965   -3.0732    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
  -11.9829   -2.2483    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
  -12.9253   -2.1014    0.0000 N   0  0  0  0  0  4  0  0  0 22  0  0
  -13.3954   -1.3152    0.0000 O   0  0  0  0  0  0  0  0  0 23  0  0
  -13.7615   -2.4635    0.0000 O   0  0  0  0  0  1  0  0  0 24  0  0
  -12.8802   -0.6708    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
  -12.4301   -1.3964    0.0000 O   0  0  0  0  0  0  0  0  0 26  0  0
  -13.8684   -0.7209    0.0000 O   0  0  0  0  0  0  0  0  0 27  0  0
  -14.2442   -1.4553    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  1  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
  4 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 16 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
  3 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
M  CHG  2  22   1  24  -1
M  END
>  <InChIKey>  (82) 
VKQFCGNPDRICFG-UHFFFAOYSA-N

>  <PubChem_CID>  (82) 


>  <BOM_1A2>  (82) 
<2,7;Rearrangement;R1><2,3;Rearrangement;R1><3,4;Rearrangement;R1><4,5;Rearrangement;R1><5,6;Rearrangement;R1><6,7;Rearrangement;R1><4,H;Dehydrogenation;R1><7,H;Dehydrogenation;R1>
<13,H;Hydroxylation;R2>

>  <BOM_2A6>  (82) 


>  <BOM_2B6>  (82) 


>  <BOM_2C8>  (82) 


>  <BOM_2C9>  (82) 
<2,7;Rearrangement;R1><2,3;Rearrangement;R1><3,4;Rearrangement;R1><4,5;Rearrangement;R1><5,6;Rearrangement;R1><6,7;Rearrangement;R1><4,H;Dehydrogenation;R1><7,H;Dehydrogenation;R1>
<27,28;Dealkylation;R2><28,H;Dealkylation;R2>

>  <BOM_2C19>  (82) 
<2,7;Rearrangement;R1><2,3;Rearrangement;R1><3,4;Rearrangement;R1><4,5;Rearrangement;R1><5,6;Rearrangement;R1><6,7;Rearrangement;R1><4,H;Dehydrogenation;R1><7,H;Dehydrogenation;R1>
<13,H;Hydroxylation;R2>
<27,28;Dealkylation;R3><28,H;Dealkylation;R3>

>  <BOM_2D6>  (82) 
<2,7;Rearrangement;R1><2,3;Rearrangement;R1><3,4;Rearrangement;R1><4,5;Rearrangement;R1><5,6;Rearrangement;R1><6,7;Rearrangement;R1><4,H;Dehydrogenation;R1><7,H;Dehydrogenation;R1>
<13,H;Hydroxylation;R2>

>  <BOM_2E1>  (82) 
<2,7;Rearrangement;R1><2,3;Rearrangement;R1><3,4;Rearrangement;R1><4,5;Rearrangement;R1><5,6;Rearrangement;R1><6,7;Rearrangement;R1><4,H;Dehydrogenation;R1><7,H;Dehydrogenation;R1>
<27,28;Dealkylation;R2><28,H;Dealkylation;R2>

>  <BOM_3A4>  (82) 
<2,7;Rearrangement;R1><2,3;Rearrangement;R1><3,4;Rearrangement;R1><4,5;Rearrangement;R1><5,6;Rearrangement;R1><6,7;Rearrangement;R1><4,H;Dehydrogenation;R1><7,H;Dehydrogenation;R1>
<13,H;Hydroxylation;R2>

>  <References>  (82) 
PMID: 15618694;PMID: 24816159
Yuan, L., Jia, P., Sun, Y., Zhao, C., Zhi, X., Sheng, N., & Zhang, L. (2014). Study of in vitro metabolism of m-nisoldipine in human liver microsomes and recombinant cytochrome P450 enzymes by liquid chromatography Cmass spectrometry. Journal of pharmaceutical and biomedical analysis, 97, 65-71.

>  <FLAG_COMMENTS>  (82) 


>  <ID>  (82) 
nisoldipine

>  <Comment>  (82) 


>  <smile>  (82) 
[CH3:1][C:2]1=[C:3]([C:25](=[O:26])[O:27][CH3:28])[CH:4]([c:16]2[cH:17][cH:18][cH:19][cH:20][c:21]2[N+:22](=[O:23])[O-:24])[C:5]([C:9](=[O:10])[O:11][CH2:12][CH:13]([CH3:14])[CH3:15])=[C:6]([CH3:8])[NH:7]1

$$$$
Methoxyflurane
     RDKit          3D

  8  7  0  0  0  0  0  0  0  0999 V2000
    1.5212   -1.8146   -0.0615 Cl  0  0  0  0  0  0  0  0  0  1  0  0
    2.3480    0.9725   -0.0168 Cl  0  0  0  0  0  0  0  0  0  2  0  0
   -0.2812    0.3042   -1.3497 F   0  0  0  0  0  0  0  0  0  3  0  0
   -0.5778    1.4731    0.4770 F   0  0  0  0  0  0  0  0  0  4  0  0
   -1.2707   -0.6731    0.4434 O   0  0  0  0  0  0  0  0  0  5  0  0
   -0.2689    0.2391    0.0038 C   0  0  1  0  0  0  0  0  0  6  0  0
    1.0991   -0.1813    0.5146 C   0  0  1  0  0  0  0  0  0  7  0  0
   -2.5696   -0.3199   -0.0109 C   0  0  0  0  0  0  0  0  0  8  0  0
  7  1  1  6
  2  7  1  0
  6  3  1  6
  4  6  1  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
M  END
>  <InChIKey>  (83) 
RFKMCNOHBTXSMU-UHFFFAOYSA-N

>  <PubChem_CID>  (83) 
4116

>  <BOM_1A2>  (83) 


>  <BOM_2A6>  (83) 
<5,8;Dealkylation;R1><8,H;Dealkylation;R1>
<1,7;Dealkylation;R2><7,H;Dealkylation;R2>
<2,7;Dealkylation;R3><7,H;Dealkylation;R3>

>  <BOM_2B6>  (83) 
<5,8;Dealkylation;R1><8,H;Dealkylation;R1>
<1,7;Dealkylation;R2><7,H;Dealkylation;R2>
<2,7;Dealkylation;R3><7,H;Dealkylation;R3>

>  <BOM_2C8>  (83) 


>  <BOM_2C9>  (83) 


>  <BOM_2C19>  (83) 


>  <BOM_2D6>  (83) 


>  <BOM_2E1>  (83) 
<5,8;Dealkylation;R1><8,H;Dealkylation;R1>
<1,7;Dealkylation;R2><7,H;Dealkylation;R2>
<2,7;Dealkylation;R3><7,H;Dealkylation;R3>

>  <BOM_3A4>  (83) 
<5,8;Dealkylation;R1><8,H;Dealkylation;R1>
<1,7;Dealkylation;R2><7,H;Dealkylation;R2>
<2,7;Dealkylation;R3><7,H;Dealkylation;R3>

>  <References>  (83) 
Kharasch ED, Hankins DC, Thummel KE. Human kidney methoxyflurane and sevoflurane metabolism: intrarenal
fluoride production as a possible mechanism of
methoxyflurane nephrotoxicity. Anesthesiology 1995; 82:
607 C8.
Chang, G. W. M., and P. C. A. Kam. "The physiological and pharmacological roles of cytochrome P450 isoenzymes." Anaesthesia 54.1 (1999): 42-50.
Nelson, Sidney D., and William F. Trager. "The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity." Drug metabolism and disposition 31.12 (2003): 1481-1497.
Kharasch, E. D., Schroeder, J. L., Liggitt, H. D., Park, S. B., Whittington, D., & Sheffels, P. (2006). New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (Part 1) Identification of the nephrotoxic metabolic pathway. The Journal of the American Society of Anesthesiologists, 105(4), 726-736.
Harrold, M., & Zavod, R. (2013). Basic concepts in medicinal chemistry. ASHP.

>  <FLAG_COMMENTS>  (83) 


>  <ID>  (83) 
Methoxyflurane

>  <Comment>  (83) 


>  <smile>  (83) 
[Cl:1][C@@H:7]([Cl:2])[C@:6]([F:3])([F:4])[O:5][CH3:8]

$$$$
Flunarizine
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -3.0735   -5.4571   -0.5171 F   0  0  0  0  0  0  0  0  0  1  0  0
   -6.8332    3.0606   -0.5322 F   0  0  0  0  0  0  0  0  0  2  0  0
   -1.0724    0.5166    0.0313 N   0  0  0  0  0  0  0  0  0  3  0  0
    1.5217    1.7903    0.1158 N   0  0  0  0  0  0  0  0  0  4  0  0
   -0.9373    1.9533    0.3014 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.1169   -0.2063    0.4983 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.2821   -0.0171    0.6538 C   0  0  2  0  0  0  0  0  0  7  0  0
    0.3320    2.5139   -0.3493 C   0  0  0  0  0  0  0  0  0  8  0  0
    1.3860    0.3535   -0.1534 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.7308    2.3235   -0.5087 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.4959   -1.4900    0.3374 C   0  0  0  0  0  0  0  0  0 11  0  0
   -3.5145    0.8157    0.3334 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.9635    1.6434    0.0090 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.1472   -2.2831    1.2599 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.8506    1.8599    1.1706 C   0  0  0  0  0  0  0  0  0 15  0  0
   -2.0324   -1.9883   -0.8631 C   0  0  0  0  0  0  0  0  0 16  0  0
   -4.2588    0.5021   -0.7856 C   0  0  0  0  0  0  0  0  0 17  0  0
   -3.3435   -3.6332    0.9691 C   0  0  0  0  0  0  0  0  0 18  0  0
   -4.9802    2.6236    0.8762 C   0  0  0  0  0  0  0  0  0 19  0  0
   -2.2289   -3.3382   -1.1538 C   0  0  0  0  0  0  0  0  0 20  0  0
   -5.3881    1.2660   -1.0801 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.8187    0.9712   -0.7778 C   0  0  0  0  0  0  0  0  0 22  0  0
   -2.8844   -4.1608   -0.2378 C   0  0  0  0  0  0  0  0  0 23  0  0
   -5.7489    2.3267   -0.2492 C   0  0  0  0  0  0  0  0  0 24  0  0
    6.0483    0.3027   -0.3203 C   0  0  0  0  0  0  0  0  0 25  0  0
    6.1868   -0.0218    1.0202 C   0  0  0  0  0  0  0  0  0 26  0  0
    7.0445    0.0096   -1.2382 C   0  0  0  0  0  0  0  0  0 27  0  0
    7.3513   -0.6556    1.4537 C   0  0  0  0  0  0  0  0  0 28  0  0
    8.2090   -0.6243   -0.8048 C   0  0  0  0  0  0  0  0  0 29  0  0
    8.3623   -0.9568    0.5412 C   0  0  0  0  0  0  0  0  0 30  0  0
  1 23  1  0
  2 24  1  0
  3  5  1  0
  3  6  1  0
  7  3  1  6
  4  8  1  0
  4  9  1  0
  4 10  1  0
  5  8  1  0
  6  9  1  0
  7 11  1  0
  7 12  1  0
 10 13  1  0
 11 14  2  0
 11 16  1  0
 12 15  2  0
 12 17  1  0
 13 22  2  0
 14 18  1  0
 15 19  1  0
 16 20  2  0
 17 21  2  0
 18 23  2  0
 19 24  2  0
 20 23  1  0
 21 24  1  0
 22 25  1  0
 25 26  2  0
 25 27  1  0
 26 28  1  0
 27 29  2  0
 28 30  2  0
 29 30  1  0
M  END
>  <InChIKey>  (84) 
SMANXXCATUTDDT-QPJJXVBHSA-N

>  <PubChem_CID>  (84) 
941361

>  <BOM_1A2>  (84) 
<3,7;Dealkylation;R1><7,H;Dealkylation;R1>
<10,4;Dealkylation;R2><10,H;Dealkylation;R2>

>  <BOM_2A6>  (84) 
<3,7;Dealkylation;R1><7,H;Dealkylation;R1>
<10,4;Dealkylation;R2><10,H;Dealkylation;R2>

>  <BOM_2B6>  (84) 


>  <BOM_2C8>  (84) 


>  <BOM_2C9>  (84) 
<3,7;Dealkylation;R1><7,H;Dealkylation;R1>
<10,4;Dealkylation;R2><10,H;Dealkylation;R2>

>  <BOM_2C19>  (84) 


>  <BOM_2D6>  (84) 
<30,H;Hydroxylation;R1>

>  <BOM_2E1>  (84) 


>  <BOM_3A4>  (84) 


>  <References>  (84) 
Rendic, Slobodan. "Summary of information on human CYP enzymes: human P450 metabolism data." Drug metabolism reviews 34.1-2 (2002): 83-448.
Zhou, S-F., et al. "Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development." Current medicinal chemistry 16.27 (2009): 3480-3675.

>  <FLAG_COMMENTS>  (84) 


>  <ID>  (84) 
Flunarizine

>  <Comment>  (84) 


>  <smile>  (84) 
[F:1][c:23]1[cH:18][cH:14][c:11]([C@@H:7]([N:3]2[CH2:5][CH2:8][N:4]([CH2:10]/[CH:13]=[CH:22]/[c:25]3[cH:26][cH:28][cH:30][cH:29][cH:27]3)[CH2:9][CH2:6]2)[c:12]2[cH:15][cH:19][c:24]([F:2])[cH:21][cH:17]2)[cH:16][cH:20]1

$$$$
NNN
     RDKit          3D

 13 14  0  0  1  0  0  0  0  0999 V2000
   -1.9054    2.4225    0.5679 O   0  0  0  0  0  0  0  0  0  1  0  0
   -1.6346    0.4277    0.0337 N   0  0  0  0  0  0  0  0  0  2  0  0
   -1.7837    1.6557   -0.3925 N   0  0  0  0  0  0  0  0  0  3  0  0
    3.0141    0.3732   -0.8851 N   0  0  0  0  0  0  0  0  0  4  0  0
   -0.6916   -0.4057   -0.7388 C   0  0  2  0  0  0  0  0  0  5  0  0
   -1.1816   -1.8521   -0.5352 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.3418   -1.7443    0.4426 C   0  0  0  0  0  0  0  0  0  7  0  0
   -2.8669   -0.3406    0.2112 C   0  0  0  0  0  0  0  0  0  8  0  0
    0.7483   -0.2109   -0.3024 C   0  0  0  0  0  0  0  0  0  9  0  0
    1.1254   -0.4250    1.0148 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.7151    0.1829   -1.2078 C   0  0  0  0  0  0  0  0  0 11  0  0
    2.4527   -0.2396    1.3852 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.3500    0.1562    0.4064 C   0  0  0  0  0  0  0  0  0 13  0  0
  1  3  2  0
  2  3  1  0
  2  5  1  0
  2  8  1  0
  4 11  2  0
  4 13  1  0
  5  6  1  0
  5  9  1  1
  6  7  1  0
  7  8  1  0
  9 10  2  0
  9 11  1  0
 10 12  1  0
 12 13  2  0
M  END
>  <InChIKey>  (85) 
XKABJYQDMJTNGQ-UHFFFAOYSA-N

>  <PubChem_CID>  (85) 
12613538

>  <BOM_1A2>  (85) 


>  <BOM_2A6>  (85) 
<2,8;Dealkylation;R1><8,H;Dealkylation;R1><2,5;Dealkylation;R1>

>  <BOM_2B6>  (85) 


>  <BOM_2C8>  (85) 


>  <BOM_2C9>  (85) 


>  <BOM_2C19>  (85) 


>  <BOM_2D6>  (85) 


>  <BOM_2E1>  (85) 


>  <BOM_3A4>  (85) 


>  <References>  (85) 
Smith, Theresa J., et al. "Characterization of xenobiotic-metabolizing enzymes and nitrosamine metabolism in the human esophagus." Carcinogenesis 19.4 (1998): 667-672.

>  <FLAG_COMMENTS>  (85) 


>  <ID>  (85) 
NNN

>  <Comment>  (85) 


>  <smile>  (85) 
[O:1]=[N:3][N:2]1[C@@H:5]([c:9]2[cH:10][cH:12][cH:13][n:4][cH:11]2)[CH2:6][CH2:7][CH2:8]1

$$$$
Medifoxamine
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -0.4399    0.6436    1.1208 O   0  0  0  0  0  0  0  0  0  1  0  0
   -0.7250   -1.5765    0.3778 O   0  0  0  0  0  0  0  0  0  2  0  0
   -3.4972   -0.9514   -0.1935 N   0  0  0  0  0  0  0  0  0  3  0  0
   -2.6418   -0.1478    0.6790 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.1733   -0.2214    0.2304 C   0  0  1  0  0  0  0  0  0  5  0  0
   -3.4335   -0.4566   -1.5683 C   0  0  0  0  0  0  0  0  0  6  0  0
   -4.8771   -0.9387    0.2908 C   0  0  0  0  0  0  0  0  0  7  0  0
    0.2245    1.7145    0.5865 C   0  0  0  0  0  0  0  0  0  8  0  0
    0.5778   -1.8819    0.0908 C   0  0  0  0  0  0  0  0  0  9  0  0
   -0.4844    2.6900   -0.1069 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.0743   -1.6535   -1.1884 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.6030    1.8177    0.7413 C   0  0  0  0  0  0  0  0  0 12  0  0
    1.3945   -2.4186    1.0809 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.1928    3.7808   -0.6519 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.4020   -1.9654   -1.4809 C   0  0  0  0  0  0  0  0  0 15  0  0
    2.2801    2.9087    0.1963 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.7222   -2.7304    0.7882 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.5750    3.8903   -0.5002 C   0  0  0  0  0  0  0  0  0 18  0  0
    3.2259   -2.5038   -0.4927 C   0  0  0  0  0  0  0  0  0 19  0  0
  1  5  1  0
  1  8  1  0
  2  5  1  0
  2  9  1  0
  3  4  1  0
  3  6  1  0
  3  7  1  0
  5  4  1  1
  8 10  2  0
  8 12  1  0
  9 11  2  0
  9 13  1  0
 10 14  1  0
 11 15  1  0
 12 16  2  0
 13 17  2  0
 14 18  2  0
 15 19  2  0
 16 18  1  0
 17 19  1  0
M  END
>  <InChIKey>  (86) 
QNMGHBMGNRQPNL-UHFFFAOYSA-N

>  <PubChem_CID>  (86) 
36109

>  <BOM_1A2>  (86) 


>  <BOM_2A6>  (86) 
<3,6;Dealkylation;R1><6,H;Dealkylation;R1>
<3,7;Dealkylation;R2><7,H;Dealkylation;R2>

>  <BOM_2B6>  (86) 


>  <BOM_2C8>  (86) 


>  <BOM_2C9>  (86) 


>  <BOM_2C19>  (86) 


>  <BOM_2D6>  (86) 


>  <BOM_2E1>  (86) 


>  <BOM_3A4>  (86) 
<3,6;Dealkylation;R1><6,H;Dealkylation;R1>
<3,7;Dealkylation;R2><7,H;Dealkylation;R2>

>  <References>  (86) 
Rendic, Slobodan. "Summary of information on human CYP enzymes: human P450 metabolism data." Drug metabolism reviews 34.1-2 (2002): 83-448.

>  <FLAG_COMMENTS>  (86) 


>  <ID>  (86) 
Medifoxamine

>  <Comment>  (86) 


>  <smile>  (86) 
[O:1]([C@@H:5]([O:2][c:9]1[cH:11][cH:15][cH:19][cH:17][cH:13]1)[CH2:4][N:3]([CH3:6])[CH3:7])[c:8]1[cH:10][cH:14][cH:18][cH:16][cH:12]1

$$$$
Formoterol
     RDKit          3D

 25 26  0  0  1  0  0  0  0  0999 V2000
   -2.8151    3.3368    0.9059 O   0  0  0  0  0  0  0  0  0  1  0  0
    2.8156   -3.3889    0.5834 O   0  0  0  0  0  0  0  0  0  2  0  0
   -2.2576   -2.8257    1.6873 O   0  0  0  0  0  0  0  0  0  3  0  0
   -3.2315   -0.8373   -2.9284 O   0  0  0  0  0  0  0  0  0  4  0  0
    0.5285    2.3873   -0.3861 N   0  0  0  0  0  0  0  0  0  5  0  0
   -2.8740   -2.0869   -0.9507 N   0  0  0  0  0  0  0  0  0  6  0  0
    1.8773    2.9144   -0.1591 C   0  0  1  0  0  0  0  0  0  7  0  0
    2.9019    2.0496   -0.9159 C   0  0  0  0  0  0  0  0  0  8  0  0
   -0.4502    3.1363    0.3842 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.8637    2.5902    0.1485 C   0  0  1  0  0  0  0  0  0 10  0  0
    1.9033    4.3769   -0.6037 C   0  0  0  0  0  0  0  0  0 11  0  0
    2.8784    0.5942   -0.5143 C   0  0  0  0  0  0  0  0  0 12  0  0
   -1.9713    1.1369    0.5551 C   0  0  0  0  0  0  0  0  0 13  0  0
   -2.3713    0.2002   -0.3822 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.0464   -0.2830   -1.1911 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.6899    0.1629    0.5226 C   0  0  0  0  0  0  0  0  0 16  0  0
   -1.6666    0.7753    1.8560 C   0  0  0  0  0  0  0  0  0 17  0  0
   -2.4699   -1.1396   -0.0069 C   0  0  0  0  0  0  0  0  0 18  0  0
   -1.7649   -0.5646    2.2312 C   0  0  0  0  0  0  0  0  0 19  0  0
    2.0251   -1.6276   -0.8209 C   0  0  0  0  0  0  0  0  0 20  0  0
    3.6688   -1.1819    0.8927 C   0  0  0  0  0  0  0  0  0 21  0  0
   -2.1667   -1.5220    1.2998 C   0  0  0  0  0  0  0  0  0 22  0  0
    2.8363   -2.0772    0.2209 C   0  0  0  0  0  0  0  0  0 23  0  0
   -3.2104   -1.8761   -2.2834 C   0  0  0  0  0  0  0  0  0 24  0  0
    1.9417   -4.2501   -0.1448 C   0  0  0  0  0  0  0  0  0 25  0  0
 10  1  1  1
  2 23  1  0
  2 25  1  0
  3 22  1  0
  4 24  2  0
  5  7  1  0
  5  9  1  0
  6 18  1  0
  6 24  1  0
  7  8  1  0
  7 11  1  6
  8 12  1  0
  9 10  1  0
 10 13  1  0
 12 15  2  0
 12 16  1  0
 13 14  2  0
 13 17  1  0
 14 18  1  0
 15 20  1  0
 16 21  2  0
 17 19  2  0
 18 22  2  0
 19 22  1  0
 20 23  2  0
 21 23  1  0
M  END
>  <InChIKey>  (87) 
BPZSYCZIITTYBL-YJYMSZOUSA-N

>  <PubChem_CID>  (87) 
3083544

>  <BOM_1A2>  (87) 


>  <BOM_2A6>  (87) 
<2,25;Dealkylation;R1><25,H;Dealkylation;R1>

>  <BOM_2B6>  (87) 


>  <BOM_2C8>  (87) 


>  <BOM_2C9>  (87) 
<2,25;Dealkylation;R1><25,H;Dealkylation;R1>

>  <BOM_2C19>  (87) 
<2,25;Dealkylation;R1><25,H;Dealkylation;R1>

>  <BOM_2D6>  (87) 
<2,25;Dealkylation;R1><25,H;Dealkylation;R1>

>  <BOM_2E1>  (87) 


>  <BOM_3A4>  (87) 


>  <References>  (87) 
PDR; Physicians' Desk Reference 57th ed 2003. Montvale,NJ: Medical Economics Co. p. 2275 (2003)

>  <FLAG_COMMENTS>  (87) 


>  <ID>  (87) 
Formoterol

>  <Comment>  (87) 


>  <smile>  (87) 
[OH:1][C@@H:10]([CH2:9][NH:5][C@@H:7]([CH2:8][c:12]1[cH:15][cH:20][c:23]([O:2][CH3:25])[cH:21][cH:16]1)[CH3:11])[c:13]1[cH:14][c:18]([NH:6][CH:24]=[O:4])[c:22]([OH:3])[cH:19][cH:17]1

$$$$
Letrozole
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0488    2.1750   -0.1529 N   0  0  0  0  0  0  0  0  0  1  0  0
    0.5991    2.3578    1.0251 N   0  0  0  0  0  0  0  0  0  2  0  0
   -0.1817    4.2817    0.0652 N   0  0  0  0  0  0  0  0  0  3  0  0
   -5.9267   -2.4767    0.5053 N   0  0  0  0  0  0  0  0  0  4  0  0
    5.8144   -2.6423    0.5551 N   0  0  0  0  0  0  0  0  0  5  0  0
   -0.0037    0.7872   -0.7151 C   0  0  2  0  0  0  0  0  0  6  0  0
   -1.2897    0.0797   -0.4508 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.2989    0.0185   -0.4316 C   0  0  0  0  0  0  0  0  0  8  0  0
   -1.8452   -0.7463   -1.4280 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.3901    0.2736   -1.2228 C   0  0  0  0  0  0  0  0  0 10  0  0
   -1.9366    0.2435    0.7741 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.3083   -0.8858    0.6000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -0.4151    3.2701   -0.7383 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.0478   -1.4084   -1.1804 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.5708   -0.4229   -0.9653 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.1391   -0.4188    1.0216 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.4891   -1.5821    0.8576 C   0  0  0  0  0  0  0  0  0 17  0  0
   -3.6946   -1.2447    0.0444 C   0  0  0  0  0  0  0  0  0 18  0  0
    3.6203   -1.3506    0.0749 C   0  0  0  0  0  0  0  0  0 19  0  0
    0.4354    3.6787    1.1236 C   0  0  0  0  0  0  0  0  0 20  0  0
   -4.9257   -1.9243    0.2986 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.8305   -2.0630    0.3397 C   0  0  0  0  0  0  0  0  0 22  0  0
  1  2  1  0
  6  1  1  1
  1 13  1  0
  2 20  2  0
  3 13  2  0
  3 20  1  0
  4 21  3  0
  5 22  3  0
  6  7  1  0
  6  8  1  0
  7  9  2  0
  7 11  1  0
  8 10  2  0
  8 12  1  0
  9 14  1  0
 10 15  1  0
 11 16  2  0
 12 17  2  0
 14 18  2  0
 15 19  2  0
 16 18  1  0
 17 19  1  0
 18 21  1  0
 19 22  1  0
M  END
>  <InChIKey>  (88) 
HPJKCIUCZWXJDR-UHFFFAOYSA-N

>  <PubChem_CID>  (88) 
3902

>  <BOM_1A2>  (88) 


>  <BOM_2A6>  (88) 
<1,6;Dealkylation;R1><6,H;Dealkylation;R1>

>  <BOM_2B6>  (88) 


>  <BOM_2C8>  (88) 


>  <BOM_2C9>  (88) 


>  <BOM_2C19>  (88) 


>  <BOM_2D6>  (88) 


>  <BOM_2E1>  (88) 


>  <BOM_3A4>  (88) 
<1,6;Dealkylation;R1><6,H;Dealkylation;R1>

>  <References>  (88) 
Jeong, Seongwook, et al. "Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4, 4  -methanol-bisbenzonitrile in vitro." Cancer chemotherapy and pharmacology 64.5 (2009): 867-875.
https://doi.org/10.1016/j.clpt.2004.12.193

>  <FLAG_COMMENTS>  (88) 


>  <ID>  (88) 
Letrozole

>  <Comment>  (88) 


>  <smile>  (88) 
[n:1]1([C@H:6]([c:7]2[cH:9][cH:14][c:18]([C:21]#[N:4])[cH:16][cH:11]2)[c:8]2[cH:10][cH:15][c:19]([C:22]#[N:5])[cH:17][cH:12]2)[n:2][cH:20][n:3][cH:13]1

$$$$
Sevoflurane
     RDKit          3D

 12 11  0  0  0  0  0  0  0  0999 V2000
    1.2852   -1.7729   -0.3891 F   0  0  0  0  0  0  0  0  0  1  0  0
    0.0143   -1.3472    1.3282 F   0  0  0  0  0  0  0  0  0  2  0  0
   -0.8714   -2.0796   -0.5270 F   0  0  0  0  0  0  0  0  0  3  0  0
   -2.4368    0.0880   -0.5846 F   0  0  0  0  0  0  0  0  0  4  0  0
   -1.5027    2.0543   -0.4320 F   0  0  0  0  0  0  0  0  0  5  0  0
   -1.5295    0.7172    1.2925 F   0  0  0  0  0  0  0  0  0  6  0  0
    3.2025    1.2778    0.1765 F   0  0  0  0  0  0  0  0  0  7  0  0
    0.9768    0.9476    0.0483 O   0  0  0  0  0  0  0  0  0  8  0  0
   -0.0791    0.1569   -0.4888 C   0  0  1  0  0  0  0  0  0  9  0  0
    0.0855   -1.2739   -0.0197 C   0  0  2  0  0  0  0  0  0 10  0  0
   -1.3951    0.7639   -0.0508 C   0  0  1  0  0  0  0  0  0 11  0  0
    2.2503    0.4680   -0.3535 C   0  0  0  0  0  0  0  0  0 12  0  0
 10  1  1  6
  2 10  1  0
  3 10  1  0
 11  4  1  6
  5 11  1  0
  6 11  1  0
  7 12  1  0
  9  8  1  1
  8 12  1  0
  9 10  1  0
  9 11  1  0
M  END
>  <InChIKey>  (89) 
DFEYYRMXOJXZRJ-UHFFFAOYSA-N

>  <PubChem_CID>  (89) 
5206

>  <BOM_1A2>  (89) 


>  <BOM_2A6>  (89) 
<12,8;Dealkylation;R1><12,H;Dealkylation;R1>

>  <BOM_2B6>  (89) 
<12,8;Dealkylation;R1><12,H;Dealkylation;R1>

>  <BOM_2C8>  (89) 


>  <BOM_2C9>  (89) 


>  <BOM_2C19>  (89) 


>  <BOM_2D6>  (89) 


>  <BOM_2E1>  (89) 
<12,8;Dealkylation;R1><12,H;Dealkylation;R1>

>  <BOM_3A4>  (89) 
<12,8;Dealkylation;R1><12,H;Dealkylation;R1>

>  <References>  (89) 
Kharasch ED, Hankins DC, Thummel KE. Human kidney methoxyflurane and sevoflurane metabolism: intrarenal
fluoride production as a possible mechanism of
methoxyflurane nephrotoxicity. Anesthesiology 1995; 82:
607 C8.
Chang, G. W. M., and P. C. A. Kam. "The physiological and pharmacological roles of cytochrome P450 isoenzymes." Anaesthesia 54.1 (1999): 42-50.

>  <FLAG_COMMENTS>  (89) 


>  <ID>  (89) 
Sevoflurane

>  <Comment>  (89) 


>  <smile>  (89) 
[F:1][C@:10]([F:2])([F:3])[C@H:9]([O:8][CH2:12][F:7])[C@:11]([F:4])([F:5])[F:6]

$$$$
Desmethylselegiline
     RDKit          3D

 13 13  0  0  1  0  0  0  0  0999 V2000
    2.2430    0.1867   -0.3554 N   0  0  0  0  0  0  0  0  0  1  0  0
    0.8905   -0.0017    0.1776 C   0  0  1  0  0  0  0  0  0  2  0  0
   -0.1436    0.3370   -0.9116 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.5747    0.2121   -0.4464 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.7661   -1.4418    0.6759 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.2306   -1.0006   -0.5858 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.2060    1.3125    0.1108 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.2380   -0.0670    0.6731 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.5529   -1.1160   -0.1566 C   0  0  0  0  0  0  0  0  0  9  0  0
   -3.5282    1.1973    0.5403 C   0  0  0  0  0  0  0  0  0 10  0  0
   -4.2016   -0.0170    0.4064 C   0  0  0  0  0  0  0  0  0 11  0  0
    4.5939    0.1224    0.1482 C   0  0  0  0  0  0  0  0  0 12  0  0
    5.7063    0.2762   -0.2765 C   0  0  0  0  0  0  0  0  0 13  0  0
  1  2  1  0
  1  8  1  0
  2  3  1  0
  2  5  1  6
  3  4  1  0
  4  6  2  0
  4  7  1  0
  6  9  1  0
  7 10  2  0
  8 12  1  0
  9 11  2  0
 10 11  1  0
 12 13  3  0
M  END
>  <InChIKey>  (90) 
UUFAJPMQSFXDFR-LLVKDONJSA-N

>  <PubChem_CID>  (90) 
185859

>  <BOM_1A2>  (90) 


>  <BOM_2A6>  (90) 
<1,8;Dealkylation;R1><8,H;Dealkylation;R1>

>  <BOM_2B6>  (90) 
<1,8;Dealkylation;R1><8,H;Dealkylation;R1>

>  <BOM_2C8>  (90) 


>  <BOM_2C9>  (90) 


>  <BOM_2C19>  (90) 


>  <BOM_2D6>  (90) 


>  <BOM_2E1>  (90) 


>  <BOM_3A4>  (90) 
<1,8;Dealkylation;R1><8,H;Dealkylation;R1>

>  <References>  (90) 
Rendic, Slobodan. "Summary of information on human CYP enzymes: human P450 metabolism data." Drug metabolism reviews 34.1-2 (2002): 83-448.

>  <FLAG_COMMENTS>  (90) 


>  <ID>  (90) 
Desmethylselegiline

>  <Comment>  (90) 


>  <smile>  (90) 
[NH:1]([C@@H:2]([CH2:3][c:4]1[cH:6][cH:9][cH:11][cH:10][cH:7]1)[CH3:5])[CH2:8][C:12]#[CH:13]

$$$$
METALAXYL
     RDKit          3D

 20 20  0  0  1  0  0  0  0  0999 V2000
    3.8417    0.6531   -0.4189 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2738   -3.4391    0.1024 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9752   -2.3805   -0.5609 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5539   -0.5969    1.0177 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2662   -0.1176   -0.4130 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4866    0.5178   -0.8399 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.8745    0.7298   -0.0687 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9912    1.1412    1.2271 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7483    1.0533   -1.0656 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3135    2.0286   -0.8456 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1155   -1.5308   -0.3095 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6697    0.1237    0.0316 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0801    1.9487    1.5558 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8371    1.8609   -0.7368 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200    0.7720    2.3014 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5980    0.5895   -2.4783 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0029    2.3086    0.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2587   -2.0274    0.1019 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0078    0.3215    0.3423 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5455   -3.9565    0.4829 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  1 19  1  0
  2 18  1  0
  2 20  1  0
  3 11  2  0
  4 12  2  0
  5  6  1  0
  5  7  1  0
  5 11  1  0
  6 10  1  1
  6 12  1  0
  7  8  2  0
  7  9  1  0
  8 13  1  0
  8 15  1  0
  9 14  2  0
  9 16  1  0
 11 18  1  0
 13 17  2  0
 14 17  1  0
M  END
>  <InChIKey>  (91) 
ZQEIXNIJLIKNTD-UHFFFAOYSA-N

>  <PubChem_CID>  (91) 


>  <BOM_1A2>  (91) 


>  <BOM_2A6>  (91) 


>  <BOM_2B6>  (91) 
<20,2;Dealkylation;R1><20,H;Dealkylation;R1>
<19,1;Dealkylation;R2><19,H;Dealkylation;R2>

>  <BOM_2C8>  (91) 


>  <BOM_2C9>  (91) 


>  <BOM_2C19>  (91) 


>  <BOM_2D6>  (91) 


>  <BOM_2E1>  (91) 


>  <BOM_3A4>  (91) 
<20,2;Dealkylation;R1><20,H;Dealkylation;R1>
<19,1;Dealkylation;R2><19,H;Dealkylation;R2>
<16,H;Hydroxylation;R3>
<14,H;Hydroxylation;R4>

>  <References>  (91) 
PMID: 21783735 

>  <FLAG_COMMENTS>  (91) 


>  <ID>  (91) 
METALAXYL

>  <Comment>  (91) 


>  <smile>  (91) 
COCC(=O)N(c1c(C)cccc1C)[C@@H](C)C(=O)OC

$$$$
Chlorpyrifos-oxon
     RDKit          2D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.1434    1.2375    0.0000 Cl  0  0  0  0  0  0  0  0  0  3  0  0
    1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    2.1434   -0.4125    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    2.1434   -1.2375    0.0000 P   0  0  0  0  0  5  0  0  0  6  0  0
    1.3184   -1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
    2.1434   -2.0625    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    2.8579   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.8579   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.9684   -1.2375    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    3.3809   -1.9520    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    4.2059   -1.9520    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.7145   -0.4125    0.0000 N   0  0  0  0  0  0  0  0  0 14  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -0.7145   -0.4125    0.0000 Cl  0  0  0  0  0  0  0  0  0 16  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -0.7145    1.2375    0.0000 Cl  0  0  0  0  0  0  0  0  0 18  0  0
  1  2  2  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
  6 11  1  0
 11 12  1  0
 12 13  1  0
  4 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
  1 17  1  0
 17 18  1  0
M  END
>  <InChIKey>  (92) 
OTMOUPHCTWPNSL-UHFFFAOYSA-N

>  <PubChem_CID>  (92) 


>  <BOM_1A2>  (92) 


>  <BOM_2A6>  (92) 


>  <BOM_2B6>  (92) 
<5,6;Hydrolysis;R1>

>  <BOM_2C8>  (92) 


>  <BOM_2C9>  (92) 


>  <BOM_2C19>  (92) 
<5,6;Hydrolysis;R1>

>  <BOM_2D6>  (92) 


>  <BOM_2E1>  (92) 


>  <BOM_3A4>  (92) 
<5,6;Hydrolysis;R1>

>  <References>  (92) 
(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985

>  <FLAG_COMMENTS>  (92) 


>  <ID>  (92) 
Chlorpyrifos-oxon

>  <Comment>  (92) 


>  <smile>  (92) 
[cH:1]1[c:2]([Cl:3])[c:4]([O:5][P:6](=[O:7])([O:8][CH2:9][CH3:10])[O:11][CH2:12][CH3:13])[n:14][c:15]([Cl:16])[c:17]1[Cl:18]

$$$$
Isoprene
     RDKit          3D

  5  4  0  0  0  0  0  0  0  0999 V2000
   -0.5185    0.0447   -0.0001 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.6822   -1.4501    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.8202    0.6168    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.5949    0.8486    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.9754   -0.0600    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  3  5  2  0
M  END
>  <InChIKey>  (93) 
RRHGJUQNOFWUDK-UHFFFAOYSA-N

>  <PubChem_CID>  (93) 
6557

>  <BOM_1A2>  (93) 


>  <BOM_2A6>  (93) 


>  <BOM_2B6>  (93) 
<3,5;Epoxidation;R1>
<1,4;Epoxidation;R2>

>  <BOM_2C8>  (93) 


>  <BOM_2C9>  (93) 


>  <BOM_2C19>  (93) 


>  <BOM_2D6>  (93) 


>  <BOM_2E1>  (93) 
<3,5;Epoxidation;R1>
<1,4;Epoxidation;R2>

>  <BOM_3A4>  (93) 


>  <References>  (93) 
Bogaards, Jan JP, Joke C. Venekamp, and Peter J. van Bladeren. "The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes." Chemico-biological interactions 102.3 (1996): 169-182.

>  <FLAG_COMMENTS>  (93) 


>  <ID>  (93) 
Isoprene

>  <Comment>  (93) 


>  <smile>  (93) 
[C:1]([CH3:2])([CH:3]=[CH2:5])=[CH2:4]

$$$$
L-775606
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   -5.7848   -6.4892    0.0000 F   0  0  0  0  0  0  0  0  0  1  0  0
   -5.5298   -5.7046    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.0819   -5.0915    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -5.8269   -4.3068    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.0200   -4.1353    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -4.4679   -4.7484    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -3.6610   -4.5769    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -3.4060   -3.7923    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -2.5990   -3.6207    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
   -2.3441   -2.8361    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -1.5371   -2.6646    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.9851   -3.2777    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
   -0.1781   -3.1062    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.0768   -2.3215    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.8838   -2.1500    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.1387   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    0.6538   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.1387   -0.0305    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
    1.9233   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    2.6378    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    3.3523   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    3.3523   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    2.6378   -1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    1.9233   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    4.0668   -1.5229    0.0000 N   0  0  0  0  0  0  0  0  0 25  0  0
    4.8204   -1.1874    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    5.3725   -1.8005    0.0000 N   0  0  0  0  0  0  0  0  0 27  0  0
    4.9600   -2.5150    0.0000 N   0  0  0  0  0  0  0  0  0 28  0  0
    4.1530   -2.3434    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -1.2400   -4.0623    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
   -2.0470   -4.2338    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
   -4.7229   -5.5330    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 16 24  1  0
 19 24  1  0
 22 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 25 29  1  0
 12 30  1  0
 30 31  1  0
  9 31  1  0
  6 32  2  0
  2 32  1  0
M  END
>  <InChIKey>  (94) 
ZUTQCPBDRJBADG-UHFFFAOYSA-N 

>  <PubChem_CID>  (94) 


>  <BOM_1A2>  (94) 


>  <BOM_2A6>  (94) 


>  <BOM_2B6>  (94) 


>  <BOM_2C8>  (94) 
<8,9;Dealkylation;R1><8,H;Dealkylation;R1>
<7,H;Hydroxylation;R2>

>  <BOM_2C9>  (94) 


>  <BOM_2C19>  (94) 


>  <BOM_2D6>  (94) 


>  <BOM_2E1>  (94) 


>  <BOM_3A4>  (94) 
<8,9;Dealkylation;R1><8,H;Dealkylation;R1>
<7,H;Hydroxylation;R2>

>  <References>  (94) 
PMID: 10659950

>  <FLAG_COMMENTS>  (94) 


>  <ID>  (94) 
L-775606

>  <Comment>  (94) 


>  <smile>  (94) 
[F:1][c:2]1[cH:3][cH:4][cH:5][c:6]([CH2:7][CH2:8][N:9]2[CH2:10][CH2:11][N:12]([CH2:13][CH2:14][CH2:15][c:16]3[cH:17][nH:18][c:19]4[cH:20][cH:21][c:22](-[n:25]5[cH:26][n:27][n:28][cH:29]5)[cH:23][c:24]34)[CH2:30][CH2:31]2)[cH:32]1

$$$$
silybin 
     RDKit          2D

 35 39  0  0  1  0  0  0  0  0999 V2000
  -10.7379   -2.1732    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
  -10.0234   -1.7607    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
  -10.0234   -0.9357    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
  -10.7379   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
  -11.4524   -0.9357    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
  -10.7379    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
  -10.0234    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -9.3090    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -9.3090   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -8.5945    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -7.8800    0.3018    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
   -7.1655    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -7.1655    1.5393    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -7.8800    1.9518    0.0000 O   0  0  0  0  0  0  0  0  0 14  0  0
   -8.5945    1.5393    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -9.3090    1.9518    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
  -10.0234    1.5393    0.0000 O   0  0  0  0  0  0  0  0  0 17  0  0
   -6.4511    1.9518    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -5.7366    1.5393    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -5.7366    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -6.4511    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -5.0221    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -4.3077    0.7143    0.0000 O   0  0  0  0  0  0  0  0  0 23  0  0
   -3.5932    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -2.8787    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -2.1643    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -1.4498    0.7143    0.0000 O   0  0  0  0  0  0  0  0  0 27  0  0
   -2.1643   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -2.8787   -0.9357    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -2.8787   -1.7607    0.0000 O   0  0  0  0  0  0  0  0  0 30  0  0
   -3.5932   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
   -4.3077   -0.9357    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
   -4.3077   -1.7607    0.0000 O   0  0  0  0  0  0  0  0  0 33  0  0
   -5.0221   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
   -5.7366   -0.9357    0.0000 O   0  0  0  0  0  0  0  0  0 35  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  3  9  1  0
 10  8  1  6
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 10 15  1  0
 15 16  1  1
 16 17  1  0
 13 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 12 21  1  0
 22 20  1  1
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 24 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 22 34  1  0
 34 35  1  6
M  END
>  <InChIKey>  (95) 
SEBFKMXJBCUCAI-ATASIELBNA-N

>  <PubChem_CID>  (95) 


>  <BOM_1A2>  (95) 


>  <BOM_2A6>  (95) 


>  <BOM_2B6>  (95) 


>  <BOM_2C8>  (95) 
<1,2;Dealkylation;R1><1,H;Dealkylation;R1>

>  <BOM_2C9>  (95) 


>  <BOM_2C19>  (95) 


>  <BOM_2D6>  (95) 


>  <BOM_2E1>  (95) 


>  <BOM_3A4>  (95) 


>  <References>  (95) 
(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3687

>  <FLAG_COMMENTS>  (95) 


>  <ID>  (95) 
silybin 

>  <Comment>  (95) 


>  <smile>  (95) 
[CH3:1][O:2][c:3]1[c:4]([OH:5])[cH:6][cH:7][c:8]([C@H:10]2[O:11][c:12]3[c:13]([cH:18][cH:19][c:20]([C@H:22]4[O:23][c:24]5[cH:25][c:26]([OH:27])[cH:28][c:29]([OH:30])[c:31]5[C:32](=[O:33])[C@@H:34]4[OH:35])[cH:21]3)[O:14][C@@H:15]2[CH2:16][OH:17])[cH:9]1

$$$$
Perospirone
     RDKit          2D

 30 34  0  0  1  0  0  0  0  0999 V2000
    0.2716   -9.9932    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.5130   -9.7382    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -0.6846   -8.9313    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.0715   -8.3792    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.7132   -8.6342    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.8847   -9.4412    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    1.1981   -7.9667    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    2.0231   -7.9667    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    0.7132   -7.2993    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
   -0.0715   -7.5542    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.7389   -7.0693    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    0.9681   -6.5147    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.4161   -5.9016    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.6710   -5.1170    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.1190   -4.5039    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.3739   -3.7192    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -0.1781   -3.1062    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.0768   -2.3215    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.8838   -2.1500    0.0000 N   0  0  0  0  0  0  0  0  0 19  0  0
    1.4358   -2.7631    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    1.1809   -3.5477    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    1.1387   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    0.6538   -0.6979    0.0000 N   0  0  0  0  0  0  0  0  0 23  0  0
    1.1387   -0.0305    0.0000 S   0  0  0  0  0  0  0  0  0 24  0  0
    1.9233   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    2.6378    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    3.3523   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    3.3523   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    2.6378   -1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    1.9233   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
  1  2  1  0
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  6
  1  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  4 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 16 21  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 25 30  1  0
 22 30  1  0
M  END
>  <InChIKey>  (96) 
FBVFZWUMDDXLLG-HDICACEKSA-N

>  <PubChem_CID>  (96) 


>  <BOM_1A2>  (96) 


>  <BOM_2A6>  (96) 


>  <BOM_2B6>  (96) 


>  <BOM_2C8>  (96) 
<15,16;Dealkylation;R1><15,H;Dealkylation;R1>
<1,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<4,H;Hydroxylation;R4>
<5,H;Hydroxylation;R5>

>  <BOM_2C9>  (96) 


>  <BOM_2C19>  (96) 


>  <BOM_2D6>  (96) 
<1,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <BOM_2E1>  (96) 


>  <BOM_3A4>  (96) 
<4,5;Dehydrogenation;R1>
<15,16;Dealkylation;R2><15,H;Dealkylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <References>  (96) 
PMID: 20363276

>  <FLAG_COMMENTS>  (96) 


>  <ID>  (96) 
Perospirone

>  <Comment>  (96) 


>  <smile>  (96) 
[CH2:1]1[CH2:2][CH2:3][C@H:4]2[C@@H:5]([CH2:6]1)[C:7](=[O:8])[N:9]([CH2:12][CH2:13][CH2:14][CH2:15][N:16]1[CH2:17][CH2:18][N:19]([c:22]3[n:23][s:24][c:25]4[cH:26][cH:27][cH:28][cH:29][c:30]34)[CH2:20][CH2:21]1)[C:10]2=[O:11]

$$$$
Enzalutamide
     RDKit          3D

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.1657    1.1150    1.4113 S   0  0  0  0  0  0  0  0  0  1  0  0
   -5.8995   -1.4283    0.5251 F   0  0  0  0  0  0  0  0  0  2  0  0
    3.6195    3.1488   -0.3259 F   0  0  0  0  0  0  0  0  0  3  0  0
    5.4054    2.7851    0.8497 F   0  0  0  0  0  0  0  0  0  4  0  0
    5.4545    2.5188   -1.3079 F   0  0  0  0  0  0  0  0  0  5  0  0
    1.3282   -3.2530   -0.8529 O   0  0  0  0  0  0  0  0  0  6  0  0
   -7.2932    0.5451   -0.4942 O   0  0  0  0  0  0  0  0  0  7  0  0
   -1.1211   -1.0095    0.1636 N   0  0  0  0  0  0  0  0  0  8  0  0
    1.1445   -1.1134    0.0966 N   0  0  0  0  0  0  0  0  0  9  0  0
   -6.4271    2.6213    0.0680 N   0  0  0  0  0  0  0  0  0 10  0  0
    7.7793    0.4166    0.0864 N   0  0  0  0  0  0  0  0  0 11  0  0
   -0.8343   -2.4126   -0.1432 C   0  0  1  0  0  0  0  0  0 12  0  0
    0.6786   -2.3323   -0.3672 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.0280   -3.3515    1.0563 C   0  0  0  0  0  0  0  0  0 14  0  0
   -1.4871   -2.9445   -1.4218 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.0764   -0.3061    0.5093 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.4336   -0.4389    0.0707 C   0  0  0  0  0  0  0  0  0 17  0  0
    2.5338   -0.7823    0.0933 C   0  0  0  0  0  0  0  0  0 18  0  0
   -3.5521   -1.2222    0.3468 C   0  0  0  0  0  0  0  0  0 19  0  0
   -2.5854    0.8970   -0.2947 C   0  0  0  0  0  0  0  0  0 20  0  0
    2.9347    0.5465   -0.0476 C   0  0  0  0  0  0  0  0  0 21  0  0
    3.4906   -1.7880    0.2314 C   0  0  0  0  0  0  0  0  0 22  0  0
   -4.8287   -0.6672    0.2571 C   0  0  0  0  0  0  0  0  0 23  0  0
   -3.8620    1.4519   -0.3847 C   0  0  0  0  0  0  0  0  0 24  0  0
    4.2917    0.8694   -0.0506 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.9835    0.6700   -0.1087 C   0  0  0  0  0  0  0  0  0 26  0  0
    4.8476   -1.4651    0.2286 C   0  0  0  0  0  0  0  0  0 27  0  0
    5.2482   -0.1364    0.0874 C   0  0  0  0  0  0  0  0  0 28  0  0
    4.6841    2.3041   -0.2038 C   0  0  2  0  0  0  0  0  0 29  0  0
   -6.3128    1.2531   -0.2036 C   0  0  0  0  0  0  0  0  0 30  0  0
    6.6466    0.1690    0.0869 C   0  0  0  0  0  0  0  0  0 31  0  0
   -7.6809    3.3396    0.0382 C   0  0  0  0  0  0  0  0  0 32  0  0
  1 16  2  0
  2 23  1  0
 29  3  1  6
  4 29  1  0
  5 29  1  0
  6 13  2  0
  7 30  2  0
  8 12  1  0
  8 16  1  0
  8 17  1  0
  9 13  1  0
  9 16  1  0
  9 18  1  0
 10 30  1  0
 10 32  1  0
 11 31  3  0
 12 13  1  0
 12 14  1  1
 12 15  1  0
 17 19  2  0
 17 20  1  0
 18 21  2  0
 18 22  1  0
 19 23  1  0
 20 24  2  0
 21 25  1  0
 22 27  2  0
 23 26  2  0
 24 26  1  0
 25 28  2  0
 25 29  1  0
 26 30  1  0
 27 28  1  0
 28 31  1  0
M  END
>  <InChIKey>  (97) 
WXCXUHSOUPDCQV-UHFFFAOYSA-N

>  <PubChem_CID>  (97) 
15951529

>  <BOM_1A2>  (97) 


>  <BOM_2A6>  (97) 


>  <BOM_2B6>  (97) 


>  <BOM_2C8>  (97) 
<10,32;Dealkylation;R1><32,H;Dealkylation;R1>

>  <BOM_2C9>  (97) 


>  <BOM_2C19>  (97) 


>  <BOM_2D6>  (97) 


>  <BOM_2E1>  (97) 


>  <BOM_3A4>  (97) 
<10,32;Dealkylation;R1><32,H;Dealkylation;R1>

>  <References>  (97) 
Benoist, Guillemette E., et al. "Pharmacokinetic aspects of the two novel oral drugs used for metastatic castration-resistant prostate cancer: abiraterone acetate and enzalutamide." Clinical pharmacokinetics 55.11 (2016): 1369-1380.

>  <FLAG_COMMENTS>  (97) 


>  <ID>  (97) 
Enzalutamide

>  <Comment>  (97) 


>  <smile>  (97) 
[S:1]=[C:16]1[N:8]([c:17]2[cH:19][c:23]([F:2])[c:26]([C:30](=[O:7])[NH:10][CH3:32])[cH:24][cH:20]2)[C@@:12]([CH3:14])([CH3:15])[C:13](=[O:6])[N:9]1[c:18]1[cH:21][c:25]([C@@:29]([F:3])([F:4])[F:5])[c:28]([C:31]#[N:11])[cH:27][cH:22]1

$$$$
Acotiamide
     RDKit          3D

 31 32  0  0  0  0  0  0  0  0999 V2000
   -0.6216    3.7318    0.3902 S   0  0  0  0  0  0  0  0  0  1  0  0
    3.7392    2.9444   -0.4866 O   0  0  0  0  0  0  0  0  0  2  0  0
   -6.6291   -0.5340   -1.8353 O   0  0  0  0  0  0  0  0  0  3  0  0
   -7.5381   -1.3705    0.6547 O   0  0  0  0  0  0  0  0  0  4  0  0
   -3.1734   -0.7776    2.4554 O   0  0  0  0  0  0  0  0  0  5  0  0
   -1.3800   -0.7968   -0.3707 O   0  0  0  0  0  0  0  0  0  6  0  0
    6.4031   -0.7592   -0.1855 N   0  0  0  0  0  0  0  0  0  7  0  0
    3.0692    0.7646   -0.8319 N   0  0  0  0  0  0  0  0  0  8  0  0
    0.4928    1.4878   -0.2462 N   0  0  0  0  0  0  0  0  0  9  0  0
   -1.8820    1.4449    0.1569 N   0  0  0  0  0  0  0  0  0 10  0  0
    6.2809   -1.8920   -1.1023 C   0  0  2  0  0  0  0  0  0 11  0  0
    7.1040   -1.1616    1.0335 C   0  0  1  0  0  0  0  0  0 12  0  0
    5.0832   -0.2192    0.1385 C   0  0  0  0  0  0  0  0  0 13  0  0
    4.3811    0.2553   -1.1252 C   0  0  0  0  0  0  0  0  0 14  0  0
    5.4457   -2.9997   -0.4664 C   0  0  0  0  0  0  0  0  0 15  0  0
    7.6715   -2.3980   -1.4724 C   0  0  0  0  0  0  0  0  0 16  0  0
    7.3273    0.0611    1.9178 C   0  0  0  0  0  0  0  0  0 17  0  0
    6.3081   -2.2341    1.7719 C   0  0  0  0  0  0  0  0  0 18  0  0
    2.8398    2.1054   -0.5265 C   0  0  0  0  0  0  0  0  0 19  0  0
    1.4478    2.4619   -0.2183 C   0  0  0  0  0  0  0  0  0 20  0  0
    1.0683    3.7296    0.0981 C   0  0  0  0  0  0  0  0  0 21  0  0
   -0.6558    2.0477    0.0629 C   0  0  0  0  0  0  0  0  0 22  0  0
   -3.5911   -0.3015    0.1423 C   0  0  0  0  0  0  0  0  0 23  0  0
   -2.1701    0.0876   -0.0599 C   0  0  0  0  0  0  0  0  0 24  0  0
   -4.4422   -0.2347   -0.9420 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.0179   -0.7134    1.3877 C   0  0  0  0  0  0  0  0  0 26  0  0
   -5.7788   -0.5956   -0.7728 C   0  0  0  0  0  0  0  0  0 27  0  0
   -6.2351   -1.0154    0.4768 C   0  0  0  0  0  0  0  0  0 28  0  0
   -5.3547   -1.0744    1.5569 C   0  0  0  0  0  0  0  0  0 29  0  0
   -6.7473   -1.7058   -2.6398 C   0  0  0  0  0  0  0  0  0 30  0  0
   -8.4448   -0.3385    1.0381 C   0  0  0  0  0  0  0  0  0 31  0  0
  1 21  1  0
  1 22  1  0
  2 19  2  0
  3 27  1  0
  3 30  1  0
  4 28  1  0
  4 31  1  0
  5 26  1  0
  6 24  2  0
  7 11  1  0
  7 12  1  0
  7 13  1  0
  8 14  1  0
  8 19  1  0
  9 20  1  0
  9 22  2  0
 10 22  1  0
 10 24  1  0
 11 15  1  1
 11 16  1  0
 12 17  1  1
 12 18  1  0
 13 14  1  0
 19 20  1  0
 20 21  2  0
 23 24  1  0
 23 25  2  0
 23 26  1  0
 25 27  1  0
 26 29  2  0
 27 28  2  0
 28 29  1  0
M  END
>  <InChIKey>  (98) 
TWHZNAUBXFZMCA-UHFFFAOYSA-N

>  <PubChem_CID>  (98) 
5282338

>  <BOM_1A2>  (98) 


>  <BOM_2A6>  (98) 


>  <BOM_2B6>  (98) 


>  <BOM_2C8>  (98) 
<12,7;Dealkylation;R1><12,H;Dealkylation;R1>
<11,7;Dealkylation;R2><11,H;Dealkylation;R2>

>  <BOM_2C9>  (98) 


>  <BOM_2C19>  (98) 


>  <BOM_2D6>  (98) 


>  <BOM_2E1>  (98) 


>  <BOM_3A4>  (98) 
<12,7;Dealkylation;R1><12,H;Dealkylation;R1>
<11,7;Dealkylation;R2><11,H;Dealkylation;R2>

>  <References>  (98) 
Backman, Janne T., et al. "Role of cytochrome P450 2C8 in drug metabolism and interactions." Pharmacological reviews68.1 (2016): 168-241.
PMDA (2014) Japanese Pharmaceuticals and Medical Devices Agency, review report: Acofide. Available from: http://www.pmda.go.jp/files/000153467.pdf (Accessed 2019.03.04).

>  <FLAG_COMMENTS>  (98) 


>  <ID>  (98) 
Acotiamide

>  <Comment>  (98) 


>  <smile>  (98) 
[s:1]1[cH:21][c:20]([C:19](=[O:2])[NH:8][CH2:14][CH2:13][N:7]([C@H:11]([CH3:15])[CH3:16])[C@@H:12]([CH3:17])[CH3:18])[n:9][c:22]1[NH:10][C:24](=[O:6])[c:23]1[cH:25][c:27]([O:3][CH3:30])[c:28]([O:4][CH3:31])[cH:29][c:26]1[OH:5]

$$$$
donepezil
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -0.5837   -5.6992    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -1.4087   -5.6992    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -1.8212   -4.9848    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.4087   -4.2703    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -0.5837   -4.2703    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -0.1712   -4.9848    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -1.8212   -3.5558    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -1.4087   -2.8414    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -1.8212   -2.1269    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.4087   -1.4124    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.5837   -1.4124    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.1712   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.6538   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    1.1387   -0.0305    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.8838    0.7541    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
    1.9233   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.6378    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.3523   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    4.0668    0.1271    0.0000 O   0  0  0  0  0  0  0  0  0 19  0  0
    4.0668    0.9521    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    3.3523   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.0668   -1.5229    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
    4.0668   -2.3479    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.6378   -1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    1.9233   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.1387   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -0.1712   -2.1269    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -0.5837   -2.8414    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  2  0
 21 22  1  0
 22 23  1  0
 21 24  1  0
 24 25  2  0
 16 25  1  0
 25 26  1  0
 13 26  1  0
 11 27  1  0
 27 28  1  0
  8 28  1  0
M  END
>  <InChIKey>  (99) 
ADEBPBSSDYVVLD-UHFFFAOYNA-N

>  <PubChem_CID>  (99) 


>  <BOM_1A2>  (99) 


>  <BOM_2A6>  (99) 


>  <BOM_2B6>  (99) 


>  <BOM_2C8>  (99) 


>  <BOM_2C9>  (99) 
<22,23;Dealkylation;R1><23,H;Dealkylation;R1>
<7,8;Dealkylation;R2><7,H;Dealkylation;R2>
<19,20;Dealkylation;R3><20,H;Dealkylation;R3>

>  <BOM_2C19>  (99) 


>  <BOM_2D6>  (99) 
<22,23;Dealkylation;R1><23,H;Dealkylation;R1>

>  <BOM_2E1>  (99) 


>  <BOM_3A4>  (99) 
<22,23;Dealkylation;R1><23,H;Dealkylation;R1>
<7,8;Dealkylation;R2><7,H;Dealkylation;R2>
<19,20;Dealkylation;R3><20,H;Dealkylation;R3>

>  <References>  (99) 
(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677

>  <FLAG_COMMENTS>  (99) 


>  <ID>  (99) 
donepezil

>  <Comment>  (99) 


>  <smile>  (99) 
[cH:1]1[cH:2][cH:3][c:4]([CH2:7][N:8]2[CH2:9][CH2:10][CH:11]([CH2:12][CH:13]3[C:14](=[O:15])[c:16]4[cH:17][c:18]([O:19][CH3:20])[c:21]([O:22][CH3:23])[cH:24][c:25]4[CH2:26]3)[CH2:27][CH2:28]2)[cH:5][cH:6]1

$$$$
Mestranol
     RDKit          2D

 23 26  0  0  1  0  0  0  0  0999 V2000
   -2.8207   -0.5585    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
   -2.5008   -1.3814    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -3.3129   -1.2362    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -4.1250   -1.0910    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -2.7301   -2.1739    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.0473   -2.6369    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -1.3959   -2.1305    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -0.5838   -2.2757    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -0.3035   -3.0516    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    0.5086   -3.1969    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.0404   -2.5662    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    0.7601   -1.7902    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    1.2920   -1.1595    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    2.1041   -1.3047    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.3844   -2.0807    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.1965   -2.2259    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    3.7283   -1.5952    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.8526   -2.7114    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -0.0520   -1.6450    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.3323   -0.8691    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -1.1444   -0.7239    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -1.6762   -1.3546    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -1.8575   -0.6122    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
  2  1  1  6
  2  3  1  0
  3  4  3  0
  2  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  2  0
 11 18  1  0
 12 19  1  0
  8 19  1  0
 19 20  1  6
 20 21  1  0
 21 22  1  0
  2 22  1  0
  7 22  1  0
 22 23  1  6
M  END
>  <InChIKey>  (100) 
IMSSROKUHAOUJS-MJCUULBUSA-N

>  <PubChem_CID>  (100) 


>  <BOM_1A2>  (100) 


>  <BOM_2A6>  (100) 


>  <BOM_2B6>  (100) 


>  <BOM_2C8>  (100) 


>  <BOM_2C9>  (100) 
<16,17;Dealkylation;R1><17,H;Dealkylation;R1>

>  <BOM_2C19>  (100) 


>  <BOM_2D6>  (100) 


>  <BOM_2E1>  (100) 


>  <BOM_3A4>  (100) 


>  <References>  (100) 
(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682

>  <FLAG_COMMENTS>  (100) 


>  <ID>  (100) 
Mestranol

>  <Comment>  (100) 


>  <smile>  (100) 
[OH:1][C@@:2]1([C:3]#[CH:4])[CH2:5][CH2:6][C@H:7]2[C@@H:8]3[CH2:9][CH2:10][c:11]4[c:12]([cH:13][cH:14][c:15]([O:16][CH3:17])[cH:18]4)[C@H:19]3[CH2:20][CH2:21][C@:22]12[CH3:23]

$$$$
Rosuvastatin
     RDKit          2D

 33 34  0  0  1  0  0  0  0  0999 V2000
  -11.0058    1.3938    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
  -10.2913    0.9813    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -9.5768    1.3938    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
  -10.2913    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -9.5768   -0.2562    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -8.8623    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -8.1479   -0.2562    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -7.4334    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.4334    0.9813    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -6.7189   -0.2562    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -6.0045    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -6.0045    0.9813    0.0000 O   0  0  0  0  0  0  0  0  0 12  0  0
   -5.2900   -0.2562    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -4.5755    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.8611   -0.2562    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
   -4.5755    0.9813    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -9.5768   -1.0812    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
  -10.2913   -1.4937    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
  -11.0058   -1.0812    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
  -11.0058   -0.2562    0.0000 N   0  0  0  0  0  0  0  0  0 20  0  0
  -11.7202   -1.4937    0.0000 N   0  0  0  0  0  0  0  0  0 21  0  0
  -12.4347   -1.0812    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
  -11.7202   -2.3187    0.0000 S   0  0  0  0  0  6  0  0  0 23  0  0
  -11.7202   -3.1437    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
  -12.5452   -2.3187    0.0000 O   0  0  0  0  0  0  0  0  0 25  0  0
  -10.8952   -2.3187    0.0000 O   0  0  0  0  0  0  0  0  0 26  0  0
   -8.8623   -1.4937    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -8.1479   -1.0812    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -7.4334   -1.4937    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -7.4334   -2.3187    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
   -6.7189   -2.7312    0.0000 F   0  0  0  0  0  0  0  0  0 31  0  0
   -8.1479   -2.7312    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
   -8.8623   -2.3187    0.0000 C   0  0  0  0  0  0  0  0  0 33  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  6
  8 10  1  0
 10 11  1  0
 11 12  1  6
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
  5 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  4 20  1  0
 19 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  2  0
 23 26  2  0
 17 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 30 32  1  0
 32 33  2  0
 27 33  1  0
M  END
>  <InChIKey>  (101) 
BPRHUIZQVSMCRT-RJCHQFKYSA-N

>  <PubChem_CID>  (101) 


>  <BOM_1A2>  (101) 


>  <BOM_2A6>  (101) 


>  <BOM_2B6>  (101) 


>  <BOM_2C8>  (101) 


>  <BOM_2C9>  (101) 
<21,22;Dealkylation;R1><22,H;Dealkylation;R1>

>  <BOM_2C19>  (101) 
<21,22;Dealkylation;R1><22,H;Dealkylation;R1>

>  <BOM_2D6>  (101) 


>  <BOM_2E1>  (101) 


>  <BOM_3A4>  (101) 


>  <References>  (101) 
(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3686

>  <FLAG_COMMENTS>  (101) 


>  <ID>  (101) 
Rosuvastatin

>  <Comment>  (101) 


>  <smile>  (101) 
[CH3:1][CH:2]([CH3:3])[c:4]1[c:5](/[CH:6]=[CH:7]/[C@H:8]([OH:9])[CH2:10][C@H:11]([OH:12])[CH2:13][C:14]([OH:15])=[O:16])[c:17](-[c:27]2[cH:28][cH:29][c:30]([F:31])[cH:32][cH:33]2)[n:18][c:19]([N:21]([CH3:22])[S:23]([CH3:24])(=[O:25])=[O:26])[n:20]1

$$$$
Zaltoprofen
     RDKit          3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    1.8980   -2.1355    0.6683 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.9272    2.2508    1.8638 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1195    1.5343   -1.1871 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8673    1.7844   -1.2168 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2639   -0.4597    1.0793 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4015   -0.7422   -0.0415 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7960   -0.2771   -0.2924 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6083    0.2947    2.0457 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2142   -1.6039    0.4229 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5766   -0.0329    0.8319 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9241   -1.8852   -0.6773 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7032    1.1238    1.4147 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6185   -2.3170   -0.4475 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5728    0.6130    0.3017 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7367   -0.7364   -0.0689 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6837   -0.2523    0.9685 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8515    1.1094   -0.9438 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3005    1.5986   -0.3952 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6285   -1.0587   -1.1105 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1733    1.2611   -1.4297 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3398   -0.0689   -1.7859 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0
  1 15  1  0
  2 12  2  0
  3 17  1  0
  4 17  2  0
  5  8  1  0
  5  9  2  0
  5 10  1  0
  6  7  1  0
  6 10  2  0
  6 11  1  0
  7 16  1  1
  7 17  1  0
  8 12  1  0
  9 13  1  0
 11 13  2  0
 12 14  1  0
 14 15  2  0
 14 18  1  0
 15 19  1  0
 18 20  2  0
 19 21  2  0
 20 21  1  0
M  END
>  <InChIKey>  (102) 
MUXFZBHBYYYLTH-UHFFFAOYSA-N

>  <PubChem_CID>  (102) 
5720

>  <BOM_1A2>  (102) 


>  <BOM_2A6>  (102) 


>  <BOM_2B6>  (102) 


>  <BOM_2C8>  (102) 


>  <BOM_2C9>  (102) 
<8,H;Hydroxylation;R1>
<1,S;S-Oxidation;R2>
<2,12;Reduction;R3>

>  <BOM_2C19>  (102) 


>  <BOM_2D6>  (102) 


>  <BOM_2E1>  (102) 


>  <BOM_3A4>  (102) 


>  <References>  (102) 
Furuta, Shigeru, et al. "Involvement of CYP2C9 and UGT2B7 in the metabolism of zaltoprofen, a nonsteroidal antiinflammatory drug, and its lack of clinically significant CYP inhibition potential." British journal of clinical pharmacology 54.3 (2002): 295-303.

>  <FLAG_COMMENTS>  (102) 


>  <ID>  (102) 
Zaltoprofen

>  <Comment>  (102) 


>  <smile>  (102) 
C[C@@H](C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2

$$$$
Diazoxon
     RDKit          2D

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.1434    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    2.1434    2.0625    0.0000 P   0  0  0  0  0  5  0  0  0  4  0  0
    2.9684    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    2.1434    2.8875    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    2.8579    3.3000    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    2.8579    4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    1.3184    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    0.9059    2.7770    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.3184    3.4914    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.4289    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    0.7145   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0 14  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    0.7145   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.4289   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.0000   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  1  0
  2 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  1 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  1  0
 17 19  1  0
M  END
>  <InChIKey>  (103) 
VBLJFQYCTRKKKF-UHFFFAOYSA-N

>  <PubChem_CID>  (103) 


>  <BOM_1A2>  (103) 


>  <BOM_2A6>  (103) 


>  <BOM_2B6>  (103) 


>  <BOM_2C8>  (103) 


>  <BOM_2C9>  (103) 


>  <BOM_2C19>  (103) 
<3,4;Hydrolysis;R1>

>  <BOM_2D6>  (103) 


>  <BOM_2E1>  (103) 


>  <BOM_3A4>  (103) 


>  <References>  (103) 
(R1) Kappers, W.A. et al.; (2001). Diazinon Is Activated by CYP2C19 in Human Liver. Toxicol. Appl. Pharmacol., Vol. 177, No. 1, (68-76) || (R2) Buratti, F.M. et al.; Toxicology and Applied Pharmacology 186 (2003) 143-154.

>  <FLAG_COMMENTS>  (103) 


>  <ID>  (103) 
Diazoxon

>  <Comment>  (103) 


>  <smile>  (103) 
[cH:1]1[c:2]([O:3][P:4](=[O:5])([O:6][CH2:7][CH3:8])[O:9][CH2:10][CH3:11])[n:12][c:13]([CH:17]([CH3:18])[CH3:19])[n:14][c:15]1[CH3:16]

$$$$
Pyributicarb
     RDKit          2D

 23 24  0  0  0  0  0  0  0  0999 V2000
   -8.6834   -1.3813    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -7.9689   -1.7938    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -7.9689   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -8.6834   -3.0313    0.0000 N   0  0  0  0  0  0  0  0  0  4  0  0
   -9.3979   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  -10.1123   -3.0313    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
  -10.8268   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -9.3979   -1.7938    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.2545   -3.0313    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
   -6.5400   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -6.5400   -1.7938    0.0000 S   0  0  0  0  0  0  0  0  0 11  0  0
   -5.8255   -3.0313    0.0000 O   0  0  0  0  0  0  0  0  0 12  0  0
   -5.1111   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -5.1111   -1.7938    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -4.3966   -1.3813    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.6821   -1.7938    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -3.6821   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -4.3966   -3.0313    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -2.9676   -3.0313    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -2.2532   -3.4438    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -3.3801   -3.7457    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -2.5551   -2.3168    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -7.2545   -3.8563    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  2  0
  1  8  1  0
  3  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 13 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
  9 23  1  0
M  END
>  <InChIKey>  (104) 
VTRWMTJQBQJKQH-UHFFFAOYSA-N

>  <PubChem_CID>  (104) 


>  <BOM_1A2>  (104) 


>  <BOM_2A6>  (104) 


>  <BOM_2B6>  (104) 


>  <BOM_2C8>  (104) 


>  <BOM_2C9>  (104) 


>  <BOM_2C19>  (104) 
<6,7;Dealkylation;R1><7,H;Dealkylation;R1>

>  <BOM_2D6>  (104) 


>  <BOM_2E1>  (104) 


>  <BOM_3A4>  (104) 


>  <References>  (104) 
(R1) Ohkawa, H and Inui, H. (2015); Metabolism of agrochemicals and relatedenvironmental chemicals based on cytochromeP450s in mammals and plants; Pest Manag Sci.; 71: 824-828

>  <FLAG_COMMENTS>  (104) 


>  <ID>  (104) 
Pyributicarb

>  <Comment>  (104) 


>  <smile>  (104) 
[cH:1]1[cH:2][c:3]([N:9]([C:10](=[S:11])[O:12][c:13]2[cH:14][cH:15][cH:16][c:17]([C:19]([CH3:20])([CH3:21])[CH3:22])[cH:18]2)[CH3:23])[n:4][c:5]([O:6][CH3:7])[cH:8]1

$$$$
desmethylcitalopram
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -4.8240    1.5365    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -4.1096    1.1240    0.0000 N   0  0  0  0  0  0  0  0  0  2  0  0
   -3.3951    1.5365    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -2.6806    1.1240    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.9662    1.5365    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -1.2517    1.1240    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -0.4671    0.8691    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
   -0.4671    0.0441    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -1.2517   -0.2109    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.5872   -0.9645    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.4077   -1.0508    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -2.8927   -0.3833    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -2.5571    0.3703    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.7366    0.4566    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.7433   -1.8044    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.0788   -2.5581    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -0.9161    1.8777    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -1.4011    2.5451    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -1.0655    3.2988    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.2450    3.3850    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    0.0905    4.1387    0.0000 F   0  0  0  0  0  0  0  0  0 21  0  0
    0.2399    2.7176    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -0.0957    1.9639    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 14  1  0
  9 14  1  0
 11 15  1  0
 15 16  3  0
  6 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 17 23  1  0
M  END
>  <InChIKey>  (105) 
DYIZNULSIBGJPJ-UHFFFAOYSA-N

>  <PubChem_CID>  (105) 


>  <BOM_1A2>  (105) 


>  <BOM_2A6>  (105) 


>  <BOM_2B6>  (105) 


>  <BOM_2C8>  (105) 


>  <BOM_2C9>  (105) 


>  <BOM_2C19>  (105) 


>  <BOM_2D6>  (105) 
<1,2;Dealkylation;R1><1,H;Dealkylation;R1>

>  <BOM_2E1>  (105) 


>  <BOM_3A4>  (105) 


>  <References>  (105) 
(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675

>  <FLAG_COMMENTS>  (105) 


>  <ID>  (105) 
desmethylcitalopram

>  <Comment>  (105) 


>  <smile>  (105) 
[CH3:1][NH:2][CH2:3][CH2:4][CH2:5][C:6]1([c:17]2[cH:18][cH:19][c:20]([F:21])[cH:22][cH:23]2)[O:7][CH2:8][c:9]2[cH:10][c:11]([C:15]#[N:16])[cH:12][cH:13][c:14]21

$$$$
Promethazine
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.7145    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.4289    2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.1434    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    2.1434    1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  4  0  0
    2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    3.5724    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.2868    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    4.2868    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    3.5724   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.8579    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.1434   -0.4125    0.0000 S   0  0  0  0  0  0  0  0  0 11  0  0
    1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.7145   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.4289    3.3000    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
    0.7145    3.7125    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    2.1434    3.7125    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  4 17  1  0
 12 17  1  0
  2 18  1  0
 18 19  1  0
 18 20  1  0
M  END
>  <InChIKey>  (106) 
PWWVAXIEGOYWEE-UHFFFAOYSA-N

>  <PubChem_CID>  (106) 


>  <BOM_1A2>  (106) 


>  <BOM_2A6>  (106) 


>  <BOM_2B6>  (106) 


>  <BOM_2C8>  (106) 


>  <BOM_2C9>  (106) 


>  <BOM_2C19>  (106) 


>  <BOM_2D6>  (106) 
<18,19;Dealkylation;R1><19,H;Dealkylation;R1>
<18,20;Dealkylation;R2><20,H;Dealkylation;R2>
<11,S;S-Oxidation;R3>
<14,H;Hydroxylation;R4>
<8,H;Hydroxylation;R5>

>  <BOM_2E1>  (106) 


>  <BOM_3A4>  (106) 


>  <References>  (106) 
PMID: 27994650;PMID: 8946477
Eh-Haj, B. M. (2021). Metabolic N-Dealkylation and N-Oxidation as Elucidators of the Role of Alkylamino Moieties in Drugs Acting at Various Receptors. Molecules, 26(7), 1917. 

>  <FLAG_COMMENTS>  (106) 


>  <ID>  (106) 
Promethazine

>  <Comment>  (106) 


>  <smile>  (106) 
[CH3:1][CH:2]([CH2:3][N:4]1[c:5]2[cH:6][cH:7][cH:8][cH:9][c:10]2[S:11][c:12]2[cH:13][cH:14][cH:15][cH:16][c:17]21)[N:18]([CH3:19])[CH3:20]

$$$$
Droloxifene
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -7.1447   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -7.1447   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.4302   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.4302   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.7158    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.7158    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -5.0013    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -4.2868    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.5724    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.1434    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -1.4289    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
   -0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -4.2868    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -5.0013   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -7.1447    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -7.8592   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -8.5737    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -8.5737    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -7.8592    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -7.8592    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
   -7.1447    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -5.7158   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -5.0013   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.2868   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -4.2868   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -5.0013   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -5.7158   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
  8 15  1  0
 15 16  2  0
  5 16  1  0
  4 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 17 23  1  0
  3 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 24 29  1  0
M  END
>  <InChIKey>  (107) 
ZQZFYGIXNQKOAV-OCEACIFDSA-N

>  <PubChem_CID>  (107) 


>  <BOM_1A2>  (107) 


>  <BOM_2A6>  (107) 


>  <BOM_2B6>  (107) 


>  <BOM_2C8>  (107) 


>  <BOM_2C9>  (107) 


>  <BOM_2C19>  (107) 


>  <BOM_2D6>  (107) 
<12,14;Dealkylation;R1><14,H;Dealkylation;R1>
<12,13;Dealkylation;R2><13,H;Dealkylation;R2>
<20,H;Hydroxylation;R3>

>  <BOM_2E1>  (107) 


>  <BOM_3A4>  (107) 
<12,14;Dealkylation;R1><14,H;Dealkylation;R1>
<12,13;Dealkylation;R2><13,H;Dealkylation;R2>
<20,H;Hydroxylation;R3>

>  <References>  (107) 
PMID: 19817501;PMID: 19902987
Dehal, Shangara S., and David Kupfer. "Cytochrome P-450 3A and 2D6 catalyze orthohydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins." Drug metabolism and disposition 27.6 (1999): 681-688.

>  <FLAG_COMMENTS>  (107) 


>  <ID>  (107) 
Droloxifene

>  <Comment>  (107) 


>  <smile>  (107) 
[CH3:1][CH2:2]/[C:3](=[C:4](/[c:5]1[cH:6][cH:7][c:8]([O:9][CH2:10][CH2:11][N:12]([CH3:13])[CH3:14])[cH:15][cH:16]1)[c:17]1[cH:18][cH:19][cH:20][c:21]([OH:22])[cH:23]1)[c:24]1[cH:25][cH:26][cH:27][cH:28][cH:29]1

$$$$
Paroxetine
     RDKit          2D

 24 27  0  0  1  0  0  0  0  0999 V2000
    4.9279    4.4104    0.0000 F   0  0  0  0  0  0  0  0  0  1  0  0
    4.9279    3.5854    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    5.6424    3.1729    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    5.6424    2.3479    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    4.9279    1.9354    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    4.2135    2.3479    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.2135    3.1729    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    4.9279    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    5.6424    0.6979    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    5.6424   -0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    4.9279   -0.5396    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
    4.2135   -0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    4.2135    0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.4990    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.7845    0.6979    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
    2.0701    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    1.3556    0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.6411    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.6411    1.9354    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.1435    2.1904    0.0000 O   0  0  0  0  0  0  0  0  0 20  0  0
   -0.6284    1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -0.1435    0.8555    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
    1.3556    2.3479    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.0701    1.9354    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  2  7  1  0
  8  5  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  8 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 18 22  1  0
 19 23  1  0
 23 24  2  0
 16 24  1  0
M  END
>  <InChIKey>  (108) 
AHOUBRCZNHFOSL-YOEHRIQHSA-N

>  <PubChem_CID>  (108) 


>  <BOM_1A2>  (108) 


>  <BOM_2A6>  (108) 


>  <BOM_2B6>  (108) 


>  <BOM_2C8>  (108) 


>  <BOM_2C9>  (108) 


>  <BOM_2C19>  (108) 


>  <BOM_2D6>  (108) 
<20,21;Dealkylation;R1><21,22;Dealkylation;R1><21,H;Dealkylation;R1>

>  <BOM_2E1>  (108) 


>  <BOM_3A4>  (108) 


>  <References>  (108) 
PMID: 19817501;PMID: 19902987

>  <FLAG_COMMENTS>  (108) 
##

>  <ID>  (108) 
Paroxetine

>  <Comment>  (108) 


>  <smile>  (108) 
[F:1][c:2]1[cH:3][cH:4][c:5]([C@@H:8]2[CH2:9][CH2:10][NH:11][CH2:12][C@H:13]2[CH2:14][O:15][c:16]2[cH:17][c:18]3[c:19]([cH:23][cH:24]2)[O:20][CH2:21][O:22]3)[cH:6][cH:7]1

$$$$
Aprindine
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -1.1810   -3.4491    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.7685   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.0565   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    0.4690   -3.4491    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.0565   -4.1636    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -0.7685   -4.1636    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    1.2940   -3.4491    0.0000 N   0  0  0  0  0  0  0  0  0  7  0  0
    1.7065   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    2.5315   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.9440   -2.0202    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    3.7690   -2.0202    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
    4.1815   -1.3057    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    5.0065   -1.3057    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    4.1815   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.7690   -3.4491    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.7065   -4.1636    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.5270   -4.2498    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    2.6985   -5.0568    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    3.4130   -5.4693    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    3.4130   -6.2943    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    2.6985   -6.7068    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    1.9840   -6.2943    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    1.9840   -5.4693    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    1.3709   -4.9173    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 18 23  1  0
 23 24  1  0
 16 24  1  0
M  END
>  <InChIKey>  (109) 
NZLBHDRPUJLHCE-UHFFFAOYSA-N

>  <PubChem_CID>  (109) 


>  <BOM_1A2>  (109) 


>  <BOM_2A6>  (109) 


>  <BOM_2B6>  (109) 


>  <BOM_2C8>  (109) 


>  <BOM_2C9>  (109) 


>  <BOM_2C19>  (109) 


>  <BOM_2D6>  (109) 
<11,12;Dealkylation;R1><12,H;Dealkylation;R1>
<11,14;Dealkylation;R2><14,H;Dealkylation;R2>
<21,H;Hydroxylation;R3>
<20,H;Hydroxylation;R4>
<1,H;Hydroxylation;R5>

>  <BOM_2E1>  (109) 


>  <BOM_3A4>  (109) 


>  <References>  (109) 
(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259988
Ebner, T., & Eichelbaum, M. (1993). The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism. British journal of clinical pharmacology, 35(4), 426-430.

>  <FLAG_COMMENTS>  (109) 


>  <ID>  (109) 
Aprindine

>  <Comment>  (109) 


>  <smile>  (109) 
[cH:1]1[cH:2][cH:3][c:4]([N:7]([CH2:8][CH2:9][CH2:10][N:11]([CH2:12][CH3:13])[CH2:14][CH3:15])[CH:16]2[CH2:17][c:18]3[cH:19][cH:20][cH:21][cH:22][c:23]3[CH2:24]2)[cH:5][cH:6]1

$$$$
Encainide
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -2.8579   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -2.1434   -2.8875    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
   -2.1434   -3.7125    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.4289   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.4289   -4.9500    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.1434   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.8579   -4.9500    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -2.8579   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -2.1434   -6.1875    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.4289   -6.6000    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
   -2.8579   -6.6000    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
   -2.8579   -7.4250    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -2.1434   -7.8375    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -2.1434   -8.6625    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.8579   -9.0750    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.5724   -8.6625    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -3.5724   -7.8375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -4.2868   -7.4250    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -5.0013   -7.8375    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -5.0013   -8.6625    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -4.2868   -9.0750    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -4.2868   -9.9000    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -5.0013  -10.3125    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -5.7158   -9.9000    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -5.7158   -9.0750    0.0000 N   0  0  0  0  0  0  0  0  0 25  0  0
   -6.4302   -8.6625    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  3  8  1  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 12 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 20 25  1  0
 25 26  1  0
M  END
>  <InChIKey>  (110) 
PJWPNDMDCLXCOM-UHFFFAOYNA-N

>  <PubChem_CID>  (110) 


>  <BOM_1A2>  (110) 


>  <BOM_2A6>  (110) 


>  <BOM_2B6>  (110) 


>  <BOM_2C8>  (110) 


>  <BOM_2C9>  (110) 


>  <BOM_2C19>  (110) 


>  <BOM_2D6>  (110) 
<25,26;Dealkylation;R1><26,H;Dealkylation;R1>
<1,2;Dealkylation;R2><1,H;Dealkylation;R2>

>  <BOM_2E1>  (110) 


>  <BOM_3A4>  (110) 


>  <References>  (110) 
(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693

>  <FLAG_COMMENTS>  (110) 


>  <ID>  (110) 
Encainide

>  <Comment>  (110) 


>  <smile>  (110) 
[CH3:1][O:2][c:3]1[cH:4][cH:5][c:6]([C:9](=[O:10])[NH:11][c:12]2[cH:13][cH:14][cH:15][cH:16][c:17]2[CH2:18][CH2:19][CH:20]2[CH2:21][CH2:22][CH2:23][CH2:24][N:25]2[CH3:26])[cH:7][cH:8]1

$$$$
N-demethylencainide
     RDKit          2D

 25 27  0  0  1  0  0  0  0  0999 V2000
   -7.5673   -1.8946    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -8.2818   -2.3071    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -8.9963   -1.8946    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -8.2818   -3.1321    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -7.5673   -3.5446    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -7.5673   -4.3696    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -8.2818   -4.7821    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -8.2818   -5.6071    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
   -8.9963   -6.0196    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -8.9963   -4.3696    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -8.9963   -3.5446    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -7.5673   -1.0696    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -8.2818   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -8.2818    0.1679    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -7.5673    0.5804    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -6.8529    0.1679    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -6.8529   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -6.1384   -1.0696    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -5.4239   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -5.4239    0.1679    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -6.1384    0.5804    0.0000 N   0  0  0  0  0  0  0  0  0 21  0  0
   -6.1384    1.4054    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -5.4239    1.8179    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -4.7095    1.4054    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -4.7095    0.5804    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
  4 11  1  0
  1 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 12 17  1  0
 17 18  1  0
 18 19  1  0
 20 19  1  1
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 20 25  1  0
M  END
>  <InChIKey>  (111) 
QLMVRMLCNYDKJN-UHFFFAOYNA-N

>  <PubChem_CID>  (111) 


>  <BOM_1A2>  (111) 


>  <BOM_2A6>  (111) 


>  <BOM_2B6>  (111) 


>  <BOM_2C8>  (111) 


>  <BOM_2C9>  (111) 


>  <BOM_2C19>  (111) 


>  <BOM_2D6>  (111) 
<8,9;Dealkylation;R1><9,H;Dealkylation;R1>

>  <BOM_2E1>  (111) 


>  <BOM_3A4>  (111) 


>  <References>  (111) 
(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693

>  <FLAG_COMMENTS>  (111) 


>  <ID>  (111) 
N-demethylencainide

>  <Comment>  (111) 


>  <smile>  (111) 
[NH:1]([C:2](=[O:3])[c:4]1[cH:5][cH:6][c:7]([O:8][CH3:9])[cH:10][cH:11]1)[c:12]1[cH:13][cH:14][cH:15][cH:16][c:17]1[CH2:18][CH2:19][C@H:20]1[NH:21][CH2:22][CH2:23][CH2:24][CH2:25]1

$$$$
O-demethylencainide
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -0.8692    0.3241    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.8692   -0.5009    0.0000 N   0  0  0  0  0  0  0  0  0  2  0  0
   -0.1548   -0.9134    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.1548   -1.7384    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -0.8692   -2.1509    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -1.5837   -1.7384    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -1.5837   -0.9134    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -2.2982   -0.5009    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -2.2982    0.3241    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -3.0127    0.7366    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -3.7271    0.3241    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -4.4416    0.7366    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.4416    1.5616    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.7271    1.9741    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.0127    1.5616    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -2.2982    1.9741    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -2.2982    2.7991    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -3.0127    3.2116    0.0000 O   0  0  0  0  0  0  0  0  0 18  0  0
   -1.5837    3.2116    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -1.5837    4.0366    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -0.8692    4.4491    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -0.1548    4.0366    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    0.5597    4.4491    0.0000 O   0  0  0  0  0  0  0  0  0 23  0  0
   -0.1548    3.2116    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -0.8692    2.7991    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 10 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 19 25  1  0
M  END
>  <InChIKey>  (112) 
QMHJFCPHRGVEAF-UHFFFAOYNA-N

>  <PubChem_CID>  (112) 


>  <BOM_1A2>  (112) 


>  <BOM_2A6>  (112) 


>  <BOM_2B6>  (112) 


>  <BOM_2C8>  (112) 


>  <BOM_2C9>  (112) 


>  <BOM_2C19>  (112) 


>  <BOM_2D6>  (112) 
<1,2;Dealkylation;R1><1,H;Dealkylation;R1>

>  <BOM_2E1>  (112) 


>  <BOM_3A4>  (112) 


>  <References>  (112) 
(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693

>  <FLAG_COMMENTS>  (112) 


>  <ID>  (112) 
O-demethylencainide

>  <Comment>  (112) 


>  <smile>  (112) 
[CH3:1][N:2]1[CH2:3][CH2:4][CH2:5][CH2:6][CH:7]1[CH2:8][CH2:9][c:10]1[cH:11][cH:12][cH:13][cH:14][c:15]1[NH:16][C:17](=[O:18])[c:19]1[cH:20][cH:21][c:22]([OH:23])[cH:24][cH:25]1

$$$$
Flecainide
     RDKit          2D

 28 29  0  0  1  0  0  0  0  0999 V2000
   -7.2995    1.5848    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -8.0139    1.1723    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -8.7284    1.5848    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -8.0139    0.3473    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -7.2995   -0.0652    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -7.2995   -0.8902    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -6.5850   -1.3027    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
   -6.5850   -2.1277    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -5.8705   -2.5402    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -5.1561   -2.9527    0.0000 F   0  0  0  0  0  0  0  0  0 10  0  0
   -5.4580   -1.8257    0.0000 F   0  0  0  0  0  0  0  0  0 11  0  0
   -6.2830   -3.2546    0.0000 F   0  0  0  0  0  0  0  0  0 12  0  0
   -8.0139   -1.3027    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -8.7284   -0.8902    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -8.7284   -0.0652    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -9.4429    0.3473    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -9.4429    1.1723    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
  -10.1574    1.5848    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -9.7449    2.2993    0.0000 F   0  0  0  0  0  0  0  0  0 19  0  0
  -10.5699    0.8704    0.0000 F   0  0  0  0  0  0  0  0  0 20  0  0
  -10.8718    1.9973    0.0000 F   0  0  0  0  0  0  0  0  0 21  0  0
   -7.2995    2.4098    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -8.0139    2.8223    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -8.7284    2.4098    0.0000 N   0  0  0  0  0  0  0  0  0 24  0  0
   -9.4429    2.8223    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -9.4429    3.6473    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -8.7284    4.0598    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -8.0139    3.6473    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
  6 13  2  0
 13 14  1  0
 14 15  2  0
  4 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
  1 22  1  0
 23 22  1  1
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 23 28  1  0
M  END
>  <InChIKey>  (113) 
DJBNUMBKLMJRSA-LDGXTIHJNA-N

>  <PubChem_CID>  (113) 


>  <BOM_1A2>  (113) 


>  <BOM_2A6>  (113) 


>  <BOM_2B6>  (113) 


>  <BOM_2C8>  (113) 


>  <BOM_2C9>  (113) 


>  <BOM_2C19>  (113) 


>  <BOM_2D6>  (113) 
<7,8;Dealkylation;R1><8,H;Dealkylation;R1>

>  <BOM_2E1>  (113) 


>  <BOM_3A4>  (113) 


>  <References>  (113) 
(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693

>  <FLAG_COMMENTS>  (113) 


>  <ID>  (113) 
Flecainide

>  <Comment>  (113) 


>  <smile>  (113) 
[NH:1]([C:2](=[O:3])[c:4]1[cH:5][c:6]([O:7][CH2:8][C:9]([F:10])([F:11])[F:12])[cH:13][cH:14][c:15]1[O:16][CH2:17][C:18]([F:19])([F:20])[F:21])[CH2:22][C@H:23]1[NH:24][CH2:25][CH2:26][CH2:27][CH2:28]1

$$$$
Azimilide
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   -3.8080    1.6036    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -3.8080    0.7786    0.0000 N   0  0  0  0  0  0  0  0  0  2  0  0
   -3.0935    0.3661    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -3.0935   -0.4589    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -3.8080   -0.8714    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
   -4.5225   -0.4589    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -4.5225    0.3661    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -3.8080   -1.6964    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -4.5225   -2.1089    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -4.5225   -2.9339    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -5.2370   -3.3464    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -5.2370   -4.1714    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
   -4.5695   -4.6563    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.7849   -4.4014    0.0000 O   0  0  0  0  0  0  0  0  0 14  0  0
   -4.8245   -5.4409    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -5.6495   -5.4409    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -5.9044   -4.6563    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -6.6890   -4.4014    0.0000 O   0  0  0  0  0  0  0  0  0 18  0  0
   -6.1344   -6.1084    0.0000 N   0  0  0  0  0  0  0  0  0 19  0  0
   -6.9549   -6.0221    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -7.4398   -6.6896    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -7.1848   -7.4742    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -7.8523   -7.9591    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -8.5197   -7.4742    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -8.2648   -6.6896    0.0000 O   0  0  0  0  0  0  0  0  0 25  0  0
   -9.3043   -7.7291    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -9.4759   -8.5361    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
  -10.2605   -8.7910    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  -10.8736   -8.2390    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
  -10.7021   -7.4320    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
   -9.9174   -7.1771    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
  -11.6582   -8.4940    0.0000 Cl  0  0  0  0  0  0  0  0  0 32  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  2  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 12 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 21 25  1  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 26 31  1  0
 29 32  1  0
M  END
>  <InChIKey>  (114) 
MREBEPTUUMTTIA-PCLIKHOPSA-N

>  <PubChem_CID>  (114) 


>  <BOM_1A2>  (114) 


>  <BOM_2A6>  (114) 


>  <BOM_2B6>  (114) 


>  <BOM_2C8>  (114) 


>  <BOM_2C9>  (114) 


>  <BOM_2C19>  (114) 


>  <BOM_2D6>  (114) 
<1,2;Dealkylation;R1><1,H;Dealkylation;R1>

>  <BOM_2E1>  (114) 


>  <BOM_3A4>  (114) 
<1,2;Dealkylation;R1><1,H;Dealkylation;R1>
<2,N;N-Oxidation;R2>

>  <References>  (114) 
PMID: 16052551 

>  <FLAG_COMMENTS>  (114) 


>  <ID>  (114) 
Azimilide

>  <Comment>  (114) 


>  <smile>  (114) 
[CH3:1][N:2]1[CH2:3][CH2:4][N:5]([CH2:8][CH2:9][CH2:10][CH2:11][N:12]2[C:13](=[O:14])[CH2:15][N:16](/[N:19]=[CH:20]/[c:21]3[cH:22][cH:23][c:24](-[c:26]4[cH:27][cH:28][c:29]([Cl:32])[cH:30][cH:31]4)[o:25]3)[C:17]2=[O:18])[CH2:6][CH2:7]1

$$$$
Ritonavir
     RDKit          2D

 50 53  0  0  1  0  0  0  0  0999 V2000
   10.4027    0.0393    0.0000 S   0  0  0  0  0  0  0  0  0  1  0  0
    7.4051   -1.1082    0.0000 S   0  0  0  0  0  0  0  0  0  2  0  0
    2.3645    0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    5.2224    0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  4  0  0
    5.2224   -1.4438    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    4.5080   -0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    7.3659    2.2688    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
    4.5080    1.4438    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    3.7935   -1.4438    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    6.6515    1.0313    0.0000 N   0  0  0  0  0  0  0  0  0 10  0  0
    8.0804    1.0313    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
   10.2631    1.3668    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    7.5446   -2.4358    0.0000 N   0  0  0  0  0  0  0  0  0 13  0  0
    3.7935    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.7935    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.0790   -0.2063    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    3.0790   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.0790    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    2.3645   -1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    5.9370    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    5.9370    2.2688    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    5.2224    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    3.0790    2.2688    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.3645   -2.2688    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    6.6515    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    5.2224    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    2.3645    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    3.7935    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    4.5080   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    3.0790   -2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
    1.6500   -2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
    7.3659    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
    2.3645    3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 33  0  0
    3.7935    3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
    3.0790   -3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 35  0  0
    1.6500   -3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 36  0  0
    3.0790    3.9188    0.0000 C   0  0  0  0  0  0  0  0  0 37  0  0
    2.3645   -3.9188    0.0000 C   0  0  0  0  0  0  0  0  0 38  0  0
    8.7949    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 39  0  0
    8.0804    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0 40  0  0
    5.9370   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 41  0  0
    9.5094    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 42  0  0
    6.6515   -1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 43  0  0
   10.8152    0.7537    0.0000 C   0  0  0  0  0  0  0  0  0 44  0  0
    9.5956    0.2108    0.0000 C   0  0  0  0  0  0  0  0  0 45  0  0
   11.6356    0.8400    0.0000 C   0  0  0  0  0  0  0  0  0 46  0  0
   12.1206    0.1725    0.0000 C   0  0  0  0  0  0  0  0  0 47  0  0
   11.9712    1.5937    0.0000 C   0  0  0  0  0  0  0  0  0 48  0  0
    6.7377   -2.2643    0.0000 C   0  0  0  0  0  0  0  0  0 49  0  0
    7.9571   -1.7213    0.0000 C   0  0  0  0  0  0  0  0  0 50  0  0
  1 44  1  0
  1 45  1  0
  2 43  1  0
  2 50  1  0
 16  3  1  1
  4 22  2  0
  5 29  1  0
  5 41  1  0
  6 29  2  0
  7 32  2  0
 14  8  1  0
  8 22  1  0
 17  9  1  0
  9 29  1  0
 20 10  1  6
 10 32  1  0
 11 32  1  0
 11 39  1  0
 11 40  1  0
 12 42  1  0
 12 44  2  0
 13 49  1  0
 13 50  2  0
 14 15  1  6
 14 18  1  0
 15 16  1  0
 16 17  1  0
 17 19  1  1
 18 23  1  0
 19 24  1  0
 20 21  1  0
 20 22  1  0
 21 25  1  0
 21 26  1  0
 23 27  2  0
 23 28  1  0
 24 30  2  0
 24 31  1  0
 27 33  1  0
 28 34  2  0
 30 35  1  0
 31 36  2  0
 33 37  2  0
 34 37  1  0
 35 38  2  0
 36 38  1  0
 39 42  1  0
 41 43  1  0
 42 45  2  0
 43 49  2  0
 44 46  1  0
 46 47  1  0
 46 48  1  0
M  END
>  <InChIKey>  (115) 
NCDNCNXCDXHOMX-XGKFQTDJSA-N

>  <PubChem_CID>  (115) 
392622

>  <BOM_1A2>  (115) 


>  <BOM_2A6>  (115) 


>  <BOM_2B6>  (115) 


>  <BOM_2C8>  (115) 


>  <BOM_2C9>  (115) 


>  <BOM_2C19>  (115) 


>  <BOM_2D6>  (115) 
<11,40;Dealkylation;R1><40,H;Dealkylation;R1>
<46,H;Hydroxylation;R2>

>  <BOM_2E1>  (115) 


>  <BOM_3A4>  (115) 
<11,40;Dealkylation;R1><40,H;Dealkylation;R1>
<29,9;Hydrolysis;R2>
<46,H;Hydroxylation;R3>
<11,39;Dealkylation;R4><39,H;Dealkylation;R4>

>  <References>  (115) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. PubMed:19515014.
Rendic, Slobodan. "Summary of information on human CYP enzymes: human P450 metabolism data." Drug metabolism reviews 34.1-2 (2002): 83-448.

>  <FLAG_COMMENTS>  (115) 


>  <ID>  (115) 
Ritonavir

>  <Comment>  (115) 


>  <smile>  (115) 
[s:1]1[c:44]([CH:46]([CH3:47])[CH3:48])[n:12][c:42]([CH2:39][N:11]([C:32](=[O:7])[NH:10][C@@H:20]([CH:21]([CH3:25])[CH3:26])[C:22](=[O:4])[NH:8][C@H:14]([CH2:15][C@H:16]([OH:3])[C@@H:17]([NH:9][C:29]([O:5][CH2:41][c:43]2[s:2][cH:50][n:13][cH:49]2)=[O:6])[CH2:19][c:24]2[cH:30][cH:35][cH:38][cH:36][cH:31]2)[CH2:18][c:23]2[cH:27][cH:33][cH:37][cH:34][cH:28]2)[CH3:40])[cH:45]1

$$$$
VINYL_CHLORIDE
     RDKit          2D

  3  2  0  0  0  0  0  0  0  0999 V2000
    1.2375   -0.7145    0.0000 Cl  0  0  0  0  0  0  0  0  0  1  0  0
    1.9520   -1.1270    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.6664   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
  1  2  1  0
  2  3  2  0
M  END
>  <InChIKey>  (116) 
BZHJMEDXRYGGRV-UHFFFAOYSA-N

>  <PubChem_CID>  (116) 


>  <BOM_1A2>  (116) 


>  <BOM_2A6>  (116) 


>  <BOM_2B6>  (116) 


>  <BOM_2C8>  (116) 


>  <BOM_2C9>  (116) 


>  <BOM_2C19>  (116) 


>  <BOM_2D6>  (116) 


>  <BOM_2E1>  (116) 
<2,3;Epoxidation;R1>

>  <BOM_3A4>  (116) 


>  <References>  (116) 
PMID: 18259985 

>  <FLAG_COMMENTS>  (116) 


>  <ID>  (116) 
VINYL_CHLORIDE

>  <Comment>  (116) 


>  <smile>  (116) 
[Cl:1][CH:2]=[CH2:3]

$$$$
Urethane
     RDKit          2D

  6  5  0  0  0  0  0  0  0  0999 V2000
    1.2375    2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    0.8250    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    1.2375    0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    0.8250    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.2375   -0.7145    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
M  END
>  <InChIKey>  (117) 
JOYRKODLDBILNP-UHFFFAOYSA-N

>  <PubChem_CID>  (117) 


>  <BOM_1A2>  (117) 


>  <BOM_2A6>  (117) 


>  <BOM_2B6>  (117) 


>  <BOM_2C8>  (117) 


>  <BOM_2C9>  (117) 


>  <BOM_2C19>  (117) 


>  <BOM_2D6>  (117) 


>  <BOM_2E1>  (117) 
<1,2;Dehydrogenation;R1>

>  <BOM_3A4>  (117) 


>  <References>  (117) 
PMID: 22531028

>  <FLAG_COMMENTS>  (117) 
Desaturaion followed by EpOxidation.

>  <ID>  (117) 
Urethane

>  <Comment>  (117) 


>  <smile>  (117) 
[CH3:1][CH2:2][O:3][C:4]([NH2:5])=[O:6]

$$$$
Vinyl_carbamate
     RDKit          2D

  6  5  0  0  0  0  0  0  0  0999 V2000
    2.4750   -1.4289    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
    2.0625   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.4750    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    1.2375   -0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  4  0  0
    0.8250    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
M  END
>  <InChIKey>  (118) 
LVLANIHJQRZTPY-UHFFFAOYSA-N

>  <PubChem_CID>  (118) 


>  <BOM_1A2>  (118) 


>  <BOM_2A6>  (118) 


>  <BOM_2B6>  (118) 


>  <BOM_2C8>  (118) 


>  <BOM_2C9>  (118) 


>  <BOM_2C19>  (118) 


>  <BOM_2D6>  (118) 


>  <BOM_2E1>  (118) 
<5,6;Epoxidation;R1>

>  <BOM_3A4>  (118) 


>  <References>  (118) 
PMID: 11181492

>  <FLAG_COMMENTS>  (118) 


>  <ID>  (118) 
Vinyl_carbamate

>  <Comment>  (118) 


>  <smile>  (118) 
[NH2:1][C:2](=[O:3])[O:4][CH:5]=[CH2:6]

$$$$
Isoflurane
     RDKit          3D

 10  9  0  0  1  0  0  0  0  0999 V2000
    0.6123    2.2006   -0.2347 Cl  0  0  0  0  0  0  0  0  0  1  0  0
    2.5543   -0.0301   -0.7397 F   0  0  0  0  0  0  0  0  0  2  0  0
    1.2635   -1.6627   -0.1010 F   0  0  0  0  0  0  0  0  0  3  0  0
    1.8332   -0.1099    1.3213 F   0  0  0  0  0  0  0  0  0  4  0  0
   -3.0010   -0.1659    0.8122 F   0  0  0  0  0  0  0  0  0  5  0  0
   -2.1455   -0.6718   -1.1259 F   0  0  0  0  0  0  0  0  0  6  0  0
   -0.7999    0.1055    0.5067 O   0  0  0  0  0  0  0  0  0  7  0  0
    0.2675    0.4569   -0.3716 C   0  0  2  0  0  0  0  0  0  8  0  0
    1.4906   -0.3365    0.0352 C   0  0  1  0  0  0  0  0  0  9  0  0
   -2.0750    0.2138   -0.1025 C   0  0  2  0  0  0  0  0  0 10  0  0
  8  1  1  1
  9  2  1  6
  3  9  1  0
  4  9  1  0
 10  5  1  1
  6 10  1  0
  7  8  1  0
  7 10  1  0
  8  9  1  0
M  END
>  <InChIKey>  (119) 
PIWKPBJCKXDKJR-UHFFFAOYSA-N

>  <PubChem_CID>  (119) 
3763

>  <BOM_1A2>  (119) 


>  <BOM_2A6>  (119) 


>  <BOM_2B6>  (119) 


>  <BOM_2C8>  (119) 


>  <BOM_2C9>  (119) 


>  <BOM_2C19>  (119) 


>  <BOM_2D6>  (119) 


>  <BOM_2E1>  (119) 
<1,8;Dealkylation;R1><8,H;Dealkylation;R1>

>  <BOM_3A4>  (119) 


>  <References>  (119) 
KARPI?SKI, TOMASZ M., ROMAN SZULC, and KRZYSZTOF SZYFTER. "ROLE OF CYTOCHROME P450 IN METABOLISM OF INHALATION ANAESTHETICS." Nowiny Lekarskie 75.3 (2006): 292-298.

>  <FLAG_COMMENTS>  (119) 


>  <ID>  (119) 
Isoflurane

>  <Comment>  (119) 


>  <smile>  (119) 
[Cl:1][C@H:8]([O:7][C@H:10]([F:5])[F:6])[C@:9]([F:2])([F:3])[F:4]

$$$$
1_2-dichloroethane
     RDKit          3D

  4  3  0  0  0  0  0  0  0  0999 V2000
    1.6464   -0.7110    0.1375 Cl  0  0  0  0  0  0  0  0  0  1  0  0
   -1.6463   -0.7111   -0.1375 Cl  0  0  0  0  0  0  0  0  0  2  0  0
    0.6836    0.7111   -0.3310 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.6837    0.7111    0.3310 C   0  0  0  0  0  0  0  0  0  4  0  0
  1  3  1  0
  2  4  1  0
  3  4  1  0
M  END
>  <InChIKey>  (120) 
WSLDOOZREJYCGB-UHFFFAOYSA-N

>  <PubChem_CID>  (120) 
11

>  <BOM_1A2>  (120) 


>  <BOM_2A6>  (120) 


>  <BOM_2B6>  (120) 


>  <BOM_2C8>  (120) 


>  <BOM_2C9>  (120) 


>  <BOM_2C19>  (120) 


>  <BOM_2D6>  (120) 


>  <BOM_2E1>  (120) 
<2,4;Dealkylation;R1><4,H;Dealkylation;R1>
<1,3;Dealkylation;R2><3,H;Dealkylation;R2>

>  <BOM_3A4>  (120) 


>  <References>  (120) 
Guengerich, F. Peter, Dong Hyun Kim, and Masahiko Iwasaki. "Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects." Chemical research in toxicology 4.2 (1991): 168-179.
Bolt, H. M., et al. "SCOEL/REC/302 1, 2-Dichloroethane (Ethylene dichloride)." (2016).

>  <FLAG_COMMENTS>  (120) 


>  <ID>  (120) 
1_2-dichloroethane

>  <Comment>  (120) 


>  <smile>  (120) 
[Cl:1][CH2:3][CH2:4][Cl:2]

$$$$
Diethyl_Ether
     RDKit          2D

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0008   -0.2762    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
    1.1747    0.5222    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -1.1754    0.5226    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    2.3873   -0.3840    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -2.3874   -0.3844    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
M  END
>  <InChIKey>  (121) 
RTZKZFJDLAIYFH-UHFFFAOYSA-N

>  <PubChem_CID>  (121) 
3283

>  <BOM_1A2>  (121) 


>  <BOM_2A6>  (121) 


>  <BOM_2B6>  (121) 


>  <BOM_2C8>  (121) 


>  <BOM_2C9>  (121) 


>  <BOM_2C19>  (121) 


>  <BOM_2D6>  (121) 


>  <BOM_2E1>  (121) 
<1,3;Dealkylation;R1><3,H;Dealkylation;R1>
<1,2;Dealkylation;R2><2,H;Dealkylation;R2>

>  <BOM_3A4>  (121) 


>  <References>  (121) 
(2012). Diethyl ether [MAK Value Documentation, 1999]. In The MAK \Collection for Occupational Health and Safety (eds and ). doi:10.1002/3527600418.mb6029e0013

>  <FLAG_COMMENTS>  (121) 


>  <ID>  (121) 
Diethyl_Ether

>  <Comment>  (121) 


>  <smile>  (121) 
[O:1]([CH2:2][CH3:4])[CH2:3][CH3:5]

$$$$
Rupatadine
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    0.9458    3.6320    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.6603    4.0445    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    1.6603    4.8695    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    2.3747    5.2820    0.0000 N   0  0  0  0  0  0  0  0  0  4  0  0
    3.0892    4.8695    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    3.0892    4.0445    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    3.8037    3.6320    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.8037    2.8070    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    4.5181    2.3945    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    4.5181    1.5695    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    3.8037    1.1570    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    3.0892    1.5695    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.0892    2.3945    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.8037    0.3320    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    4.5470   -0.0260    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    5.1517    0.5352    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    5.9401    0.2920    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    6.1237   -0.5123    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    6.9120   -0.7555    0.0000 Cl  0  0  0  0  0  0  0  0  0 19  0  0
    5.5189   -1.0735    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    4.7305   -0.8303    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.2162   -1.4753    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    3.3912   -1.4753    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.8768   -0.8303    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    2.0884   -1.0735    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.4837   -0.5123    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    1.6673    0.2920    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    2.4556    0.5352    0.0000 N   0  0  0  0  0  0  0  0  0 28  0  0
    3.0604   -0.0260    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    2.3747    3.6320    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  8 13  1  0
 11 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 15 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 14 29  1  0
 24 29  1  0
  6 30  2  0
  2 30  1  0
M  END
>  <InChIKey>  (122) 
WUZYKBABMWJHDL-UHFFFAOYSA-N

>  <PubChem_CID>  (122) 


>  <BOM_1A2>  (122) 


>  <BOM_2A6>  (122) 


>  <BOM_2B6>  (122) 


>  <BOM_2C8>  (122) 


>  <BOM_2C9>  (122) 


>  <BOM_2C19>  (122) 


>  <BOM_2D6>  (122) 


>  <BOM_2E1>  (122) 


>  <BOM_3A4>  (122) 
<7,8;Dealkylation;R1><7,H;Dealkylation;R1>

>  <References>  (122) 
https://www.pharmacorama.com/en/ezine/20100130120151.php; PMID: 27632557

>  <FLAG_COMMENTS>  (122) 


>  <ID>  (122) 
Rupatadine

>  <Comment>  (122) 


>  <smile>  (122) 
[CH3:1][c:2]1[cH:3][n:4][cH:5][c:6]([CH2:7][N:8]2[CH2:9][CH2:10]/[C:11](=[C:14]3\[c:15]4[cH:16][cH:17][c:18]([Cl:19])[cH:20][c:21]4[CH2:22][CH2:23][c:24]4[cH:25][cH:26][cH:27][n:28][c:29]43)[CH2:12][CH2:13]2)[cH:30]1

$$$$
bromperidol
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -0.6698    0.4143    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    0.0446    0.0018    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.0446   -0.8232    0.0000 N   0  0  0  0  0  0  0  0  0  3  0  0
   -0.6698   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.3843   -0.8232    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -1.3843    0.0018    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.2088    0.0306    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -2.6460   -0.6691    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.4705   -0.6403    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -3.8578    0.0882    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -3.4206    0.7878    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -2.5961    0.7590    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.6823    0.1170    0.0000 Br  0  0  0  0  0  0  0  0  0 13  0  0
   -1.8215    0.7014    0.0000 O   0  0  0  0  0  0  0  0  0 14  0  0
    0.7591   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.4736   -0.8232    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.1881   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    2.9025   -0.8232    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    2.9025    0.0018    0.0000 O   0  0  0  0  0  0  0  0  0 19  0  0
    3.6170   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    4.3315   -0.8232    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    5.0459   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    5.0459   -2.0607    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    4.3315   -2.4732    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    3.6170   -2.0607    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    5.7604   -2.4732    0.0000 F   0  0  0  0  0  0  0  0  0 26  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  7 12  1  0
 10 13  1  0
  6 14  1  0
  3 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 20 25  1  0
 23 26  1  0
M  END
>  <InChIKey>  (123) 
RKLNONIVDFXQRX-UHFFFAOYSA-N

>  <PubChem_CID>  (123) 


>  <BOM_1A2>  (123) 


>  <BOM_2A6>  (123) 


>  <BOM_2B6>  (123) 


>  <BOM_2C8>  (123) 


>  <BOM_2C9>  (123) 


>  <BOM_2C19>  (123) 


>  <BOM_2D6>  (123) 


>  <BOM_2E1>  (123) 


>  <BOM_3A4>  (123) 
<15,3;Dealkylation;R1><15,H;Dealkylation;R1>

>  <References>  (123) 
PMID: 11133003

>  <FLAG_COMMENTS>  (123) 


>  <ID>  (123) 
bromperidol

>  <Comment>  (123) 


>  <smile>  (123) 
[CH2:1]1[CH2:2][N:3]([CH2:15][CH2:16][CH2:17][C:18](=[O:19])[c:20]2[cH:21][cH:22][c:23]([F:26])[cH:24][cH:25]2)[CH2:4][CH2:5][C:6]1([c:7]1[cH:8][cH:9][c:10]([Br:13])[cH:11][cH:12]1)[OH:14]

$$$$
Troleandomycin
     RDKit          2D

 57 60  0  0  1  0  0  0  0  0999 V2000
    4.7187    1.4033    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    5.2907    0.8088    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
    5.0619    0.0162    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    4.2611   -0.1820    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    4.0323   -0.9746    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    3.2314   -1.1728    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    2.6594   -0.5783    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    2.4306   -1.3709    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    3.0026   -1.9654    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    1.6297   -1.5691    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.4009   -2.3617    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    0.6001   -2.5599    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.0280   -1.9654    0.0000 O   0  0  0  0  0  0  0  0  0 13  0  0
   -0.7728   -2.1636    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -1.3449   -1.5691    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -1.0016   -2.9562    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -0.4296   -3.5507    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.3713   -3.3525    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.9433   -3.9470    0.0000 O   0  0  0  0  0  0  0  0  0 19  0  0
    1.7441   -3.7488    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    1.9729   -2.9562    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    2.3162   -4.3433    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
   -0.6584   -4.3433    0.0000 N   0  0  0  0  0  0  0  0  0 23  0  0
   -0.0864   -4.9378    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -1.4593   -4.5415    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.0577   -0.9746    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    0.2568   -1.1728    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    1.2865   -0.1820    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    0.7145    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
    0.0000    0.8250    0.0000 O   0  0  0  0  0  0  0  0  0 31  0  0
    0.9433    1.2051    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
    0.3713    1.7996    0.0000 O   0  0  0  0  0  0  0  0  0 33  0  0
    1.7441    1.4033    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
    2.3162    0.8088    0.0000 C   0  0  0  0  0  0  0  0  0 35  0  0
    1.9729    2.1959    0.0000 C   0  0  0  0  0  0  0  0  0 36  0  0
    1.4009    2.7904    0.0000 O   0  0  0  0  0  0  0  0  0 37  0  0
    1.6297    3.5830    0.0000 C   0  0  0  0  0  0  0  0  0 38  0  0
    2.4306    3.7812    0.0000 C   0  0  0  0  0  0  0  0  0 39  0  0
    1.0577    4.1775    0.0000 O   0  0  0  0  0  0  0  0  0 40  0  0
    2.7738    2.3941    0.0000 C   0  0  0  0  0  0  0  0  0 41  0  0
    3.0026    3.1867    0.0000 C   0  0  0  0  0  0  0  0  0 42  0  0
    3.3458    1.7996    0.0000 C   0  0  0  0  0  0  0  0  0 43  0  0
    4.1467    1.9978    0.0000 C   0  0  0  0  0  0  0  0  0 44  0  0
    3.1170    1.0070    0.0000 O   0  0  0  0  0  0  0  0  0 45  0  0
    3.6891    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 46  0  0
    4.4899    0.6107    0.0000 O   0  0  0  0  0  0  0  0  0 47  0  0
    3.4602   -0.3801    0.0000 C   0  0  0  0  0  0  0  0  0 48  0  0
    4.2724   -0.5248    0.0000 C   0  0  0  0  0  0  0  0  0 49  0  0
    4.6043   -1.5691    0.0000 O   0  0  0  0  0  0  0  0  0 50  0  0
    5.4052   -1.3709    0.0000 C   0  0  0  0  0  0  0  0  0 51  0  0
    5.9772   -1.9654    0.0000 C   0  0  0  0  0  0  0  0  0 52  0  0
    5.6340   -0.5783    0.0000 C   0  0  0  0  0  0  0  0  0 53  0  0
    6.4348   -0.3801    0.0000 O   0  0  0  0  0  0  0  0  0 54  0  0
    6.6636    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 55  0  0
    6.0916    1.0070    0.0000 C   0  0  0  0  0  0  0  0  0 56  0  0
    7.4645    0.6107    0.0000 O   0  0  0  0  0  0  0  0  0 57  0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  1
  7  6  1  6
  7  8  1  0
  8  9  1  6
  8 10  1  0
 10 11  1  1
 12 11  1  1
 12 13  1  0
 13 14  1  0
 14 15  1  1
 14 16  1  0
 16 17  1  0
 17 18  1  0
 12 18  1  0
 18 19  1  6
 19 20  1  0
 20 21  1  0
 20 22  2  0
 17 23  1  1
 23 24  1  0
 23 25  1  0
 10 26  1  0
 26 27  1  1
 26 28  1  0
 29 28  1  6
 29 30  1  0
 30 31  1  0
 29 31  1  0
 29 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  1  1
 34 36  1  0
 36 37  1  1
 37 38  1  0
 38 39  1  0
 38 40  2  0
 36 41  1  0
 41 42  1  1
 41 43  1  0
 43 44  1  1
 43 45  1  0
 45 46  1  0
 46 47  2  0
 46 48  1  0
  7 48  1  0
 48 49  1  6
  5 50  1  0
 50 51  1  0
 51 52  1  6
 51 53  1  0
  3 53  1  0
 53 54  1  1
 54 55  1  0
 55 56  1  0
 55 57  2  0
M  END
>  <InChIKey>  (124) 
LQCLVBQBTUVCEQ-QTFUVMRISA-N

>  <PubChem_CID>  (124) 


>  <BOM_1A2>  (124) 


>  <BOM_2A6>  (124) 


>  <BOM_2B6>  (124) 


>  <BOM_2C8>  (124) 


>  <BOM_2C9>  (124) 


>  <BOM_2C19>  (124) 


>  <BOM_2D6>  (124) 


>  <BOM_2E1>  (124) 


>  <BOM_3A4>  (124) 
<23,24;Dealkylation;R1><24,H;Dealkylation;R1>
<23,25;Dealkylation;R2><25,H;Dealkylation;R2>

>  <References>  (124) 
PMID: 23333322;PMID: 9187528

>  <FLAG_COMMENTS>  (124) 


>  <ID>  (124) 
Troleandomycin

>  <Comment>  (124) 


>  <smile>  (124) 
[CH3:1][O:2][C@H:3]1[CH2:4][C@H:5]([O:6][C@H:7]2[C@H:8]([CH3:9])[C@@H:10]([O:11][C@@H:12]3[O:13][C@H:14]([CH3:15])[CH2:16][C@H:17]([N:23]([CH3:24])[CH3:25])[C@H:18]3[O:19][C:20]([CH3:21])=[O:22])[C@@H:26]([CH3:27])[CH2:28][C@@:29]3([CH2:30][O:31]3)[C:32](=[O:33])[C@H:34]([CH3:35])[C@@H:36]([O:37][C:38]([CH3:39])=[O:40])[C@@H:41]([CH3:42])[C@@H:43]([CH3:44])[O:45][C:46](=[O:47])[C@@H:48]2[CH3:49])[O:50][C@@H:51]([CH3:52])[C@@H:53]1[O:54][C:55]([CH3:56])=[O:57]

$$$$
p-Hydroxynefazodone
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    9.0613    0.0488    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
    8.2465    0.1778    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    7.7273   -0.4633    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    6.9124   -0.3343    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    6.6168    0.4359    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    7.1360    1.0771    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    7.9508    0.9480    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    8.4700    1.5892    0.0000 Cl  0  0  0  0  0  0  0  0  0  8  0  0
    5.8019    0.5650    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    5.2828   -0.0761    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    4.4679    0.0529    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    4.1723    0.8231    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    3.3574    0.9522    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    2.8382    0.3110    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.0234    0.4401    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.5042   -0.2011    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
    1.7177   -0.9979    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
    1.0258   -1.4473    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.3847   -0.9281    0.0000 N   0  0  0  0  0  0  0  0  0 19  0  0
    0.6803   -0.1579    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    0.2310    0.5340    0.0000 O   0  0  0  0  0  0  0  0  0 21  0  0
   -0.4122   -1.1416    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -0.9956   -0.5582    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -1.7925   -0.7718    0.0000 O   0  0  0  0  0  0  0  0  0 24  0  0
   -2.3758   -0.1884    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -3.1727   -0.4019    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -3.7561    0.1814    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -3.5426    0.9783    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -2.7457    1.1918    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -2.1623    0.6085    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
    0.9826   -2.2711    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
    0.2476   -2.6457    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
    4.6914    1.4643    0.0000 C   0  0  0  0  0  0  0  0  0 33  0  0
    5.5063    1.3352    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  2  7  1  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 16 20  1  0
 20 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 25 30  1  0
 18 31  1  0
 31 32  1  0
 12 33  1  0
 33 34  1  0
  9 34  1  0
M  END
>  <InChIKey>  (125) 
XGIODORTBODPTQ-UHFFFAOYSA-N

>  <PubChem_CID>  (125) 


>  <BOM_1A2>  (125) 


>  <BOM_2A6>  (125) 


>  <BOM_2B6>  (125) 


>  <BOM_2C8>  (125) 


>  <BOM_2C9>  (125) 


>  <BOM_2C19>  (125) 


>  <BOM_2D6>  (125) 


>  <BOM_2E1>  (125) 


>  <BOM_3A4>  (125) 
<1,2;Oxidation;R1><2,3;Reduction;R1><3,4;Oxidation;R1><4,5;Reduction;R1><5,6;Reduction;R1><6,7;Oxidation;R1><2,7;Reduction;R1><5,9;Oxidation;R1>
<4,5;Epoxidation;R2>

>  <References>  (125) 
(R1) Bolleddula, J. et al. (2014); Biotransformation and bioactivation reactions of alicyclic amines in drug molecules, Drug Metabolism Reviews, 46:3, 379-419, DOI: 10.3109/03602532.2014.924962.

>  <FLAG_COMMENTS>  (125) 


>  <ID>  (125) 
p-Hydroxynefazodone

>  <Comment>  (125) 


>  <smile>  (125) 
[OH:1][c:2]1[cH:3][cH:4][c:5]([N:9]2[CH2:10][CH2:11][N:12]([CH2:13][CH2:14][CH2:15][n:16]3[n:17][c:18]([CH2:31][CH3:32])[n:19]([CH2:22][CH2:23][O:24][c:25]4[cH:26][cH:27][cH:28][cH:29][cH:30]4)[c:20]3=[O:21])[CH2:33][CH2:34]2)[cH:6][c:7]1[Cl:8]

$$$$
D-617
     RDKit          2D

 21 21  0  0  1  0  0  0  0  0999 V2000
   -0.7145    4.5375    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -0.7145    5.3625    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.0000    4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    0.0000    3.3000    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.7145    2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.7145    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -0.1105    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -0.9355    2.0625    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    0.7145   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.7145   -1.2375    0.0000 O   0  0  0  0  0  0  0  0  0 13  0  0
    1.4289   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -0.7145   -0.4125    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    1.5395    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    1.9520    1.3480    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    1.9520    2.7770    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
  1  2  1  0
  1  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  3  0
  6  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  2  0
  9 18  1  0
  6 19  1  0
 19 20  1  0
 19 21  1  0
M  END
>  <InChIKey>  (126) 
WLOBUUJURNEQCL-UHFFFAOYNA-N

>  <PubChem_CID>  (126) 


>  <BOM_1A2>  (126) 


>  <BOM_2A6>  (126) 


>  <BOM_2B6>  (126) 


>  <BOM_2C8>  (126) 
<16,17;Dealkylation;R1><17,H;Dealkylation;R1>

>  <BOM_2C9>  (126) 


>  <BOM_2C19>  (126) 


>  <BOM_2D6>  (126) 


>  <BOM_2E1>  (126) 


>  <BOM_3A4>  (126) 
<1,2;Dealkylation;R1><2,H;Dealkylation;R1>

>  <References>  (126) 
(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545?????552; doi: 10.1046/j.1365-2125.1999.00923.x || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423
Di Nardo, G., & Gilardi, G. (2012). Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites. International journal of molecular sciences, 13(12), 15901-15924.

>  <FLAG_COMMENTS>  (126) 


>  <ID>  (126) 
D-617

>  <Comment>  (126) 


>  <smile>  (126) 
[NH:1]([CH3:2])[CH2:3][CH2:4][CH2:5][C@:6]([C:7]#[N:8])([c:9]1[cH:10][cH:11][c:12]([O:13][CH3:14])[c:15]([O:16][CH3:17])[cH:18]1)[CH:19]([CH3:20])[CH3:21]

$$$$
N-Desmethyltamoxifen
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   -6.3622   -0.7911    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -7.0766   -0.3786    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -7.0766    0.4464    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.3622    0.8589    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.6477    0.4464    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.6477   -0.3786    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -6.3622    1.6839    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -7.0766    2.0964    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.0766    2.9214    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -7.7911    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -7.7911    4.1589    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -7.0766    4.5714    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -6.3622    4.1589    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -6.3622    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -7.7911    1.6839    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -8.5056    2.0964    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -5.6477    2.0964    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -5.6477    2.9214    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -4.9332    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -4.2188    2.9214    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -3.5043    3.3339    0.0000 O   0  0  0  0  0  0  0  0  0 21  0  0
   -2.7898    2.9214    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -2.0753    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -1.3609    2.9214    0.0000 N   0  0  0  0  0  0  0  0  0 24  0  0
   -0.6464    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.2188    2.0964    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -4.9332    1.6839    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  9 14  1  0
  8 15  1  0
 15 16  1  0
  7 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 20 26  1  0
 26 27  2  0
 17 27  1  0
M  END
>  <InChIKey>  (127) 
NYDCDZSEEAUOHN-IZHYLOQSSA-N

>  <PubChem_CID>  (127) 


>  <BOM_1A2>  (127) 


>  <BOM_2A6>  (127) 


>  <BOM_2B6>  (127) 


>  <BOM_2C8>  (127) 


>  <BOM_2C9>  (127) 


>  <BOM_2C19>  (127) 


>  <BOM_2D6>  (127) 
<1,H;Hydroxylation;R1>

>  <BOM_2E1>  (127) 


>  <BOM_3A4>  (127) 
<24,25;Dealkylation;R1><25,H;Dealkylation;R1>

>  <References>  (127) 
(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423 || (R3) Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987 || (R4) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015
Ref: Hussaarts, K. G. A. M. Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen. Cancers 2019 11 (3), 403.

>  <FLAG_COMMENTS>  (127) 


>  <ID>  (127) 
N-Desmethyltamoxifen

>  <Comment>  (127) 


>  <smile>  (127) 
[cH:1]1[cH:2][cH:3][c:4](/[C:7](=[C:8](/[c:9]2[cH:10][cH:11][cH:12][cH:13][cH:14]2)[CH2:15][CH3:16])[c:17]2[cH:18][cH:19][c:20]([O:21][CH2:22][CH2:23][NH:24][CH3:25])[cH:26][cH:27]2)[cH:5][cH:6]1

$$$$
Nimodipine
     RDKit          2D

 30 31  0  0  0  0  0  0  0  0999 V2000
   -6.8305    0.9929    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -7.5450    0.5804    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -7.5450   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -8.2595   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -8.9740   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -8.9740    0.5804    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -8.2595    0.9929    0.0000 N   0  0  0  0  0  0  0  0  0  7  0  0
   -9.6884    0.9929    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -9.6884   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -9.6884   -1.4821    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
  -10.4029   -0.2446    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
  -11.1174   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
  -11.8318   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
  -11.1174   -1.4821    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -8.2595   -1.4821    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -7.5450   -1.8946    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -7.5450   -2.7196    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -8.2595   -3.1321    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -8.9740   -2.7196    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -8.9740   -1.8946    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -6.8305   -3.1321    0.0000 N   0  0  0  0  0  4  0  0  0 21  0  0
   -6.8305   -3.9571    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
   -6.1161   -2.7196    0.0000 O   0  0  0  0  0  1  0  0  0 23  0  0
   -6.8305   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -6.8305   -1.4821    0.0000 O   0  0  0  0  0  0  0  0  0 25  0  0
   -6.1161   -0.2446    0.0000 O   0  0  0  0  0  0  0  0  0 26  0  0
   -5.4016   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -4.6871   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -3.9727   -0.6571    0.0000 O   0  0  0  0  0  0  0  0  0 29  0  0
   -3.2582   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  1  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
  4 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 15 20  1  0
 17 21  1  0
 21 22  2  0
 21 23  1  0
  3 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
M  CHG  2  21   1  23  -1
M  END
>  <InChIKey>  (128) 
UIAGMCDKSXEBJQ-UHFFFAOYSA-N

>  <PubChem_CID>  (128) 


>  <BOM_1A2>  (128) 


>  <BOM_2A6>  (128) 


>  <BOM_2B6>  (128) 


>  <BOM_2C8>  (128) 


>  <BOM_2C9>  (128) 


>  <BOM_2C19>  (128) 


>  <BOM_2D6>  (128) 


>  <BOM_2E1>  (128) 


>  <BOM_3A4>  (128) 
<2,7;Rearrangement;R1><2,3;Rearrangement;R1><3,4;Rearrangement;R1><4,5;Rearrangement;R1><5,6;Rearrangement;R1><6,7;Rearrangement;R1><4,H;DehydrogenationR1><7,H;DehydrogenationR1>
<29,30;Dealkylation;R2><30,H;Dealkylation;R2>

>  <References>  (128) 
PMID: 22469047 

>  <FLAG_COMMENTS>  (128) 


>  <ID>  (128) 
Nimodipine

>  <Comment>  (128) 


>  <smile>  (128) 
[CH3:1][C:2]1=[C:3]([C:24](=[O:25])[O:26][CH2:27][CH2:28][O:29][CH3:30])[CH:4]([c:15]2[cH:16][c:17]([N+:21](=[O:22])[O-:23])[cH:18][cH:19][cH:20]2)[C:5]([C:9](=[O:10])[O:11][CH:12]([CH3:13])[CH3:14])=[C:6]([CH3:8])[NH:7]1

$$$$
Asunaprevir
     RDKit          2D

 51 55  0  0  1  0  0  0  0  0999 V2000
    1.6500    1.2766    0.0000 Cl  0  0  0  0  0  0  0  0  0  1  0  0
   10.3495   -0.5410    0.0000 S   0  0  0  0  0  6  0  0  0  2  0  0
    8.7086   -0.7136    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   11.0170   -0.0561    0.0000 O   0  0  0  0  0  0  0  0  0  4  0  0
    9.6821   -1.0260    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    7.8880   -0.7998    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    4.5624    0.4715    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
    7.3262   -1.7730    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    3.8949   -2.8492    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    5.0509   -3.6890    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
    4.5624    3.7715    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    7.7387    0.6214    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    9.8646    0.1264    0.0000 N   0  0  0  0  0  0  0  0  0 13  0  0
    6.1701   -0.9330    0.0000 N   0  0  0  0  0  0  0  0  0 14  0  0
    5.2003   -2.2680    0.0000 N   0  0  0  0  0  0  0  0  0 15  0  0
    5.2769    1.7090    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
    8.5592    0.7076    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    8.4730    1.5281    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    9.2266    1.1926    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    9.0441    0.0402    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   10.8345   -1.2085    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    7.9880    2.1955    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   11.5881   -1.5441    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   10.9207   -2.0290    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    6.5826   -0.2185    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    7.4032   -0.1323    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    6.0306    0.3945    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    5.2769    0.0590    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    5.3632   -0.7615    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    8.3235    2.9493    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
    6.5057   -1.6867    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
    6.0208   -2.3542    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
    6.3563   -3.1078    0.0000 C   0  0  0  0  0  0  0  0  0 33  0  0
    6.6918   -3.8616    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
    5.6027   -3.4434    0.0000 C   0  0  0  0  0  0  0  0  0 35  0  0
    7.1100   -2.7723    0.0000 C   0  0  0  0  0  0  0  0  0 36  0  0
    4.5624    1.2965    0.0000 C   0  0  0  0  0  0  0  0  0 37  0  0
    4.7154   -2.9354    0.0000 C   0  0  0  0  0  0  0  0  0 38  0  0
    3.8479    1.7090    0.0000 C   0  0  0  0  0  0  0  0  0 39  0  0
    3.8479    2.5340    0.0000 C   0  0  0  0  0  0  0  0  0 40  0  0
    3.1105    1.2679    0.0000 C   0  0  0  0  0  0  0  0  0 41  0  0
    5.2769    2.5340    0.0000 C   0  0  0  0  0  0  0  0  0 42  0  0
    4.5624    2.9465    0.0000 C   0  0  0  0  0  0  0  0  0 43  0  0
    3.4099   -3.5166    0.0000 C   0  0  0  0  0  0  0  0  0 44  0  0
    3.1105    2.9752    0.0000 C   0  0  0  0  0  0  0  0  0 45  0  0
    2.3629    1.6919    0.0000 C   0  0  0  0  0  0  0  0  0 46  0  0
    2.3629    2.5512    0.0000 C   0  0  0  0  0  0  0  0  0 47  0  0
    2.9250   -4.1840    0.0000 C   0  0  0  0  0  0  0  0  0 48  0  0
    2.7425   -3.0317    0.0000 C   0  0  0  0  0  0  0  0  0 49  0  0
    4.0774   -4.0016    0.0000 C   0  0  0  0  0  0  0  0  0 50  0  0
    5.2769    4.1840    0.0000 C   0  0  0  0  0  0  0  0  0 51  0  0
  1 46  1  0
  2  4  2  0
  2  5  2  0
  2 13  1  0
  2 21  1  0
  3 20  2  0
  6 26  2  0
 28  7  1  6
  7 37  1  0
  8 31  2  0
  9 38  1  0
  9 44  1  0
 10 38  2  0
 11 43  1  0
 11 51  1  0
 17 12  1  1
 12 26  1  0
 13 20  1  0
 14 25  1  0
 14 29  1  0
 14 31  1  0
 32 15  1  6
 15 38  1  0
 16 37  2  0
 16 42  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 18 19  1  0
 18 22  1  6
 21 23  1  0
 21 24  1  0
 22 30  2  0
 23 24  1  0
 25 26  1  1
 25 27  1  0
 27 28  1  0
 28 29  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 33 35  1  0
 33 36  1  0
 37 39  1  0
 39 40  2  0
 39 41  1  0
 40 43  1  0
 40 45  1  0
 41 46  2  0
 42 43  2  0
 44 48  1  0
 44 49  1  0
 44 50  1  0
 45 47  2  0
 46 47  1  0
M  END
>  <InChIKey>  (129) 
XRWSZZJLZRKHHD-WVWIJVSJSA-N

>  <PubChem_CID>  (129) 
16076883

>  <BOM_1A2>  (129) 


>  <BOM_2A6>  (129) 


>  <BOM_2B6>  (129) 


>  <BOM_2C8>  (129) 


>  <BOM_2C9>  (129) 


>  <BOM_2C19>  (129) 


>  <BOM_2D6>  (129) 


>  <BOM_2E1>  (129) 


>  <BOM_3A4>  (129) 
<11,51;Dealkylation;R1><51,H;Dealkylation;R1>

>  <References>  (129) 
Gong, Jiachang, et al. "Characterization of ADME properties of [14C] asunaprevir (BMS-650032) in humans." Xenobiotica 46.1 (2016): 52-64.

>  <FLAG_COMMENTS>  (129) 


>  <ID>  (129) 
Asunaprevir

>  <Comment>  (129) 


>  <smile>  (129) 
[Cl:1][c:46]1[cH:41][c:39]2[c:37]([O:7][C@@H:28]3[CH2:27][C@@H:25]([C:26](=[O:6])[NH:12][C@@:17]4([C:20](=[O:3])[NH:13][S:2](=[O:4])(=[O:5])[CH:21]5[CH2:23][CH2:24]5)[C@H:18]([CH:22]=[CH2:30])[CH2:19]4)[N:14]([C:31](=[O:8])[C@@H:32]([NH:15][C:38]([O:9][C:44]([CH3:48])([CH3:49])[CH3:50])=[O:10])[C:33]([CH3:34])([CH3:35])[CH3:36])[CH2:29]3)[n:16][cH:42][c:43]([O:11][CH3:51])[c:40]2[cH:45][cH:47]1

$$$$
Brinzolamide
     RDKit          3D

 23 24  0  0  1  0  0  0  0  0999 V2000
    0.3779    1.9156    0.2123 S   0  0  1  0  0  6  0  0  0  1  0  0
   -2.4299    1.2981   -0.5663 S   0  0  0  0  0  0  0  0  0  2  0  0
   -4.8382   -0.3542   -0.7189 S   0  0  2  0  0  6  0  0  0  3  0  0
    0.0031    2.9006    1.2068 O   0  0  0  0  0  0  0  0  0  4  0  0
    0.6748    2.2729   -1.1591 O   0  0  0  0  0  0  0  0  0  5  0  0
    4.9963    0.2262   -1.6965 O   0  0  0  0  0  0  0  0  0  6  0  0
   -4.9839    0.5548   -1.8501 O   0  0  0  0  0  0  0  0  0  7  0  0
   -5.0573   -1.7855   -0.8849 O   0  0  0  0  0  0  0  0  0  8  0  0
    1.6264    0.8905    0.8366 N   0  0  0  0  0  0  0  0  0  9  0  0
    0.8178   -1.9944    0.4003 N   0  0  0  0  0  0  0  0  0 10  0  0
   -5.8634    0.2080    0.5397 N   0  0  0  0  0  0  0  0  0 11  0  0
    0.1690   -1.0986    1.3614 C   0  0  1  0  0  0  0  0  0 12  0  0
    1.1831   -0.0653    1.9140 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.0195   -0.4696    0.6789 C   0  0  0  0  0  0  0  0  0 14  0  0
   -0.9828    0.8035    0.1521 C   0  0  0  0  0  0  0  0  0 15  0  0
    2.9153    1.5523    1.1476 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.3080   -1.0543    0.4741 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.8244    1.5418   -0.0736 C   0  0  0  0  0  0  0  0  0 18  0  0
   -3.1679   -0.2049   -0.1928 C   0  0  0  0  0  0  0  0  0 19  0  0
    1.9832   -2.6285    0.9953 C   0  0  0  0  0  0  0  0  0 20  0  0
    4.1325    0.1345   -0.5713 C   0  0  0  0  0  0  0  0  0 21  0  0
    2.6451   -3.5866    0.0196 C   0  0  0  0  0  0  0  0  0 22  0  0
    5.3020   -1.0570   -2.2251 C   0  0  0  0  0  0  0  0  0 23  0  0
  1  4  2  0
  1  5  2  0
  1  9  1  1
  1 15  1  0
  2 15  1  0
  2 19  1  0
  3  7  2  0
  3  8  2  0
  3 11  1  1
  3 19  1  0
  6 21  1  0
  6 23  1  0
  9 13  1  0
  9 16  1  0
 12 10  1  6
 10 20  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 14 17  1  0
 16 18  1  0
 17 19  2  0
 18 21  1  0
 20 22  1  0
M  END
>  <InChIKey>  (130) 
HCRKCZRJWPKOAR-JTQLQIEISA-N

>  <PubChem_CID>  (130) 
68844

>  <BOM_1A2>  (130) 


>  <BOM_2A6>  (130) 


>  <BOM_2B6>  (130) 


>  <BOM_2C8>  (130) 


>  <BOM_2C9>  (130) 


>  <BOM_2C19>  (130) 


>  <BOM_2D6>  (130) 


>  <BOM_2E1>  (130) 


>  <BOM_3A4>  (130) 
<10,20;Dealkylation;R1><20,H;Dealkylation;R1>
<16,9;Dealkylation;R2><16,H;Dealkylation;R2>

>  <References>  (130) 
Rendic, Slobodan. "Summary of information on human CYP enzymes: human P450 metabolism data." Drug metabolism reviews 34.1-2 (2002): 83-448.

>  <FLAG_COMMENTS>  (130) 


>  <ID>  (130) 
Brinzolamide

>  <Comment>  (130) 


>  <smile>  (130) 
[S@:1]1(=[O:4])(=[O:5])[N:9]([CH2:16][CH2:18][CH2:21][O:6][CH3:23])[CH2:13][C@H:12]([NH:10][CH2:20][CH3:22])[c:14]2[c:15]1[s:2][c:19]([S@@:3](=[O:7])(=[O:8])[NH2:11])[cH:17]2

$$$$
Primaquine
     RDKit          3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -2.5851   -2.8603   -0.7778 O   0  0  0  0  0  0  0  0  0  1  0  0
    1.0285   -0.0521    0.6669 N   0  0  0  0  0  0  0  0  0  2  0  0
    5.4330    1.4442   -1.7003 N   0  0  0  0  0  0  0  0  0  3  0  0
   -0.6563    2.1552    0.5203 N   0  0  0  0  0  0  0  0  0  4  0  0
    1.9458   -1.1688    0.7589 C   0  0  1  0  0  0  0  0  0  5  0  0
    3.3965   -0.6686    0.7311 C   0  0  0  0  0  0  0  0  0  6  0  0
    3.7125    0.1505   -0.5265 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.6566   -1.9312    2.0478 C   0  0  0  0  0  0  0  0  0  8  0  0
   -0.2918   -0.1773    0.2736 C   0  0  0  0  0  0  0  0  0  9  0  0
    5.1435    0.6856   -0.4890 C   0  0  0  0  0  0  0  0  0 10  0  0
   -1.1455    0.9423    0.2000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.7991   -1.4537   -0.0613 C   0  0  0  0  0  0  0  0  0 12  0  0
   -2.4847    0.7633   -0.2056 C   0  0  0  0  0  0  0  0  0 13  0  0
   -2.1192   -1.6228   -0.4600 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.9620   -0.5173   -0.5326 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.3113    1.8931   -0.2698 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.8100    3.1442    0.0596 C   0  0  0  0  0  0  0  0  0 17  0  0
   -1.4870    3.2201    0.4452 C   0  0  0  0  0  0  0  0  0 18  0  0
   -1.6646   -3.9466   -0.6804 C   0  0  0  0  0  0  0  0  0 19  0  0
  1 14  1  0
  1 19  1  0
  2  5  1  0
  2  9  1  0
  3 10  1  0
  4 11  2  0
  4 18  1  0
  5  6  1  0
  5  8  1  1
  6  7  1  0
  7 10  1  0
  9 11  1  0
  9 12  2  0
 11 13  1  0
 12 14  1  0
 13 15  1  0
 13 16  2  0
 14 15  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <InChIKey>  (131) 
INDBQLZJXZLFIT-UHFFFAOYSA-N

>  <PubChem_CID>  (131) 
4908

>  <BOM_1A2>  (131) 


>  <BOM_2A6>  (131) 


>  <BOM_2B6>  (131) 


>  <BOM_2C8>  (131) 


>  <BOM_2C9>  (131) 


>  <BOM_2C19>  (131) 


>  <BOM_2D6>  (131) 
<18,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<16,H;Hydroxylation;R3>
<15,H;Hydroxylation;R4>
<12,H;Hydroxylation;R5>

>  <BOM_2E1>  (131) 


>  <BOM_3A4>  (131) 
<10,3;Dealkylation;R1><10,H;Dealkylation;R1>

>  <References>  (131) 
Rendic, Slobodan. "Summary of information on human CYP enzymes: human P450 metabolism data." Drug metabolism reviews 34.1-2 (2002): 83-448.
Marcsisin, S. R., Reichard, G., & Pybus, B. S. (2016). Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: current state of the art. Pharmacology & therapeutics, 161, 1-10.

>  <FLAG_COMMENTS>  (131) 
It should also be a substrate for CYP2D6 and reported as substrate for CYP2A6 in some other paper. The corresponding metabolites/metabolic pathways can not be identified.

>  <ID>  (131) 
Primaquine

>  <Comment>  (131) 


>  <smile>  (131) 
[O:1]([c:14]1[cH:12][c:9]([NH:2][C@@H:5]([CH2:6][CH2:7][CH2:10][NH2:3])[CH3:8])[c:11]2[n:4][cH:18][cH:17][cH:16][c:13]2[cH:15]1)[CH3:19]

$$$$
thioridazine
     RDKit          3D

 25 28  0  0  0  0  0  0  0  0999 V2000
   -0.9640    0.8750    0.5140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -0.4900    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9660   -0.9560    1.9930 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2420    1.4560    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -1.4430    0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    0.7390    1.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1130    1.7600    0.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4150    3.5460   -2.7700 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1700   -0.9020   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.2420   -1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3120    3.1940   -1.3480 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.5680   -2.7940    0.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -2.2540   -0.7700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6850   -2.7690   -1.8460 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5840   -3.2010   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4880    2.3410   -3.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5630    4.4280   -3.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4720    2.7920    0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    1.3590    1.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930    4.4630   -0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -4.5780   -1.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3800    5.7340   -2.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560    3.4020    0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6200    2.6890    1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2650    5.4220   -0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  1  7  1  0
  2  5  2  0
  2  9  1  0
  3  5  1  0
  3  6  1  0
  4  6  2  0
  4 18  1  0
  5 12  1  0
  6 19  1  0
  7 10  1  0
  8 11  1  0
  8 16  1  0
  8 17  1  0
  9 13  2  0
 11 10  1  6
 11 20  1  0
 12 15  2  0
 13 14  1  0
 13 15  1  0
 14 21  1  0
 17 22  1  0
 18 23  2  0
 19 24  2  0
 20 25  1  0
 22 25  1  0
 23 24  1  0
M  END
>  <InChIKey>  (132) 
KLBQZWRITKRQQV-MRXNPFEDSA-N

>  <PubChem_CID>  (132) 
6604030

>  <BOM_1A2>  (132) 
<14,S;S-Oxidation;R1>
<3,S;S-Oxidation;R2>
<16,8;Dealkylation;R3><16,H;Dealkylation;R3>

>  <BOM_2A6>  (132) 
<3,S;S-Oxidation;R1>

>  <BOM_2B6>  (132) 
<3,S;S-Oxidation;R1>
<14,S;S-Oxidation;R2>

>  <BOM_2C8>  (132) 


>  <BOM_2C9>  (132) 
<3,S;S-Oxidation;R1>
<14,S;S-Oxidation;R2>

>  <BOM_2C19>  (132) 
<14,S;S-Oxidation;R1>
<3,S;S-Oxidation;R2>
<16,8;Dealkylation;R3><16,H;Dealkylation;R3>

>  <BOM_2D6>  (132) 
<14,S;S-Oxidation;R1>
<3,S;S-Oxidation;R2>
<16,8;Dealkylation;R3><16,H;Dealkylation;R3>

>  <BOM_2E1>  (132) 
<3,S;S-Oxidation;R1>

>  <BOM_3A4>  (132) 
<14,S;S-Oxidation;R1>
<3,S;S-Oxidation;R2>
<16,8;Dealkylation;R3><16,H;Dealkylation;R3>

>  <References>  (132) 
Wojcikowski,Drug Metab. Disp.,34,471,2006 PMID:16272405
Wojcikowski et al.,Drug Metab. Disp.,34,471,2006

>  <FLAG_COMMENTS>  (132) 


>  <ID>  (132) 
thioridazine

>  <Comment>  (132) 


>  <smile>  (132) 
CSc1ccc2c(c1)N(CC[C@H]1CCCCN1C)c1ccccc1S2

$$$$
DMBA
     RDKit          2D

 20 23  0  0  0  0  0  0  0  0999 V2000
    1.0720    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 14  2  0
  1 18  1  0
  2  3  2  0
  2 15  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 14  1  0
  6  7  2  0
  6 20  1  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 19  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <InChIKey>  (133) 
ARSRBNBHOADGJU-UHFFFAOYSA-N

>  <PubChem_CID>  (133) 
6001

>  <BOM_1A2>  (133) 
<3,4;Epoxidation;R1>
<8,9;Epoxidation;R2>
<15,16;Epoxidation;R3>
<19,H;Hydroxylation;R4>
<20,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <BOM_2A6>  (133) 


>  <BOM_2B6>  (133) 
<3,4;Epoxidation;R1>
<8,9;Epoxidation;R2>
<15,16;Epoxidation;R3>
<19,H;Hydroxylation;R4>
<20,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <BOM_2C8>  (133) 
<3,4;Epoxidation;R1>
<8,9;Epoxidation;R2>
<15,16;Epoxidation;R3>
<19,H;Hydroxylation;R4>
<20,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <BOM_2C9>  (133) 
<3,4;Epoxidation;R1>
<8,9;Epoxidation;R2>
<15,16;Epoxidation;R3>
<19,H;Hydroxylation;R4>
<20,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <BOM_2C19>  (133) 


>  <BOM_2D6>  (133) 


>  <BOM_2E1>  (133) 
<3,4;Epoxidation;R1>
<8,9;Epoxidation;R2>
<19,H;Hydroxylation;R3>
<20,H;Hydroxylation;R4>
<17,H;Hydroxylation;R5>
<15,H;Hydroxylation;R6>

>  <BOM_3A4>  (133) 
<3,4;Epoxidation;R1>
<8,9;Epoxidation;R2>
<15,16;Epoxidation;R3>
<19,H;Hydroxylation;R4>
<20,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <References>  (133) 
Shou, M.; Korzekwa, K.R.; Krausz, K.W.; Buters, J.T.; Grogan, J.; Goldfarb, I.; Ardwick, J.P.H.; Gonzalez, F.J.; Gelboin, H.V. Specificity of cDNA-Expressed Human and Rodent Cytochrome P450s in the Oxidative Metabolism of the Potent Carcinogen 7,12-Dimethylbenz[a]anthracene. Mol. Carcinog. 1996, 17, 241-249. 

>  <FLAG_COMMENTS>  (133) 


>  <ID>  (133) 
DMBA

>  <Comment>  (133) 


>  <smile>  (133) 
Cc1c2ccccc2c(C)c2c1ccc1ccccc12

$$$$
NNK
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450   -0.6570   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3060   -0.0310   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740    1.3520   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2030    2.0870    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.1250    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2980    3.3380    0.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5960    1.3670    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7630    2.3580    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0850    1.5880    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2020    2.5370    0.0450 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6820    3.0880    1.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7620    2.8860   -1.0630 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6900    3.6740   -1.0540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
M  END
>  <InChIKey>  (134) 
FLAQQSHRLBFIEZ-UHFFFAOYSA-N

>  <PubChem_CID>  (134) 
47289

>  <BOM_1A2>  (134) 
<11,12;Dealkylation;R1><11,H;Dealkylation;R1>
<13,H;Dealkylation;R2><13,12;Dealkylation;R2><11,12;Dealkylation;R2>

>  <BOM_2A6>  (134) 
<11,12;Dealkylation;R1><11,H;Dealkylation;R1>
<13,H;Dealkylation;R2><13,12;Dealkylation;R2><11,12;Dealkylation;R2>
<3,N;N-Oxidation;R3>

>  <BOM_2B6>  (134) 


>  <BOM_2C8>  (134) 
<11,12;Dealkylation;R1><11,H;Dealkylation;R1>
<13,H;Dealkylation;R2><13,12;Dealkylation;R2><11,12;Dealkylation;R2>
<3,N;N-Oxidation;R3>

>  <BOM_2C9>  (134) 
<3,N;N-Oxidation;R1>

>  <BOM_2C19>  (134) 


>  <BOM_2D6>  (134) 
<3,N;N-Oxidation;R1>

>  <BOM_2E1>  (134) 
<11,12;Dealkylation;R1><11,H;Dealkylation;R1>
<13,H;Dealkylation;R2><13,12;Dealkylation;R2><11,12;Dealkylation;R2>
<3,N;N-Oxidation;R3>

>  <BOM_3A4>  (134) 
<11,12;Dealkylation;R1><11,H;Dealkylation;R1>
<3,N;N-Oxidation;R2>

>  <References>  (134) 
Staretz et al.,Drug Metab. Disp.,25,154,1997 PMID: 9029045
Smith, T.J.; Guo, Z.Y.; Guengerich, F.P.; Yung, C.S. Metabolism of 4-Methylnitrosamino-1(3-pyridyl)1-butanone (NNK) by Human Cytochrome P4501A2 and Its Inhibition by Phenethyl Isothiocyanate. Carcinogenesis 1996, 17, 809-813. PMID: 8625495
Smith et al.,Canc. Res.,52,1757,1992

>  <FLAG_COMMENTS>  (134) 
Followed Xenosite
### Check, Need to update

>  <ID>  (134) 
NNK

>  <Comment>  (134) 


>  <smile>  (134) 
CN(CCCC(=O)c1cccnc1)N=O

$$$$
diazepam
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.6960   -2.6210    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480   -1.4280    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6990   -0.2110    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3780   -0.2110   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2740   -1.4340   -0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3840   -2.6240   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4340   -4.1300   -0.4890 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3810    1.0230   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4190    0.9480    0.4870 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2840    0.9660    1.6700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1000    2.9820    0.0240 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870    2.0450   -0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4880    2.1530   -1.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0960    2.0770   -1.0260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8020    1.0530   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2530    0.2050    0.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6940    1.9320   -0.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5780    0.2380    1.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0160    1.9560   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4580    1.1090    0.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  6  7  1  0
  8 14  2  0
  8 15  1  0
  9 10  1  0
  9 12  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 15 16  2  0
 15 17  1  0
 16 18  1  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
M  END
>  <InChIKey>  (135) 
AAOVKJBEBIDNHE-UHFFFAOYSA-N

>  <PubChem_CID>  (135) 
3016

>  <BOM_1A2>  (135) 


>  <BOM_2A6>  (135) 


>  <BOM_2B6>  (135) 
<10,9;Dealkylation;R1><10,H;Dealkylation;R1>

>  <BOM_2C8>  (135) 
<10,9;Dealkylation;R1><10,H;Dealkylation;R1>

>  <BOM_2C9>  (135) 
<10,9;Dealkylation;R1><10,H;Dealkylation;R1>

>  <BOM_2C19>  (135) 
<10,9;Dealkylation;R1><10,H;Dealkylation;R1>
<13,H;Hydroxylation;R2>

>  <BOM_2D6>  (135) 


>  <BOM_2E1>  (135) 


>  <BOM_3A4>  (135) 
<10,9;Dealkylation;R1><10,H;Dealkylation;R1>
<13,H;Hydroxylation;R2>

>  <References>  (135) 
Yang et al.,Drug Metab. Disp.,27,102,1999

>  <FLAG_COMMENTS>  (135) 


>  <ID>  (135) 
diazepam

>  <Comment>  (135) 


>  <smile>  (135) 
CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21

$$$$
